WO2006103107A1 - Phosphorylated waxy potato starch - Google Patents

Phosphorylated waxy potato starch Download PDF

Info

Publication number
WO2006103107A1
WO2006103107A1 PCT/EP2006/003027 EP2006003027W WO2006103107A1 WO 2006103107 A1 WO2006103107 A1 WO 2006103107A1 EP 2006003027 W EP2006003027 W EP 2006003027W WO 2006103107 A1 WO2006103107 A1 WO 2006103107A1
Authority
WO
WIPO (PCT)
Prior art keywords
starch
potato
seq
plants
gene
Prior art date
Application number
PCT/EP2006/003027
Other languages
French (fr)
Inventor
Stephan Soyka
Jens Pilling
Claus Frohberg
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Priority to EP06723985.5A priority Critical patent/EP1869089B1/en
Priority to US11/909,926 priority patent/US8148517B2/en
Priority to CA2600989A priority patent/CA2600989C/en
Priority to AU2006228670A priority patent/AU2006228670B2/en
Publication of WO2006103107A1 publication Critical patent/WO2006103107A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • C12N9/1071,4-Alpha-glucan branching enzyme (2.4.1.18)

Definitions

  • the present invention relates to potato starches having an amylose content of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per milligram of starch and an increased content of side chains having a DP of from 12 to 19 as compared with the potato starch from corresponding wild-type potato plants.
  • polysaccharide starch is composed of chemically uniform basic units, i.e. the glucose molecules, it is a complex mixture of different molecular forms which exhibit differences with regard to the degree of polymerization and branching and consequently differ greatly from each other in their physicochemical properties.
  • amylose starch an essentially unbranched polymer composed of alpha-1 ,4-glycosidically linked glucose units
  • amylopectin starch a branched polymer in which the branches are formed as a result of the appearance of additional alpha-1 ,6-glycosidic linkages.
  • Another important difference between amylose and amylopectin lies in their molecular weights.
  • amylose depending on the origin of the starch, has a molecular weight of 5 ⁇ 10 5 - 10 6 Da, the molecular weight of amylopectin is between 10 7 and 10 8 Da.
  • the two macromolecules can be differentiated by their molecular weight and their different physicochemical properties, something which can most readily be visualized by their different iodine- binding properties.
  • Amylose was regarded for a long time as being a linear polymer which consisted of alpha-1 ,4-glycosidically linked alpha-D-glucose monomers. However, more recent studies have demonstrated the presence of a small proportion of alpha-1 ,6-glycosidic branching points (approx. 0.1%) (Hizukuri and Takagi, Carbohydr. Res. 134 (1984), 1-10; Takeda et al., Carbohydr. Res. 132, (1984), 83-92).
  • Amylopectin constitutes a complex mixture composed of glucose chains which are branched differently. Amylopectin is more strongly branched than amylose.
  • the functional properties such as the solubility, the retrogradation behavior, the ability to bind water, the film-forming properties, the viscosity, the pasting properties, the freeze/thaw stability, the acid stability, the gel strength and the starch grain size of starches are influenced, inter alia, by the amylose/amylopectin ratio, the molecular weight, the pattern of side chain distribution of the amylopectin, the content of ions, the content of lipid and protein, the mean starch grain size, the starch grain morphology, etc.
  • the functional properties of starch are also influenced by the content of phosphate, in the starch.
  • starch phosphate The content of starch phosphate varies in dependence on the plant type. Thus, for example, certain corn mutants synthesize a starch having an elevated content of starch phosphate (waxy corn 0.002% and high-amylose corn 0.013%) whereas conventional corn types only exhibit traces of starch phosphate. Small quantities of starch phosphate are also found in wheat (0.001%) whereas it has not been possible to detect any starch phosphate in oats and sorghum. Relatively large quantities of starch phosphate have thus far been detected in tuber or root storage starch, for example tapioca (0.008%), sweet potato (0.011%), arrowroot (0.021%) or potato (0.089%).
  • Starch phosphate can be present in the form of monoesters at the C2, C3 or C6 position in the polymerized glucose monomers (Takeda and Hizukuri, 1971 , Starch/Starke 23, 267-272). In general, from about 30% to 40% of the covalently bound starch phosphate groups are located in the C3 position, and from about 60% to 70% are located in the C6 position, in the glucose monomers (Blennow et al., 2000, Int. J. of Biological Macromolecules 27, 211-218).
  • Potato amylopectin starches i.e. starches having an amylopectin content of more than 90% and an amylose content of less than 10%, can be obtained from potato plants in which the activity of the starch granule-bound starch synthase GBSSI ("Granule-Bound Starch Synthase I") is reduced (Shure et al., 1983, Cell 35, 225-233; Hovenkamp-Hermelink et al., 1987, Theoretical and Applied Genetics 75, 217-221 ; Visser et al., 1991 , MoI. Gen. Genet. 225, 289-296). GBSSI is involved in the formation of amylose.
  • GBSSI is involved in the formation of amylose.
  • starch from these plants exhibits a relative shift of the amylopectin side chains from relatively long chains to short chains (Lloyd et al., 1999, Biochemical Journal 338, 515-521), an increased content of phosphate, no change in the amylose content (Abel et al., 1996, The Plant Journal 10(6), 9891- 9991) and a reduced final viscosity in the RVA analysis (Abel, 1995, Berlin Free University thesis).
  • WO 01/19975 describes plants in which the GBSSI and the SSII and/or SSIII activities are reduced. As compared with starch from wild-type potatoes, starch from potatoes having reduced activities of GBSSI, SSII and SSIII exhibit a lower amylose content, altered swellability and pasting properties and higher freeze/thaw stability.
  • WO 01/12782 describes plants in which both the GBSSI activity and the BEI activity are reduced. Starch from these potato plants exhibits a reduced amylose content as compared with potato starch from wild-type plants and an elevated phosphate content and/or a reduced pasting temperature in the RVA analysis as compared with potato starch from plants having the waxy phenotype.
  • WO 00/08184 describes, inter alia, plants in which both the SSIII activity and the BEI activity are reduced. Starch from these plants exhibits a markedly elevated phosphate content as compared with starch from wild- type plants.
  • the present invention is based on the object of making available potato amylopectin starches having novel properties, novel plant cells and/or plants which produce the starches, as well as means and methods for generating said plant cells and/or plants.
  • the present invention relates to potato starches which have an amylose content, as measured by the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight and a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per mg of starch (dry weight), and an elevated content of side chains having a DP of from 12 to 19 as compared with potato starch derived from corresponding wild-type potato plants.
  • the present invention furthermore relates to potato starches which have an amylose content, as measured by the method ("General methods") of Hovenkamp-Hermelink et al.
  • the present invention furthermore relates to potato starches which have an amylose content, as measured by the method ("General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per mg of starch (dry weight) and a shear stability of 58% to 80%, in particular of 60% to 78%, preferably of 66% to 77%, particularly preferably of 67% to 75%.
  • an amylose content as measured by the method (“General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per mg of starch (dry weight) and a shear stability of 58% to 80%, in particular of 60% to 78%, preferably of 66% to 77%, particularly preferably of 67% to 75%.
  • the present invention furthermore relates to potato starches which have an amylose content, as measured by the method ("General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight and a peak viscosity determined by the Rotovisko method of 332 SKT to 500 SKT, in particular of 345 SKT - 450 SKT, preferably of 360 SKT to 420 SKT and particularly preferably of 370 SKT to 400 SKT.
  • an amylose content as measured by the method (“General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight and a peak viscosity determined by the Rotovisko method of 332 SKT to 500 SKT, in particular of 345 SKT - 450 SKT, preferably of 360 SKT to 420 SKT and particularly preferably of 370 SKT to 400 SKT.
  • the present invention furthermore relates to potato starches which have an amylose content, as measured by the method ("General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight, a phosphate content in the C6 position of between 35 and IOO nmol of phosphate per mg of starch (dry weight) and a peak viscosity determined by the Rotovisko method of 332 SKT to 500 SKT, in particular of 345 SKT - 450 SKT, preferably of 360 SKT to 420 SKT and particularly preferably of 370 SKT to 400 SKT.
  • an amylose content as measured by the method (“General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight, a phosphate content in the C6 position of between 35 and IOO nmol of phosphate per mg of starch (dry weight) and a peak viscosity determined by the Rotovisko
  • amylose content is determined using the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), which is described below for potato starch. This method can also be applied to starches which are isolated from other plant species. Methods for isolating starches are known to the skilled person and are described in detail below in the "General methods" section.
  • phosphate content in the C6 position is to be understood as meaning the content of phosphate groups which are covalently bonded to carbon atom position 6 in the glucose monomers in the starch.
  • the C2, C3 and C6 positions in the glucose units can be phosphorylated in the starch in vivo.
  • total phosphate content is to be understood as meaning the quantity of starch phosphate which is in total covalently bonded to glucose molecules in the starch.
  • the total phosphate content is determined using the method which is described below ("General methods: determining the total phosphate content").
  • the side chain distribution in the starch is determined as described below in the section entitled "General methods: using gel permeation chromatography to analyze the side chain distribution in total starch".
  • wild-type potato plant cell means that the cells are potato plant cells which were used as the starting material for producing the plant cells according to the invention, i.e. their genetic information corresponds, apart from the genetic modification which has been introduced, to that of a plant cell according to the invention.
  • wild-type potato plant means that the plants are plants which were used as the starting material for producing the plants according to the invention which are described below, i.e. their genetic information corresponds, apart from the genetic modification which has been introduced, to that of a plant according to the invention.
  • the term "corresponding" means that, when comparing several objects, the objects in question, which are being compared with each other, were maintained under identical conditions.
  • the term “corresponding” means that, when comparing several objects, the objects in question, which are being compared with each other, were maintained under identical conditions.
  • corresponding means, with regard to wild-type plant cells or wild-type plants, in particular, that the plant cells or plants which are being compared with each other were grown under identical culture conditions and that they are of the same (culture) age.
  • the potato starches according to the invention have an amylose content, as measured using the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 5% by weight, particularly preferably of less than 3% by weight.
  • the potato starch according to the invention has an elevated phosphate content in the C6 position of 40-85 nmol of C6-P per mg of starch, particularly preferably of 45-70 nmol of C6-P per mg of starch, very particularly preferably of 50- 65 nmol of C6-P per mg of starch.
  • the potato starch according to the invention exhibits an elevated phosphate content as compared with that in potato starch derived from corresponding wild-type potato plants.
  • the term "elevated phosphate content” means that the phosphate content in the C6 position in the starch according to the invention is elevated, in particular elevated by 415%-520%, preferably by 430%-500%, and particularly preferably by
  • the potato starch according to the invention exhibits an "elevated content of side chains having a DP of ⁇ 12".
  • the potato starch according to the invention exhibits an "elevated content of side chains having a DP of 20-25".
  • this means an increase in the proportion of the sum of side chains in the starch having a DP ( degree of polymerization) of 20-25 to 132%-160%, preferably to 136%- 150%, and particularly preferably to 139%-148%, as compared with the proportion of side chains having a DP of 20-25 (100%) in potato starch which is derived from corresponding wild-type potato plants.
  • the potato starch according to the invention exhibits a "reduced content of side chains having a DP of
  • the potato starches according to the invention exhibit a "reduced content of side chains having a DP of >123".
  • this means a reduction in the proportion of the sum of side chains in the starch having a DP ( degree of polymerization) of greater than 123 to 0.1%-3.8%, preferably to 0.3%-3.0%, and particularly preferably to 0.5%-2.5%, as compared with the proportion of side chains having a DP greater than 123 (100%) in potato starch which is derived from corresponding wild-type potato plants.
  • the potato starches according to the invention exhibit a total phosphate content to phosphate content in the C6 position ratio of 1.20-1.50, particularly preferably of 1.30- 1.40.
  • the potato starches according to the invention exhibit high freeze/thaw stability.
  • high freeze/thaw stability means a freeze/thaw stability of at least 60%, in particular of at least 70%, preferably of at least 80%, and particularly preferably of at least 95%.
  • the freeze/thaw stability is determined using the method which is described below ("General methods").
  • the potato starches according to the invention exhibit a high degree of heat stability.
  • the term "high degree of heat stability” means a heat stability of at least 30%, in particular of at least 40%, and preferably of at least 50%.
  • the heat stability is determined using the method which is described below ("General methods").
  • the potato starches according to the invention exhibit a high degree of shear stability.
  • the term "high degree of shear stability” means a shear stability of 58% to 80%, in particular of 60% to 78%, preferably of 66% to 77%, particularly preferably of 67% to 75%.
  • the shear stability is determined using the method which is described below ("General methods: Method k).
  • the potato starches according to the invention exhibit a viscosity behavior (e.g. pasting temperature, final viscosity) which is altered as compared with that of potato starch which is derived from corresponding wild-type potato plants.
  • the viscosity properties are determined using the RVA or the Rotovisko method which is described below ("General methods").
  • the potato starches according to the invention exhibit an increased peak viscosity determined by the Rotovisko method ("General methods: Method I").
  • the term "increased peak viscosity determined by the Rotovisko method” means an increase of the peak viscosity by 23% to 70%, in particular by 27% to 60%, preferably by 35% to 55%, particularly preferably by 40% to 50% compared with the peak viscosity of potato starch which is derived from corresponding wild-type potato plants (100%).
  • the potato starches according to the invention exhibit a peak viscosity determined by the Rotovisko method of 332 SKT to 500 SKT, in particular of 345 SKT - 450 SKT, preferably of 360 SKT to 420 SKT and particularly preferably of 370 SKT to 400 SKT.
  • the potato starches according to the invention exhibit a DSC peak temperature which is altered as compared with that of potato starch which is derived from corresponding wild-type potato plants.
  • the DSC peak temperature is determined using the method which is described below ("General methods").
  • the potato starches according to the invention exhibit a gel strength which is reduced as compared with that of potato starch which is derived from corresponding wild-type potato plants.
  • the gel strength is determined using the method which is described below ("General methods").
  • the potato starches according to the invention exhibit a gel strength of 1 ,0 g to 10,0 g , in particular of 3,5 g to 7,5 g, preferably of 3,7 g to 6,5 g and particularly preferably of 4,0 g to 6,O g.
  • the potato starches according to the invention are preferably native potato starches.
  • native starch means that methods known to the skilled person are used to extract the starch from plants or starch-storing parts of plants without the extracted starch being chemically modified following the extraction.
  • the present invention relates to a method for the manufacture of the (potato) starch according to the invention, including the step of extracting the starch from a plant cell according to the invention or from a plant according to the invention, from propagation material according to the invention of such a plant and/or from harvestable plant parts according to the invention of such a plant, preferably from starch-storing parts according to the invention of such a plant.
  • a method also includes the step of harvesting the cultivated plants or plant parts and/or the propagation material of these plants before the extraction of the starch and, further, particularly preferably the step of cultivating plants according to the invention before harvesting.
  • the present invention also relates to potato starches according to the invention which possess one or more of the above-described properties. That is, this invention description discloses any combination of the following starch properties: amylose content or amylose/amylopectin ratio, phosphate content, side chain distribution, freeze/thaw stability and heat stability. Any combinations of two, three, four, five, six, seven, eight, nine and all the properties are to be regarded as being disclosed.
  • the starches according to the invention exhibit properties which appear to make them particularly suitable for being used in processes in which a pronounced ability to swell, a high degree of freeze/thaw stability and/or a high charge density are advantageous. These requirements apply, for example, to thickeners in the foodstuffs industry, especially when these thickeners are frozen for storage or processing and/or a particularly high thickening efficiency is desirable.
  • the starches according to the invention are particularly well suited for being used in the paper industry.
  • the high charge density is advantageous since it makes it possible to produce frequently employed amphoteric starches in what is only a one-step derivatization reaction and to a large extent dispense with additional derivatization reactions for introducing negative charges into the starches.
  • Standard methods which are known to the skilled person, can be used to chemically and/or physically modify the potato starches according to the invention, preferably native potato starches, after they have been extracted from the potato tubers.
  • native potato starch can be altered by, e.g., physical (e.g. thermal or mechanical) and/or chemical derivatization and/or breakdown products of the starch (e.g. dextrins) which are obtained by enzymic, acid-hydrolytic or thermal degradation.
  • physical e.g. thermal or mechanical
  • chemical derivatization and/or breakdown products of the starch e.g. dextrins
  • dextrins chemical derivatization and/or breakdown products of the starch
  • the native potato starches according to the invention are better suited than are conventional potato starches (derived from wild-type potato plants) for being used as starting substance for preparing the derivatized potato starches because this starting substance exhibits, for example, a higher proportion of reactive functional groups, as a result of the higher content of covalently bonded starch phosphate, is more strongly hydrophilic and is more accessible to chemical agents.
  • the present invention therefore also relates to derivatized potato starches which contain the, preferably native, potato starches according to the invention and to methods for preparing such a derivatized starch, in which methods potato starch according to the invention, which is preferably native, is subsequently, i.e. after having been extracted from the potato tuber, chemically and/or physically modified, preferably in vitro.
  • the derivatized starch according to the invention is, in particular, heat- treated starch.
  • the present invention preferably relates to acid-modified starch which has preferably been treated with acid, preferably with hydrochloric acid (at a concentration of up to 1M) in an aqueous system at temperatures of up to 50 0 C.
  • the present invention relates to derivatized starches which were obtained by subjecting the, preferably native, potato starch according to the invention to a temperature treatment in a dry system, preferably at temperatures of from preferably 12O 0 C to 14O 0 C.
  • the derivatized starches are starch ethers, in particular starch alkyl ethers, O-allyl ethers, hydroxyalkyl ethers, O- carboxymethyl ethers, nitrogen-containing starch ethers, phosphate- containing starch ethers or sulfur-containing starch ethers.
  • the derivatized starches are crosslinked starches.
  • the derivatized starches are starch graft polymers.
  • the derivatized starches are oxidized starches.
  • the derivatized starches are starch esters, in particular starch esters which were introduced into the starch using organic acids.
  • the starch esters are particularly preferably phosphate, nitrate, sulfate, xanthate, acetate or citrate starches.
  • the derivatized starches according to the invention are suitable for a variety of uses in the pharmaceutical industry and in the foodstuffs and/or nonfoodstuffs spheres.
  • Methods for preparing derivatized starches according to the invention are known to the skilled person and are adequately described in the general literature. A review regarding the preparation of derivatized starches can be found, for example, in Orthoefer (in: Corn, Chemistry and Technology, 1987, eds. Watson and Ramstad, Chapter 16, 479-499).
  • the present invention likewise relates to derivatized starch which can be obtained using the method according to the invention for preparing a derivatized starch.
  • the present invention furthermore relates to the use of potato starches according to the invention, which are preferably native, for preparing derivatized potato starch.
  • the potato starches according to the invention are suitable, in native or derivatized form, for a variety of uses in the foodstuffs or nonfoodstuffs sphere.
  • the possibilities for using the starch can be divided into two large areas.
  • One of the areas comprises the hydrolysis products of the starch, principally glucose and glucan building blocks, which are obtained using enzymic or chemical methods. They serve as starting compounds for further chemical modifications and processes such as fermentation.
  • the simplicity and economical implementation of a hydrolysis process can be of importance for reducing the cost.
  • the process proceeds essentially enzymatically using amyloglucosidase. It will be possible to conceive of saving costs by making less use of enzymes.
  • a change in the structure of the starch e.g. an increase in the surface of the granule, easier digestibility as a result of a lower degree of branching, or a steric structure which limits accessibility for the enzymes employed, could bring this about.
  • the starch can be used as an auxiliary for different production processes or as an additive in industrial products.
  • the paper and paperboard industry is to be mentioned, in particular, in connection with using the starch as an auxiliary.
  • the starch is first and foremost for retardation (retention of solids), for binding filler and fines particles, as a stabilizer and for dewatering.
  • the favorable properties of the starch are exploited in relation to stiffness, hardness, rattle, feel, shine, glaze, plybond strength and the surfaces.
  • Paper and paperboard industry Four areas of application, namely surface, coating, pulp and spraying are to be distinguished within the paper manufacturing process.
  • the demands placed on the starch with regard to surface treatment are essentially a high degree of brightness, an appropriate viscosity, high viscosity stability, good film formation and low dust formation.
  • the solids content, an appropriate viscosity, high binding ability and high pigment affinity are of importance.
  • rapid, uniform and loss-free dispersion, high mechanical stability and complete retention in the paper web are of importance.
  • an appropriate solids content, a high viscosity and a high binding ability are likewise of importance.
  • a large area for using the starches is constituted by the adhesives industry, where the possibilities of employment are divided into four constituent areas: use as pure starch glue, use in connection with starch glues which are prepared using special chemicals, use of starch as a substance added to synthetic resins and polymer dispersions, and use of starches as extenders for synthetic adhesives.
  • 90% of the starch-based adhesives are used in the areas constituting corrugated board production, production of paper sacks and bags, production of materials for bonding paper and aluminum, production of cardboard articles, and production of remoistening glue for envelopes, postage stamps, etc.
  • the area of textile production and textile care product production represents a large field for using the starches as auxiliaries and additives.
  • the following four areas of use can be distinguished within the textile industry: the use of starch as a sizing material, i.e. as an auxiliary for smoothing and strengthening burring behavior, for protecting against the tractive forces which act during weaving, and for increasing the abrasion resistance in connection with weaving; starch as an agent for textile finishing, especially after quality- impairing pretreatments such as bleaching, dyeing, etc.; starch as a thickener in connection with producing pigment pastes for preventing dye diffusions; and starch as a substance added to warping agents for sewing cottons.
  • the fourth area of employment is the use of the starches as additives for building materials.
  • An example is the production of gypsum plasterboards in which the starch which is mixed in the gypsum slurry forms a paste with the water, diffuses to the surface of the gypsum panel, where it binds the paperboard to the panel.
  • Other areas of employment are admixing to rendering fibers and mineral fibers.
  • starch products are used for delaying setting.
  • the starch in plant protection products for the purpose of modifying the specific properties of the preparations.
  • the starch can be used for improving the wetting properties of plant protection products and fertilizers, for the metered release of the active compounds, for converting liquid, volatile and/or malodorous active compounds into microcrystalline, stable and formable substances, for mixing incompatible compounds and for extending the duration of action by reducing decomposition.
  • the starch can be used as a binder for tablets or for binder dilution in capsules.
  • the starch can also be used as a tablet disintegrant since it absorbs liquid after swallowing and after a short time swells to such an extent that the active compound is released.
  • medicinal glidants and wound powders are based on starch.
  • starches are, for example, employed as carriers of powder additives, such as perfumes and salicylic acid. Toothpastes constitute a relatively area for using the starch.
  • starch additive can be used to agglomerate or briquette coal in a quantitatively high-grade manner, thereby preventing any premature decomposition of the briquettes.
  • the addition of starch is between 4 and 6% in the case of grilling coal and between 0.1 and 0.5% in the case of calorized coal.
  • the starch can also be used as a flocculant in connection with ore and coal slurry dressing.
  • Another area of use is as a substance which is added to foundry auxiliaries.
  • cores which are produced from sands to which binder has been added.
  • the binder which is nowadays mainly used is bentonite to which modified starches, usually swelling starches, have been added.
  • the purpose of adding the starch is to increase the flow resistance and to improve binding strength.
  • the swelling starches can exhibit other requirements in relation to production technology, such as dispersible in cold water, rehydratable, readily miscible in sand and high water-binding capacity.
  • the starch can be used for improving technical and optical quality.
  • the reasons in this connection are the improvement in the surface shine, the improvement in the feel and the appearance (for this, starch is dusted onto the tacky gummed areas of rubbers prior to cold vulcanization) and the improvement in the printability of the rubber.
  • starches according to the invention is in the area of extracting raw materials using drills.
  • auxiliaries and/or lubricants which prevent the drill or the drilling gear from overheating.
  • starch When compared with other substances such as talc, it is uncompetitive to use the starch simply as a filler. The situation is different when the specific properties of the starch come into play and the property profiles of the final products are markedly altered as a result.
  • An example of this is the use of starch products in the finishing of thermoplastics such as polyethylene.
  • the starch and the synthetic polymer are combined, by being coexpressed in a ratio of 1 :1 , into a "masterbatch", from which various products are produced using granular polyethylene and conventional process technology.
  • starch into polyethylene films makes it possible to achieve an increase in substance permeability in the case of hollow bodies, an improvement in water vapor permeability, an improvement in antistatic behavior, an improvement in antiblocking behavior and an improvement in printability when using aqueous pigments.
  • starch in polyurethane foams.
  • Solid plastic products such as pots, plates and bowls, having a starch content of more than 50% can also be produced.
  • starch/polymer mixtures are to be judged as being advantageous since they exhibit a very much higher degree of biodegradability.
  • starch graft polymers have become exceptionally important. These polymers are products having a starch backbone and a side lattice of a synthetic monomer which is grafted on in accordance with the principle of the free- radical chain mechanism.
  • the starch graft polymers which are nowadays available are characterized by an improved ability to bind and retain up to 1000 g of water per g of starch in association with high viscosity.
  • the areas in which these superabsorbers can be used have expanded greatly in recent years and lie in the hygiene sphere, involving products such as diapers and paddings, and in the agricultural sector, for example in connection with seed pelleting.
  • Factors which are crucially relevant for using the novel starches are, on the one hand, the structure, water content, protein content, lipid content, fiber content, ash/phosphate content, amylose/amylopectin ratio, molar mass distribution, degree of branching, granule size and shape, and crystallinity, and also, on the other hand, the properties which lead to the following features: flow and sorption behavior, pasting temperature, viscosity, thickening efficiency, solubility, paste structure and transparency, heat, shearing and acid stability, retrogradation tendency, gel formation, freeze/thaw stability, complex formation, iodine binding, film formation, adhesive strength, enzyme stability, digestibility and reactivity.
  • the potato starch according to the invention which is preferably native, can be prepared by isolating it from genetically modified potato plants in which the genetic modification leads to a reduction in the GBSSI, SSIII and BEI activities and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, as compared with the activities of the corresponding wild-type potato plant cells or wild-type potato plants.
  • the present invention therefore also relates to plant cells and plants which are genetically modified, with the genetic modification leading to a reduction in the GBSSI, SSIII and BEI activities, and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, as compared with the activities of corresponding wild-type plant cells or wild-type plants.
  • GBSSI is to be understood as meaning any enzyme which belongs to the isoform I class of starch granule-bound starch synthases (EC 2.4.1.21 ).
  • GBSSI gene is to be understood as meaning a nucleic acid molecule or polynucleotide (cDNA or DNA) which encodes GBSSI.
  • Polynucleotides encoding GBSSI have been described in the case of a variety of plant species, such as corn (Genbank Ace. Nos. AF079260, AF079261), wheat (Genbank Ace. Nos. AB019622, AB019623, AB019624), rice (Genbank Ace. Nos. AF092443, AF09244, AF031162), barley (Genbank Ace. Nos. X07931 , X07932), and potato (Genbank Ace. No.
  • the GBSSI gene exhibits an identity of at least 70%, in particular of at least 80%, of at least 90%, preferably of at least 95%, with the coding region of the nucleotide sequence which is depicted in SEQ ID NO 6.
  • the GBSSI gene is, in connection with the present invention, a nucleic acid molecule (cDNA or DNA) which encodes potato plant GBSSI; particular preference is given to the GBSSI gene which is specified under SEQ ID NO 6.
  • SSIII is to be understood as meaning a particular class of soluble starch synthases
  • SSIIIs are described, for example, in Marshall et al. (1996, The Plant Cell 8, 1121-1135), Li et al. (2000, Plant Physiology 123, 613-624), Abel et al. (1996, The Plant Journal 10(6), 981-991 ) and in WO 00/66745.
  • the structure of SSIIIs frequently exhibits a sequence of particular domains and possesses a signal peptide, for transport into plastids, at its N terminus. There then follow, in the direction of the C terminus, an N-terminal region, an SSIII-specific region and a catalytic domain (Li et al., 2000, Plant Physiology 123, 613-624).
  • an SSIII protein exhibits what is termed a carbohydrate binding domain (CBM).
  • CBM carbohydrate binding domain
  • an SSIII protein is to be understood as being a protein which exhibits an identity of at least 70%, preferably of at least 80%, particularly preferably of at least 90%, very particularly preferably of at least 95%, with the sequence depicted in SEQ ID NO 2.
  • SSIII gene is to be understood as meaning a nucleic acid molecule (DNA or cDNA) which encodes an SSIII protein. Nucleic acid molecules encoding SSIIIs have been described in the case of a variety of plant species, for example the potato (Abel et al., 1996, The Plant Journal 10(6), 981-991).
  • an "SSIII gene” is to be understood as meaning a nucleic acid molecule which exhibits an identity of least 70%, in particular of at least 80%, preferably of at least 90%, very particularly preferably of at least 95%, with the coding region of the sequence depicted in SEQ ID NO 1.
  • the SSIII gene is, in connection with the present invention, a nucleic acid molecule (cDNA or DNA) which encodes potato plant SSIII; particular preference is given to the potato SSIII gene which is specified under SEQ ID NO 1.
  • BEI is to be understood as meaning an isoform I branching enzyme (BE) ( ⁇ -1 ,4-glucan: ⁇ -1 ,4- glucan 6-glycosyltransferase; E. C. 2.4.1.18), which catalyzes a trans- glycosylation reaction in which ⁇ -1 ,4-linkages in an ⁇ -1 ,4-glucan donor are hydrolyzed and the ⁇ -1 ,4-glucan chains which are released in this connection are transferred to an ⁇ -1 ,4-glucan acceptor chain and, in association with this, converted into ⁇ -1 ,6 linkages.
  • BEI is preferably derived from potato plants.
  • BEI gene is to be understood as meaning a nucleic acid molecule or polynucleotide (cDNA or DNA) which encodes BEI.
  • Polynucleotides encoding BEIs have been described in the case of a variety of plant species, for example in the case of corn (Genbank Ace. Nos. D11081 , AF072724), rice (Genbank Ace. No. D11082) and potato.
  • Various forms of the potato BEI gene or potato BEI have, for example, been described by Khoshnoodi et al. (1996, Eur. J. Biochem. 242 (1 ), 148-155, Genbank Ace. No.
  • the BEI gene exhibits an identity of at least 70%, in particular of at least 80%, of at least 90%, preferably at least 95%, with the coding region of the nucleotide sequence depicted in SEQ ID NO 4.
  • the BEI gene is, in connection with the present invention, a nucleic acid molecule (cDNA or DNA) which encodes potato plant BEI; particular preference is given to the BEI gene specified under SEQ ID NO 4.
  • the BEI gene is principally expressed in the tubers and hardly at all in the leaves (Larsson et al., 1998, Plant MoI. Biol. 37, 505-511).
  • identity is to be understood as meaning the number of amino acids/nucleotides which concur with those of other proteins/nucleic acids, expressed as a percentage.
  • the identity is preferably determined using computer programs. If sequences which are being compared with each other are of differing lengths, the identity is to be determined such that the number of amino acids which the shorter sequence has in common with the longer sequence determines the percentage identity.
  • the identity is preferably determined using the ClustalW computer program (Thompson et al., 1994, Nucleic Acids Research 22, 4673-4680), which is known and available to the public.
  • ClustalW is made publicly available by Julie Thompson (Thompson@EMBL-Heidelberg.de) and Toby Gibson (Gibson@EMBL- Heidelberg.de), European Molecular Biology Laboratory, Meyerhofstrasse 1 , 69117 Heidelberg, Germany.
  • ClustalW can also be downloaded from a variety of internet sites, including from IGBMC (Institut de Genetique et de Biologie Moleisme et Cellulaire, B.P.163, 67404 lllkirch Cedex, France; (ftp://ftp-igbmcu.-strasbg.fr/pub/) and from EBI
  • sequence database searches One option for finding similar sequences is to carry out sequence database searches.
  • sequence database searches one or more sequences are predetermined to be what is termed the query.
  • Statistical computer programs are then used to compare this query sequence with sequences which are contained in the chosen databases.
  • database searches blast searches
  • Such database searches are known to the skilled person and can be carried out using the databases provided by different suppliers. If such a database search is carried out using the NCBI (National Center for Biotechnology Information, http://www.ncbi.nim.nih.gov/) database, the standard settings which are predetermined for the given comparison query should then be used.
  • the genetic modification of the plant cells according to the invention or of the plants according to the invention is elicited by mutagenesis of one or more genes.
  • the nature of the mutation is immaterial in this regard as long as it leads to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13.
  • mutagenesis is to be understood as meaning any type of introduced mutations, such as deletions, point mutations (nucleotide substitutions), insertions, inversions, gene conversions or chromosome translocations.
  • a mutation which leads to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13 can arise spontaneously in a plant and the corresponding plants can be selected and propagated using the methods which are described below.
  • a mutation which leads to a reduction the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13 can also be produced by using chemical agents or energy-rich radiation (e.g. x-radiation, neutron radiation, gamma radiation or UV radiation).
  • chemical agents or energy-rich radiation e.g. x-radiation, neutron radiation, gamma radiation or UV radiation.
  • Scarascia-Mugnozza et al. (1993, Mutation Breeding Review 10, 1-28) provide a review of the generation of wheat mutants using different types of energy-rich radiation and chemical agents.
  • Svec et al. (1998, Cereal Research Communications 26 (4), 391-396) describe the use of N-ethyl-N-nitrosourea for generating mutants in triticale.
  • MMS methylmethanesulfonic acid
  • gamma radiation for generating millet mutants has been described by Shashidhara et al. (1990, Journal of Maharashtra Agricultural Universities 15 (1), 20-23).
  • mutants in plant species which chiefly multiply vegetatively has been described, for example, in the case of potatoes which produce an altered starch (Hovenkamp-Hermelink et al., 1987, see above) and in the case of mint in which the oil yield is increased or the oil quality is altered (Dwivedi et al., 2000, Journal of Medicinal and Aromatic Plant Sciences 22, 460-463).
  • a method for identifying mutations with the aid of hybridization patterns is, for example, that of searching for restriction fragment length differences (restriction fragment length polymorphisms, RFLPs) (Nam et al., 1989, The Plant Cell 1 , 699-705; Leister and Dean, 1993, The Plant Journal 4 (4), 745-750).
  • restriction fragment length differences restriction fragment length polymorphisms, RFLPs
  • PCR-based method is that of analyzing amplified fragment length differences (amplified fragment length polymorphisms, AFLPs) (Castiglioni et al., 1998, Genetics 149, 2039-2056; Meksem et al., 2001 , Molecular Genetics and Genomics 265, 207-214; Meyer et al., 1998, Molecular and General Genetics 259, 150-160).
  • amplified fragment length polymorphisms amplified fragment length polymorphisms, AFLPs
  • restriction endonuclease-cut amplified fragments cleaved amplified polymorphic sequences, CAPS
  • CAPS restriction endonuclease-cut amplified polymorphic sequences
  • TILLING targeting-induced local lesions in genomes
  • Hoogkamp et al. 2000, Potato Research 43, 179-189 have produced stable monoploid mutants from a potato mutant (am ⁇ which was produced by means of chemical mutagenesis. These plants no longer synthesize any active GBSSI and therefore produce a starch which is amylose-free. The monoploid potato plants which are obtained can be used as the starting material for further mutageneses.
  • SEQ ID No 13 can be achieved by reducing the expression of one or more of the gene(s) which encode(s) GBSSI or SSIII or BEI and which exhibit(s) the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13 and/or by reducing the quantity of relevant enzyme material in the plant cells and/or by reducing the enzymic activity of the relevant proteins in the plant cells.
  • the reduction in the expression can, for example, be determined by measuring the quantity of transcripts which encode the relevant enzymes, e.g. by means of Northern blot analysis or RT-PCR.
  • a reduction preferably denotes a reduction in the quantity of transcripts by at least 50%, in particular by at least 70%, preferably by at least 85%, and particularly preferably by at least 95%, as compared with the quantity in corresponding wild-type plant cells.
  • a reduction preferably denotes a reduction in the quantity of relevant protein by at least 50%, in particular by at least 70%, preferably by at least 85%, and particularly preferably by at least 95%, as compared with that in corresponding wild- type plant cells.
  • the genetic modification of the plant cell according to the invention comprises introducing one or more foreign nucleic acid molecules/polynucleotides whose presence and/or expression leads to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies), and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, as compared with that/those in corresponding wild-type plant cells.
  • the term genetic modification is understood as meaning the introduction of homologous and/or heterologous and/or mutagenized foreign nucleic acid molecules/polynucleotides into a plant cell, with said introduction of these molecules leading to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene which is specified under SEQ ID NO 11 or SEQ ID NO 13. In this way, it is consequently possible to generate transgenic plant cells according to the invention.
  • transgenic means that the genetic information in the plant cells according to the invention differs from that of corresponding wild-type plant cells as a result of the introduction of a foreign nucleic acid molecule/polynucleotide, or several foreign nucleic acid molecules/polynucleotides, into the cell.
  • the term "foreign nucleic acid molecule/polynucleotide” or “foreign nucleic acid molecules/polynucleotides” is to be understood as meaning such a molecule which either naturally does not occur in corresponding wild-type plant cells or which does not occur naturally in the specific spatial arrangement in corresponding wild-type plant cells, or which is located at a site in the genome of the plant cell at which it does not naturally occur. Preference is given to the foreign nucleic acid molecule/polynucleotide being a recombinant molecule which is composed of different elements whose combination, or specific spatial arrangement, does not occur naturally in plant cells.
  • the foreign nucleic acid molecule(s)/polynucleotide(s) which is/are used for the genetic modification can be one integrated nucleic acid construct or several separate nucleic acid constructs, in particular what are termed single, double, triple or quadruple constructs.
  • the foreign nucleic acid molecule/polynucleotide can, for example, be what is termed a "quadruple construct", which is understood as meaning a single vector for plant transformation, which vector contains the genetic information for inhibiting the expression of one or more endogenous GBSSI genes, for inhibiting the expression of one or more SSIII genes, for inhibiting the expression of one or more BEI genes and for inhibiting the expression of the gene specified under SEQ ID NO 11 or SED ID NO 13, or whose presence or whose expression leads to a reduction in the GBSSI, SSIII and BEI activities and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13.
  • a quaddruple construct which is understood as meaning a single vector for plant transformation, which vector contains the genetic information for inhibiting the expression of one or more endogenous GBSSI genes, for inhibiting the expression of one or more SSIII genes, for inhibiting the expression of one or more BEI genes and for inhibiting the expression of the gene specified under S
  • the foreign nucleic acid molecule/polynucleotide can be what is termed a "double construct", which is understood as meaning a vector for plant transformation which contains the genetic information for inhibiting the expression of two of the four target genes (GBSSI gene, SSIII gene, BEI gene, gene having the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13) or whose presence or whose expression leads to a reduction in the activity of two of the four enzymes (GBSSI, SSIII, BEI or protein having the amino acid sequence specified under SEQ ID NO 12 or SEQ ID NO 14).
  • double construct which is understood as meaning a vector for plant transformation which contains the genetic information for inhibiting the expression of two of the four target genes (GBSSI gene, SSIII gene, BEI gene, gene having the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13) or whose presence or whose expression leads to a reduction in the activity of two of the four enzymes (GBSSI, SSIII, BEI
  • the expression of the third and fourth target genes is inhibited, and/or the activities of the third and fourth enzymes are reduced, using a separate foreign nucleic acid molecule/polynucleotide which contains the appropriate genetic information for inhibiting these two additional target genes.
  • foreign nucleic acid molecules/polynucleotides are introduced into the genome of the plant cell, with one of these foreign nucleic acid molecules being, for example, a DNA molecule which, for example, constitutes a cosuppression construct which brings about a reduction in the expression of one or more endogenous GBSSI genes and leads to the inhibition of the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, and another foreign nucleic acid molecule being a DNA molecule which, for example, encodes an antisense RNA which beings about a reduction in the expression of one or more endogenous SSIII and/or BEI genes.
  • a DNA molecule which, for example, constitutes a cosuppression construct which brings about a reduction in the expression of one or more endogenous GBSSI genes and leads to the inhibition of the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13
  • another foreign nucleic acid molecule being a DNA molecule which, for example, encodes an antisense RNA
  • any combination of antisense, cosuppression, ribozyme and double-stranded RNA constructs or in-vivo mutagenesis which leads to a simultaneous reduction in the expression of endogenous genes which encode BGSSI, SSIII and BEI or which exhibit the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13, or which leads to a simultaneous reduction in the GBSSI, SSIII or BEI activities and to inhibition of the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, is also suitable when constructing the foreign nucleic acid molecules.
  • the foreign nucleic acid molecules can either be inserted into the genome of the plant cell simultaneously (cotransformation) or consecutively, that is chronologically one after the other (super-transformation).
  • the foreign nucleic acid molecules/polynucleotides can also be introduced into different individual plants belonging to a species.
  • Subsequent crossing can then be used to generate plants in which the activities of all three enzymes (GBSSI, SSIII and BEI) are reduced and the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13 is reduced.
  • mutants instead of a wild-type plant cell or wild-type plant, with the mutant being distinguished by the fact that it already exhibits a reduced activity of one or more enzymes (GBSSI, SSIII, BEI and protein having the amino acid sequence specified under SEQ ID NO 12 or SEQ ID NO 14).
  • the mutants can be either spontaneously arising mutants or else mutants which have been generated by the selective use of mutagens. Possibilities for generating such mutants have been described above.
  • the plant cells according to the invention can also be produced by using what is termed insertion mutagenesis (review article: Thorneycroft et al., 2001 , Journal of Experimental Botany 52 (361), 1593-1601 ).
  • Insertion mutagenesis is to be understood, in particular, as being the insertion of transposons or of what is termed transfer DNA (T-DNA) into a gene which encodes GBSSI and/or SSIII and/or BEI and/or has the nucleotide sequence specified under SEQ ID NO 11 or SEQ NO 13.
  • the transposons can be either those which naturally occur in a wild-type plant cell (endogenous transposons) or those which do not naturally occur in said cell but which are introduced into the cell using genetic methods such as transformation of the cell (heterologous transposons).
  • endogenous transposons or those which do not naturally occur in said cell but which are introduced into the cell using genetic methods such as transformation of the cell (heterologous transposons).
  • heterologous transposons The skilled person is familiar with using transposons to change the expression of genes.
  • Ramachandran and Sundaresan (2001 , Plant Physiology and Biochemistry 39, 234-252) have provided a review regarding the use of endogenous and heterologous transposons as tools in plant biotechnology. The possibility of identifying mutants in which specific genes have been inactivated by transposon insertion mutagenesis is described in a review by Maes et al. (1999, Trends in Plant Science 4 (3), 90-96).
  • the plant cells according to the invention and the plants according to the invention can be produced using either homologous or heterologous transposons, with the use of homologous transposons also having to be understood as meaning the transposons which are already naturally present in the plant genome.
  • T-DNA insertion mutagenesis is based on specific segments (T-DNA) of Agrobacterium Ti plasmids being able to integrate into the genome of plant cells.
  • the site for the integration into the plant chromosome is not fixed; rather, integration can take place at any arbitrary site. If the T-DNA integrates into a segment of the chromosome which constitutes a gene function, the integration can then lead to a change in the expression of the gene and consequently also to a change in the activity of a protein which is encoded by the gene in question.
  • T-DNA insertions for generating mutants has been described, for example, in the case of Arabidopsis thaliana (Krysan et al., 1999, The Plant Cell 11 , 2283- 2290; Atipiroz-Leehan and Feldmann, 1997, Trends in Genetics 13 (4), 152-156; Parinov and Sundaresan, 2000, Current Opinion in Biotechnology 11 , 157-161) and rice (Jeon and An, 2001 , Plant Science 161 , 211-219; Jeon et al., 2000, The Plant Journal 22 (6), 561-570).
  • T-DNA mutagenesis is in principle suitable for generating the plant cells according to the invention and the plants according to the invention.
  • the presence and/or the expression of one or more foreign nucleic acid molecules/polynucleotides leads to the expression of endogenous genes which encode GBSSI and/or SSIII and/or BEI, and/or which exhibit the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13, being inhibited.
  • a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and/or a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13 in the plant cells can also be elicited by simultaneously expressing sense and antisense RNA molecules of the respective target gene to be repressed, preferably of the GBSSI and/or SSIII and/or BEI gene and/or of the gene having the nucleotide sequence which is specified under SEQ ID NO 11 or SEQ ID NO 13.
  • the skilled person is familiar with these methods.
  • a DNA molecule which comprises the entire sequence encoding GBSSI and/or SSIII and/or BEI and/or the nucleotide sequence which is specified under SEQ ID NO 11 or SEQ ID NO 13, including any flanking sequences which may possibly be present, or else use DNA molecules which only comprise parts of the coding sequence, with these parts having to be sufficiently long to bring about an antisense effect or cosuppression effect in the cells.
  • sequences having a minimum length of 15 bp preferably having a minimum length of 20-30 bp, particularly preferably having a length of 100- 500 bp, in particular sequences having a length of more than 500 bp, are suitable for exerting very efficient antisense or cosuppression inhibition.
  • polynucleotide sequences which have a high degree of identity with the sequences which occur endogenously in the plant cell and which encode GBSSI or SSIII or BEI, or which are depicted under SEQ ID NO 11 or SEQ ID NO 13, is also suitable for antisense or cosuppression approaches.
  • the minimum identity should be greater than approx. 65%.
  • sequences having identifies of at least 90%, in particular of between 95 and 100%, is to be preferred.
  • introns i.e. noncoding regions of genes which encode GBSSI or SSIII or BEI or which exhibit the nucleotide sequence depicted under SEQ ID NO 11 or SEQ ID NO 13, for achieving an antisense or cosuppression effect.
  • ribozymes for the purpose of reducing the activity of particular enzymes in cells is also known to the skilled person and is described, for example, in EP-B1 0321201.
  • the expression of ribozymes in plant cells has been described, for example, by Feyter et al. (1996, MoI. Gen. Genet. 250, 329-338).
  • a reduction in the GBSSI and/or SSIII and/or BEI activities(- ies) and/or a reduction in the expression of the gene depicted under SEQ ID NO 11 or SEQ ID NO 13 in the plant cells can also be achieved by what is termed "in-vivo mutagenesis", in which transformation of cells is used to introduce a hybrid RNA-DNA oligonucleotide ("chimeroplast”) into cells (Kipp et al., poster session at the 5th International Congress of Plant Molecular Biology, 21-27 September 1997, Singapore; R.A. Dixon and CJ.
  • RNA-DNA oligonucleotide While a part of the DNA component of the RNA-DNA oligonucleotide is homologous with a polynucleotide sequence in an endogenous GBSSI and/or SSIII and/or BEI gene and/or a gene depicted under SEQ ID NO 11 or SEQ ID NO 13, it exhibits a mutation as compared with the polynucleotide sequence of an endogenous GBSSI or SSIII or BEI gene or contains a heterologous region which is surrounded by the homolgous regions.
  • the mutation or heterologous region contained in the DNA component of the RNA-DNA oligonucleotide can be transferred into the genome of a plant cell. This leads to a reduction in the activities(- ies) of GBSSI and/or SSIII and/or BEI and/or to a reduction in the expression of the gene which is specified under SEQ ID NO 11 or SEQ ID NO 13.
  • a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) in the plant cells can also be elicited by simultaneously expressing sense and antisense RNA molecules of the respective target gene to be repressed, preferably of the GBSSI and/or SSIII and/or BEI gene and/or of the gene which is specified in SEQ ID NO 11 or SEQ ID NO 13.
  • chimeric constructs which contain inverted repeats of the respective target gene or parts of the target gene.
  • the chimeric constructs encode sense and antisense RNA molecules of the respective target gene.
  • sense and antisense RNA are synthesized simultaneously as one RNA molecule, with sense and antisense RNA being separated from each other by a spacer and being able to form a double-stranded RNA molecule (RNAi technology).
  • Sense and antisense sequences of the target gene or the target genes can also be expressed separately from each other using identical or different promoters (Nap et al., 6th International Congress of Plant Molecular Biology, 18-24 June 2000, Quebec, poster S7-27, lecture session S7).
  • DNA molecules which are derived from GBSSI or SSIII or BEI genes or genes having the nucleotide sequence depicted under SEQ ID NO 11 or SEQ ID NO 13, or cDNAs, into the genome of plants, with the DNA molecules which are to be transcribed being under the control of a promoter which regulates the expression of said DNA molecules.
  • RNA molecules of promoter DNA molecules can lead in trans to methylation and transcriptional inactivation of homolgous copies of these promoters, which will be termed target promoters in that which follows (Mette et al., 2000, EMBO J. 19, 5194-5201).
  • target promoter it is consequently possible to use inactivation of the target promoter to reduce the expression of a particular target gene (e.g. GBSSI, SSIII or BEI gene; gene having the nucleotide sequence depicted under SEQ ID NO 11 or SEQ ID NO 13) which is naturally under the control of this target promoter.
  • a particular target gene e.g. GBSSI, SSIII or BEI gene; gene having the nucleotide sequence depicted under SEQ ID NO 11 or SEQ ID NO 13
  • the DNA molecules which comprise the target promoters of the genes (target genes) to be repressed are not, in contrast to the original function of promoters in plants, being used as elements for regulating the expression of genes or cDNAs but, instead, themselves being used as transcribable DNA molecules.
  • the molecules can be present as RNA hairpin molecules
  • target promoter DNA molecules leads, in planta, to the formation of double-stranded target promoter RNA molecules (Mette et al., EMBO J. 19, 5194-5201 ). These molecules can inactivate the target promoter.
  • Reduction of the GBSSI and/or SSIII and/or BEI activities(-ies), and inhibition of the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, in the plant cells can consequently also be achieved by generating double-stranded RNA molecules of promoter sequences of GBSSI or SSIII or BEI genes or of genes having the nucleotide sequence depicted under SEQ ID NO 11 or SEQ ID NO 13.
  • GBSSI and/or SSIII and/or BEI promoters preference is given to introducing inverted repeats of promoter DNA molecules of GBSSI and/or SSIII and/or BEI promoters into the genome of plants, with the target promoter DNA molecules (GBSSI, SSIII or BEI promoter) to be transcribed being under the control of a promoter which regulates the expression of said target promoter DNA molecules.
  • the skilled person also knows that he can reduce the GBSSI and/or SSIII and/or BEI activities(-ies), and inhibit the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, by expressing nonfunctional derivatives, in particular transdominant mutants, of the enzymes and/or by expressing antagonists/inhibitors of the enzymes.
  • Antagonists/inhibitors of the enzymes can, for example, be antibodies, antibody fragments or molecules having similar binding properties.
  • a cytoplasmic scFv antibody has been used to modulate the activity of the phytochrome A protein in recombinantly altered tobacco plants (Owen, 1992, Bio/Technology 10, 790-794; Review: Franken et al., 1997, Current Opinion in Biotechnology 8, 411-416; Whitelam, 1996, Trends Plant Sci. 1 , 268-272).
  • any promoter which is active in plant cells is suitable for expressing the foreign nucleic acid molecule/polynucleotide (the foreign nucleic acid molecules/polynucleotides).
  • the promoter can be selected such that the expression takes place constitutively in the plants according to the invention or only in one particular tissue, at a particular timepoint in the development of the plant or at a timepoint which is determined by external influences.
  • the promoter can be homologous or heterologous in relation to the plant.
  • Examples of appropriate promoters for expressing nucleic acids/polynucleotides which reduce the activity of a target gene are the promoter of the cauliflower mosaic virus 35S RNA and the corn ubiquitin promoter for constitutive expression, the patatin gene promoter B33 (Rocha-Sosa et al., 1989, EMBO J. 8, 23-29), the MCPI promoter of the potato metallocarboxypeptidase inhibitor gene (HU 9801674) or the potato GBSSI promoter (WO 92/11376) for tuber-specific expression in potatoes or a promoter which allows expression only in photosynthetically active tissues, e.g. the ST-LS1 promoter (Stockhaus et al., 1987, Proc. Natl.
  • the potato patatin gene, MCPI and GBSSI promoters are promoters which are preferred for expressing the foreign nucleic acid molecule/polynucleotide (the foreign nucleic acid molecules/polynucleotides).
  • the foreign nucleic acid molecule/polynucleotide (the foreign nucleic acid molecules/poly- nucleotides) in those organs in the plant which store starch.
  • the examples of these organs are the tuber of the potato plant or the grains or endosperm of corn, wheat or rice plants. Preference is therefore given to using promoters which mediate expression in these organs.
  • promoters which are only activated at a timepoint which is determined by external influences (see, for example, WO 93/07279). Promoters of heat shock proteins, which permit simple induction, may be of particular interest in this connection. It is furthermore possible to use seed-specific promoters, such as the Vicia faba USP promoter, which ensures seed-specific expression in Vicia faba and other plants (Fiedler et al., 1993, Plant MoI. Biol. 22, 669-679; Baumlein et al., 1991 , MoI. Gen. Genet. 225, 459-467), and also fruit-specific promoters, as described, for example, in WO 91/01373.
  • a termination sequence which serves the purpose of correctly terminating the transcription and of adding a poly A tail to the transcript, with the tail being attributed a function in stabilizing the transcripts, to be present.
  • a large number of techniques are available for introducing DNA into a host plant cell. These techniques include transforming plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transforming agent, fusing protoplasts, injecting, electroporating the DNA, introducing the DNA by means of a biolistic approach, and also other possibilities.
  • the present invention also relates to a plant cell which is genetically modified, with the genetic modification leading to reduction of the GBSSI,
  • BEI gene and/or to a mutation or an insertion in at least one gene having the nucleotide sequence specified under SEQ ID NO: 1
  • the present invention also relates to any type of material for propagating plants according to the invention.
  • the plant cells according to the invention can be used for regenerating whole plants.
  • the present invention likewise relates to the plants which can be obtained by regenerating the plant cells according to the invention.
  • the plants according to the invention or the plant cells according to the invention can belong to any arbitrary plant species, that is either to monocotyledonous or to dicotyledonous plants.
  • the plants according to the invention are preferably agriculturally useful plants, i.e. plants which are cultivated by man for purposes of nutrition or for technical, in particular, industrial purposes, and their cells.
  • the invention preferably relates to fiber- forming (e.g. flax, hemp and cotton), oil-storing (e.g. rape, sunflower and soybean), sugar-storing (e.g. sugar beet, sugar cane and sweet sorghum) and protein-storing plants (e.g. leguminosae) and their cells.
  • the invention relates to forage plants, in particular forage grasses and pasture grasses (alfalfa, clover, etc.) and vegetable plants (e.g. tomato, salad and chicory) and their cells.
  • forage grasses and pasture grasses alfalfa, clover, etc.
  • vegetable plants e.g. tomato, salad and chicory
  • the invention relates to starch-storing plants (e.g. wheat, barley, oats, rye, potato, corn, rice, pea and tapioca), particularly preferably potatoes, and their cells.
  • starch-storing plants e.g. wheat, barley, oats, rye, potato, corn, rice, pea and tapioca
  • potatoes particularly preferably potatoes, and their cells.
  • potato plant or “potato” means plant species of the genus Solanum, particularly tuber-producing species of the genus Solanum and, in particular, Solanum tuberosum.
  • the present invention furthermore relates to a method for producing a plant according to the invention, in which
  • a plant cell is genetically modified, with the genetic modification being the introduction of one or more foreign nucleic acid molecule(s) whose presence and/or expression leads to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, as compared with those in corresponding wild-type plant cells, b) a plant is regenerated from step a) plant cells; and c) where appropriate, further plants are produced using the plants in accordance with step b).
  • the genetic modification which is introduced into the plant cell in accordance with step a) can in principle be any type of modification which leads to a reduction in the activity of one or more SSIII proteins which occur(s) endogenously in the plant and of one or more BEI proteins which occur(s) endogenously in the plant and of one or more GBSSI proteins which occur(s) endogenously in the plant and of one or more proteins which occur(s) endogenously in the plant and which exhibit(s) at least 80%, preferably 90%, particularly preferably 95%, identity with the nucleic acid molecule specified under SEQ ID NO 12 or SEQ ID NO 14.
  • step (b) can be regenerated using methods which are known to the skilled person (e.g. described in "Plant Cell Culture Protocols", 1999, edtd. by R.D. Hall, Humana Press, ISBN 0-89603-549-2). Further plants can be regenerated in accordance with step (c) of the method according to the invention by means, for example, of vegetative propagation (for example using cuttings or tubers or using a callus culture and regenerating whole plants) or by means of sexual propagation.
  • the sexual propagation preferably takes place in a controlled manner, i.e. selected plants possessing particular properties are crossed with each other and propagated.
  • the selection is preferably made such that the further plants which are obtained in accordance with step c) exhibit the genetic modification which was introduced in step a).
  • Starch was isolated from potato plants, as described above, and the amylose to amylopectin ratio was determined using the method described by Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246). The amylose content is calculated by applying the formula cited on page 243 of this article.
  • the C2, C3 and C6 positions of the glucose units can be phosphorylated.
  • 50 mg of starch were hydrolyzed, at 95 0 C for 4 h, in 500 //I of 0.7 M HCI. The mixtures were then centrifuged at 15500 g for 10 min and the supematants were taken off. 7 ⁇ volumes of the supematants were mixed with 193 /vl of imidazole buffer (10O mM imidazole, pH 6.9; 5 mM MgCI 2 ,
  • step 2 the temperature was increased from 5O 0 C to 95 0 C at a heating rate of 12°C per min while the stirring rate remained the same (step 2).
  • the temperature was then kept at 95 0 C for 2.5 min while the stirring rate remained the same (step 3).
  • the solution was cooled down from 95 0 C to 50 0 C at a cooling rate of 12 0 C per min while the stirring rate remained the same (step 4).
  • the last step (step 5) maintains the temperature of 50 0 C for 2 min while the stirring rate remains the same. The viscosity was determined during the entire period.
  • the maximum viscosity is understood as meaning the highest viscosity value, as measured in cP (centipoise), which is achieved in step 2 or 3 of the temperature profile.
  • the minimum viscosity is understood as meaning the lowest viscosity value, as measured in cP, which occurs in the temperature profile after the maximum viscosity. This normally occurs in step 3 of the temperature profile.
  • the final viscosity is understood as meaning the viscosity value, as measured in cP, which occurs at the end of the measurement.
  • the pasting temperature is understood as being the temperature in the temperature profile at which the viscosity for the first time increases by 55 cP over a period of 20 sec.
  • the samples were fixed under the probe (cylindrical plunger having a planar surface) of a TA-XT2 texture analyzer supplied by Stable Micro Systems (Surrey, UK), and the gel strength was determined using the following parameters:
  • the supernatant was treated with 3 volumes of ethanol and the amylopectin which precipitated out was separated off by centrifuging at 2000 g (RT) for 5 minutes.
  • the pellet (amylopectin) was then washed with ethanol and dried using acetone.
  • a 1 % solution of amylopectin was then prepared in 10 mM sodium acetate, pH 3.5, with the amylopectin being dissolved at 65-95 0 C for 1-2 h. In each case 100 ⁇ l of this solution were treated, for the digestion, with 180 //I of 10 mM sodium acetate, pH 3.5, and 1 ⁇ of isoamylase (Megazyme) and the mixture was incubated at 37 0 C for about 16 h.
  • the relative proportion of short side chains in the total content of all the side chains was determined by determining the content of a particular side chain as a percentage of the total content of all the side chains.
  • the total content of all the detectable side chains was elucidated by determining the total area under the peaks which represent the DP6 to 34 degrees of polymerization in the HPLC chromatogram.
  • the column was eluted with 90% (v/v) DMSO, 90 mM sodium acetate at a flow rate of 0.7 ml/min and over a period of 1 h.
  • the columns which were used were calibrated with dextran standards (Fluka, product #31430).
  • the dextrans which were used, their appurtenant molar masses, and the elution volumes, are shown in Table 1.
  • the resulting calibration straight lines were used to depict the elution plot as a molecular weight distribution Fi ure 1 :
  • Tab. 1 Dextran standard calibration table
  • the dextrans which were used, their appurtenant molar masses, and the elution volumes, are shown in Tab. 1.
  • the resulting calibration straight lines are used to depict the elution plot as a molecular weight distribution (Fig. 1 ).
  • glucose was specified to have a molecular weight of 162.
  • the total area in the GPC chromatogram is stipulated to be 100% and the amounts represented by the area of the individual sections are calculated based on the amount represented by the total area:
  • Freeze/thaw stability(%) 50 x 100 x TS in the weighing pan (g) aliquot (g) x starch TS in the sample (g) h) Determining the heat stability
  • Heat stability (%) Scale graduation (after autoclaving) x 100
  • Shear stability was determined using a ,,Viskotester VT 550" (Type 002 - 7026), Gebr ⁇ der Haake, Dieselstra ⁇ e 4, D 76227 Düsseldorf.
  • 70 g of a starch suspension (5% w/v) were transferred to the container that is used for the measurements. This container was transferred to the heating device which had been adjusted to 90 0 C prior to that.
  • the slurry was stirred by a paddle agitator at 128 rpm (revolutions per minute) while the viscosity was recorded (software version 2.30. P). After 15 minutes the speed of the stirrer was increased to 512 rpm. After 5 minutes stirrer speed again was reduced to 128 rpm. Total time for the measurement was 21 minutes.
  • Viscosity is expressed as a relative viscosity having the unit "Skalenmaschine" (SKT).
  • Shear stability is expressed as the ratio of the viscosities after 21 min of the starch slurry that was stirred at 512 rpm to the slurry that was stirred at 128 rpm only.
  • Peak viscosity was determined using a ,,Viskotester VT 550" (Type 002 - 7026) Gebr ⁇ der Haake, Dieselstra ⁇ e 4, D 76227 Düsseldorf.
  • Viscosity is expressed as a relative viscosity having the unit "Skalenmaschine" (SKT). Peak viscosity is the maximum viscosity as recorded during the period of measurement.
  • Seq lD I Nucleic acid sequence of the potato (Solanum tuberosum) starch synthase SSIII, with the sequences which encode the corresponding SSIII protein being indicated.
  • Seq ID 2 Amino acid sequence of a potato SSIII protein.
  • Seq ID 3 Amino acid sequence of the Pfam cbm25 binding domain of the potato (Solanum tuberosum) SSIII protein.
  • Seq ID 4 Nucleic acid sequence encoding the potato (Solanum tuberosum) branching enzyme BEI.
  • Seq ID 5 Amino acid sequence of the potato (Solanum tuberosum) branching enzyme BEI.
  • Seq ID 6 Coding nucleic acid sequence of the potato (Solanum tuberosum) GBSSI gene.
  • Seq ID 7 Amino acid sequence of potato (Solanum tuberosum) GBSSI.
  • SEQ ID NO 9 Nucleic acid sequence containing the region encoding the 3 1 region of a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence is inserted in plasmid AN 46-196.
  • SEQ ID NO 10 Nucleic acid sequence containing the region encoding the 5 1 region of a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence is inserted in plasmid AN 47-196.
  • SEQ ID NO 11 Nucleic acid sequence containing the complete region encoding a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence is inserted in plasmid AN 49. This plasmid was deposited, in accordance with the Budapest Treaty, on September 15,
  • SEQ ID NO 12 Amino acid sequence encoding a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence can be deduced from the nucleic acid sequence inserted in plasmid AN 49 or from the nucleic acid sequence described under SEQ ID NO 11.
  • SEQ ID NO 13 Nucleic acid sequence containing the complete region encoding a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence was obtained by joining together the nucleic acid sequences which are described under SEQ ID NO 9 and SEQ ID NO 10. This nucleic acid sequence constitutes an allelic variant of the nucleic acid sequence described under SEQ ID NO 11 encoding a protein involved in starch biosynthesis.
  • SEQ ID NO 14 Amino acid sequence encoding a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence can be deduced from the nucleic acid sequence described under SEQ ID NO 13 and constitutes the amino acid sequence of an allelic variant of the amino acid sequence described under SEQ ID NO 12 encoding a protein involved in starch biosynthesis.
  • Primer KM2_Spe ( ⁇ '-TCAAACTAGTCACAACCAGTCC- ATTTCTGG-3 1 )
  • SEQ ID NO 17 Primer SoputE (5 l -CACTTTAGAAGGTATCAGAGC-3 1 )
  • Fig. 1 Calibration curve for GPC
  • transgenic plants which exhibit reduced BEI, SSIII and GBSSI activities transgenic plants which exhibited reduced BEI and SSIII activities were first of all generated.
  • agrobacteria were used, as described in Rocha-Sosa et al. (1989, EMBO J. 8, 23-29), to transfer the T-DNA of the plasmid pB33-aBEI-aSSIII-Kan into potato plants.
  • the expression vector pBin33-Kan was first of all constructed.
  • the promoter of the Solanum tuberosum patatin gene B33 (Rocha-Sosa et al., 1989, see above) was ligated, as a Dra ⁇ fragment (nucleotides -1512 - +14), into the vector pUC19 (Genbank Ace. No. M77789), which had been cut with Sst ⁇ and whose ends had been smoothed using T4 DNA polymerase. This resulted in the plasmid pUC19-B33.
  • the B33 promoter was excised from this plasmid using EcoRI and Sma ⁇ and ligated into the vector pBinAR, which had been cut correspondingly. This resulted in the plant expression vector pBin33-Kan.
  • the plasmid pBinAR is a derivative of the vector plasmid pBin19 (Bevan, 1984, Nucl. Acid Research 12, 8711-8721) and was constructed by H ⁇ fgen and Willmitzer (Plant Sci. 66 (1990), 221-230).
  • a Hindll fragment of 1631 bp in length, which contains a partial cDNA encoding the potato BEI enzyme (Kossmann et al., 1991 , MoI. Gen. Genet.
  • tissue samples of potato tubers were disrupted in 5O mM Tris-HCI, pH 7.6, 2 mM DTT, 2.5 mM EDTA, 10% glycerol and 0.4 mM PMSF.
  • the electrophoresis was carried out in a MiniProtean Il chamber (BioRAD).
  • the monomer concentration of the gels which were 1.5 mm thick, was 7.5% (w/v), while 25 mM Tris-glycine, pH 8.4, served as the gel buffer and running buffer.
  • Equal quantities of protein extract were loaded on and fractionated for 2 h at 10 mA per gel.
  • the activity gels were then incubated in 50 mM Tricine-NaOH, pH 8.5, 25 mM potassium acetate, 2 mM EDTA, 2 mM DTT, 1 mM ADP-glucose, 0.1% (w/v) amylopectin and 0.5 M sodium citrate. Glucans which were formed were stained with Lugol's solution.
  • BEI activity was likewise detected using nondenaturing gel electrophoresis: in order to isolate proteins from plants, the sample material was triturated in liquid nitrogen, taken up in extraction buffer (50 mM Na citrate, pH 6.5; 1 mM EDTA, 4 mM DTT) and, after centrifugation (10 min, 14 000 g, 4°C), used directly for measuring the protein concentration as described by Bradford. From 5 to 20 ⁇ g, as required, of total protein extract were then treated with 4-fold loading buffer (20% glycerol, 125 mM Tris HCI, pH 6.8) and loaded onto a "BE activity gel".
  • extraction buffer 50 mM Na citrate, pH 6.5; 1 mM EDTA, 4 mM DTT
  • centrifugation 10 min, 14 000 g, 4°C
  • Plasmid p35SaGBSSI-Met was prepared by inserting an Asp718/Xbal fragment of 1921 bp in length, containing a partial cDNA encoding potato GBSSI (Hergersberg, 1988, see above) into the vector pBinAR-Met, which had also been opened, in the antisense orientation with regard to the 35S promoter.
  • Vector pBinAR-Met is derived from the plasmid pGPTV-DHFR, which is a derivative of the vector pBin19 (Becker et al., 1992, Plant MoI. Biol. 20, 1195-1197).
  • pBinAR-Met contains the dhfr gene, which mediates resistance to methotrexate, instead of the nptll gene and the 3" end of gene 7 of the T-DNA of the Ti plasmid pTiACH ⁇ (nucleotides 2106-2316; Gielen et al., 1984, EMBO J. 3, 835-846) instead of the 3' end of the nopaline synthase gene.
  • plasmid pA7 (compare description of vector pBinAR above) as the starting point, the EcoRI/Hindlll fragment, comprising the 35S promoter, the ocs terminator and the intercollated part of the polylinker, was ligated into plasmid pGPTV-DHFR, which was cut correspondingly.
  • the resulting vector was designated pBinAR-Met.
  • Tissue samples were taken from tubers derived from the independent transformants among the plants which were obtained by transformation with the plasmid p35SaGBSSI-Met, and which were designated asBEI-asSSIII-asGBSSI plants, and the samples were stained with iodine solution and examined under the microscope.
  • the starches of the independent lines whose granules stained brown were used for further analysis of the starch properties.
  • the nucleotide sequence (SEQ ID No. 11 or SEQ ID No.13) encoding a Solanum tuberosum protein having the amino acid sequence specified under SEQ ID No. 12 or SEQ ID No.14 has not been previously described. By making sequence comparisons using different branching enzymes, it was possible to identify a domain which was used to screen EST databases.
  • Primers were now prepared once again in order to also amplify previously unknown sequences of the protein having the amino acid sequence depicted under SEQ ID NO 12 or SEQ ID NO 14.
  • the resulting fragment of approx.
  • the resulting fragment of approx. 2 kb in size, was cloned in an undirected manner into the pCR4-TOPO Invitrogen vector (product number: 45-0030).
  • the resulting plasmid was designated AN 47-196.
  • the sequence of the fragment inserted in plasmid AN 47-196 is depicted under SEQ ID NO 10.
  • sequence information in the nucleic acid sequence depicted under SEQ ID No. 13 was obtained by joining the nucleic acid sequences described under SEQ ID NO 9 and SEQ ID NO 10.
  • This nucleic acid sequence is an allelic variant of the nucleic acid sequence described under SEQ ID No 11 encoding a protein (SEQ ID No. 14) which is involved in starch biosynthesis.
  • Agrobacteria were used, as described in Rocha-Sosa et al. (EMBO J. 8, (1989), 23-29), to the T-DNA of the plasmid AN 54-196 (see below) into the potato plants having a reduced expression of the BEI, SSIII and GBSSI genes, which plants were described in example 1 and designated, in that example, as asBEI-asSSIII-asGBSSI plants.
  • the plants which were obtained by transformation with plasmid AN 54-196 were designated asBEI-asSSIII-asGBSSMBE3 and, in addition to exhibiting reduced expression of the BEI, SSIII and GBSSI genes, also exhibited a reduction in the expression of the gene described under SEQ ID No.
  • Tissue samples were taken from tubers derived from independent transformants, stained with iodine and examined under the microscope. The phosphate content in the C6 position was also determined. The starches from the independent lines whose granules stained brown and which exhibited a phosphate content which was greater than that of the starting lines (see example 1 ) were used for further analysis of the starch properties.
  • AN 54-196 is a derivative of plasmid pBinB33-Hyg, into which a constituent sequence of the coding nucleic acid sequence specified under SEQ ID NO 11 or SEQ ID NO 13 was inserted as an inverted repeat (RNAi technology) under the control of the promoter of the Solanum tuberosum patatin gene B33 (Rocha-Sosa et al., 1989).
  • a PCR product was first of all amplified from a tuber-specific Solanum tuberosum (cv Desiree) cDNA library using the primers B1_Asp (GAT GGG TAC CAG CAC TTC TAC TTG GCA GAG G) and B2_Sal (TCA AGT CGA CCA CAA CCA GTC CAT TTC TGG) resulting in the cleavage sites Asp7" ⁇ 8 and Sail being added.
  • the PCR product (625 bp) which was obtained was cloned, in the antisense orientation with regard to the B33 promoter, by way of these two cleavage sites.
  • the EcoR ⁇ -Hind ⁇ fragment comprising the B33 promoter, a part of the polylinker and the ocs terminator, was excised from plasmid pBinB33 and ligated into the vector pBIB-Hyg (Becker, 1990), which had been cut correspondingly.
  • the plasmid pBinB33 was obtained by ligating the promoter of the Solanum tuberosum patatin gene B33 (Rocha-Sosa et al., 1989), as a Dra ⁇ fragment (nucleotides -1512 - +14), into the Ssfl-cut vector pUC19, whose ends had been smoothed using T4 DNA polymerase.
  • the plasmid pBinAR is a derivative of the vector plasmid pBin19 (Bevan, 1984) and was constructed as follows:
  • a fragment of 529 bp in length which comprises nucleotides 6909-7437 of the cauliflower mosaic virus 35S RNA promoter (Pietrzak et al., 1986, Nucleic Acids Research 14, 5857-5868), was isolated, as an EcoR ⁇ /Kpn ⁇ fragment, from the plasmid pDH51 (Pietrzak et al., 1986) and ligated between the EcoRI and Kpn ⁇ cleavage sites of the pUC18 polylinker. This resulted in the plasmid pUC18-35S.
  • a fragment of 192 bp in length which comprises the polyadenylation signal (3 1 end) of the octopine synthase gene (gene 3) of the T-DNA of the Ti-plasmid pTiACH ⁇ (Gielen et al., 1984) (nucleotides 11749-11939), was isolated from the plasmid pAGV40 (Herrera-Estrella et al., 1983) using the restriction endonucleases Hind ⁇ and PvuW. After Ssp ⁇ linkers had been added to the PwII cleavage site, the fragment was ligated between the Sph ⁇ and Hind ⁇ cleavage sites of pUC18-35S. This resulted in the plasmid pA7.
  • starches were isolated from the tubers obtained from different independent lines of the asBEI-asSSIII-asGBSSI-iBE3 potato transformants described in example 3. The physicochemical properties of these starches were then analyzed. The results which were obtained on the basis of the starches which were prepared from the plant cells or plants according to the invention are given below either as absolute values or as percentage values based on starch from corresponding wild-type plant cells or wild-type plants (designated WT starch in that which follows) (table 2). In addition, the table contains starch data from "single” or “double” combinations disclosed in WO 00/08184 and WO 01/12782:
  • the absolute values for the amylose content were determined in the case of the starches from the corresponding wild-type plants (Desiree variety), from the starting line (asBEI-asSSIII-asGBSSI) and from the asBEI-asSSIII-asGBSSI-iBE3 potato plants (table 3):
  • the side-chain profile of the potato starch was analyzed by determining the content of a particular group of side chains expressed as a percentage of the total content of all the side chains in the GPC chromatogram (table 4) (see General methods "Using gel permeation chromatography to analyze the side-chain distribution of total starch"):
  • Table 4 Distribution of the side-chain profile of total starch in the lines asBEI-asSIII, asBEI-asSSIII-asGBSSI asBEI-asSSIII-asGBSSI-iBE3 and the corresponding wild type, divided into groups having different degrees of polymerization
  • the ratio of the total phosphate content to the phosphate content in the C6 position was also determined:
  • freeze/thaw stability of the potato starches according to the invention was analyzed by the method described above (see General Methods, Method g) "Determining the freeze/thaw stability"):

Abstract

The invention relates to potato starches having an amylose content of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per milligram of starch and a content of side chains having a DP of from 12 to 19 which is elevated as compared with that in potato starch from corresponding wild-type potato plants.

Description

Phosphorylated waxy potato starch
The present invention relates to potato starches having an amylose content of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per milligram of starch and an increased content of side chains having a DP of from 12 to 19 as compared with the potato starch from corresponding wild-type potato plants.
In view of the increasing importance which is currently being attached to plant components as renewable sources of raw material, one of the tasks of biotechnological research is to endeavor to adapt these plant raw materials to the requirements of the processing industry. In addition to this, it is necessary to achieve a great diversity of substances in order to enable renewable raw materials to be used in as many areas of employment as possible.
While the polysaccharide starch is composed of chemically uniform basic units, i.e. the glucose molecules, it is a complex mixture of different molecular forms which exhibit differences with regard to the degree of polymerization and branching and consequently differ greatly from each other in their physicochemical properties. A distinction is made between amylose starch, an essentially unbranched polymer composed of alpha-1 ,4-glycosidically linked glucose units, and amylopectin starch, a branched polymer in which the branches are formed as a result of the appearance of additional alpha-1 ,6-glycosidic linkages. Another important difference between amylose and amylopectin lies in their molecular weights. While amylose, depending on the origin of the starch, has a molecular weight of 5χ105 - 106 Da, the molecular weight of amylopectin is between 107 and 108 Da. The two macromolecules can be differentiated by their molecular weight and their different physicochemical properties, something which can most readily be visualized by their different iodine- binding properties.
Amylose was regarded for a long time as being a linear polymer which consisted of alpha-1 ,4-glycosidically linked alpha-D-glucose monomers. However, more recent studies have demonstrated the presence of a small proportion of alpha-1 ,6-glycosidic branching points (approx. 0.1%) (Hizukuri and Takagi, Carbohydr. Res. 134 (1984), 1-10; Takeda et al., Carbohydr. Res. 132, (1984), 83-92). Amylopectin constitutes a complex mixture composed of glucose chains which are branched differently. Amylopectin is more strongly branched than amylose. Side chains are linked by way of α-1 ,6-glycosidic bonds to the main chain, which is composed of α-1 ,4-glycosidically linked α-D-glucose monomers. According to textbook data (Voet and Voet, Biochemistry, John Wiley & Sons, 1990), the cc-1 ,6 branches occur every 24 to 30 glucose residues on average. This corresponds to a degree of branching of approx. 3%-4%. The data with regard to the degree of branching are variable and depend on the origin (e.g. plant species, plant variety, etc.) of the given starch. In typical plants which are used for industrial starch production, e.g. corn, wheat or potato, approx. 20%-30% of the synthesized starch is composed of amylose starch and approx. 70%-80% is composed of amylopectin starch.
The functional properties, such as the solubility, the retrogradation behavior, the ability to bind water, the film-forming properties, the viscosity, the pasting properties, the freeze/thaw stability, the acid stability, the gel strength and the starch grain size of starches are influenced, inter alia, by the amylose/amylopectin ratio, the molecular weight, the pattern of side chain distribution of the amylopectin, the content of ions, the content of lipid and protein, the mean starch grain size, the starch grain morphology, etc. The functional properties of starch are also influenced by the content of phosphate, in the starch. In this connection, a distinction is made between phosphate which is covalently bonded in the form of monoesters to the glucose molecules of the starch (termed starch phosphate below) and phosphate in the form of phospholipids which are associated with the starch.
The content of starch phosphate varies in dependence on the plant type. Thus, for example, certain corn mutants synthesize a starch having an elevated content of starch phosphate (waxy corn 0.002% and high-amylose corn 0.013%) whereas conventional corn types only exhibit traces of starch phosphate. Small quantities of starch phosphate are also found in wheat (0.001%) whereas it has not been possible to detect any starch phosphate in oats and sorghum. Relatively large quantities of starch phosphate have thus far been detected in tuber or root storage starch, for example tapioca (0.008%), sweet potato (0.011%), arrowroot (0.021%) or potato (0.089%). The percentage values of the starch phosphate content which have been cited above in each case relate to the dry weight of the starch and were determined by Jane et al. (1996, Cereal Foods World 41 (11), 827-832). Starch phosphate can be present in the form of monoesters at the C2, C3 or C6 position in the polymerized glucose monomers (Takeda and Hizukuri, 1971 , Starch/Starke 23, 267-272). In general, from about 30% to 40% of the covalently bound starch phosphate groups are located in the C3 position, and from about 60% to 70% are located in the C6 position, in the glucose monomers (Blennow et al., 2000, Int. J. of Biological Macromolecules 27, 211-218).
Potato amylopectin starches, i.e. starches having an amylopectin content of more than 90% and an amylose content of less than 10%, can be obtained from potato plants in which the activity of the starch granule-bound starch synthase GBSSI ("Granule-Bound Starch Synthase I") is reduced (Shure et al., 1983, Cell 35, 225-233; Hovenkamp-Hermelink et al., 1987, Theoretical and Applied Genetics 75, 217-221 ; Visser et al., 1991 , MoI. Gen. Genet. 225, 289-296). GBSSI is involved in the formation of amylose. Inhibition of the GBSSI activity leads to the synthesis of starch which is almost exclusively composed of amylopectin. The corresponding GBSSI gene in maize is known under the name "waxy". Amylopectin starches are also termed waxy starches.
Plants in which the activity of soluble starch synthase III (SSIII) is reduced have also been described (Abel et al., 1996, The Plant Journal 10(6), 981- 991 ; Lloyd et al., 1999, Biochemical Journal 338, 515-521 ). As compared with starch which is isolated from corresponding wild-type plants, starch from these plants exhibits a relative shift of the amylopectin side chains from relatively long chains to short chains (Lloyd et al., 1999, Biochemical Journal 338, 515-521), an increased content of phosphate, no change in the amylose content (Abel et al., 1996, The Plant Journal 10(6), 9891- 9991) and a reduced final viscosity in the RVA analysis (Abel, 1995, Berlin Free University dissertation).
Plants in which the activity of branching enzyme I (BEI) is reduced have also been described (Kossmann et al., 1991 , MoI. Gen. Genet. 230, 39-44; Safford et al., 1998, Carbohydrate Polymers 35, 155-168; WO 92/14827). Safford et al. (1998, see above) report that corresponding potatoes produce a starch which has a slightly altered amylose/amylopectin ratio. Nor does the degree of branching of the amylopectin differ significantly from that of a starch which is isolated from wild-type potatoes. However, the starch-bound phosphate content is slightly increased.
WO 01/19975 describes plants in which the GBSSI and the SSII and/or SSIII activities are reduced. As compared with starch from wild-type potatoes, starch from potatoes having reduced activities of GBSSI, SSII and SSIII exhibit a lower amylose content, altered swellability and pasting properties and higher freeze/thaw stability.
WO 01/12782 describes plants in which both the GBSSI activity and the BEI activity are reduced. Starch from these potato plants exhibits a reduced amylose content as compared with potato starch from wild-type plants and an elevated phosphate content and/or a reduced pasting temperature in the RVA analysis as compared with potato starch from plants having the waxy phenotype.
WO 00/08184 describes, inter alia, plants in which both the SSIII activity and the BEI activity are reduced. Starch from these plants exhibits a markedly elevated phosphate content as compared with starch from wild- type plants.
The present invention is based on the object of making available potato amylopectin starches having novel properties, novel plant cells and/or plants which produce the starches, as well as means and methods for generating said plant cells and/or plants.
This object is achieved by the provision of the embodiments which are described in the patent claims.
The present invention relates to potato starches which have an amylose content, as measured by the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight and a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per mg of starch (dry weight), and an elevated content of side chains having a DP of from 12 to 19 as compared with potato starch derived from corresponding wild-type potato plants. The present invention furthermore relates to potato starches which have an amylose content, as measured by the method ("General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight, a phosphate content in the C6 position of between 35 and IOO nmol of phosphate per mg of starch (dry weight) and a total phosphate content to phosphate content in the C6 position ratio of 1.10-1.60.
The present invention furthermore relates to potato starches which have an amylose content, as measured by the method ("General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per mg of starch (dry weight) and a shear stability of 58% to 80%, in particular of 60% to 78%, preferably of 66% to 77%, particularly preferably of 67% to 75%.
The present invention furthermore relates to potato starches which have an amylose content, as measured by the method ("General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight and a peak viscosity determined by the Rotovisko method of 332 SKT to 500 SKT, in particular of 345 SKT - 450 SKT, preferably of 360 SKT to 420 SKT and particularly preferably of 370 SKT to 400 SKT.
The present invention furthermore relates to potato starches which have an amylose content, as measured by the method ("General methods") of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight, a phosphate content in the C6 position of between 35 and IOO nmol of phosphate per mg of starch (dry weight) and a peak viscosity determined by the Rotovisko method of 332 SKT to 500 SKT, in particular of 345 SKT - 450 SKT, preferably of 360 SKT to 420 SKT and particularly preferably of 370 SKT to 400 SKT.
In connection with the present invention, the amylose content is determined using the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), which is described below for potato starch. This method can also be applied to starches which are isolated from other plant species. Methods for isolating starches are known to the skilled person and are described in detail below in the "General methods" section.
In connection with the present invention, the term "phosphate content in the C6 position" is to be understood as meaning the content of phosphate groups which are covalently bonded to carbon atom position 6 in the glucose monomers in the starch. In principle, the C2, C3 and C6 positions in the glucose units can be phosphorylated in the starch in vivo. In connection with the present invention, the phosphate content in the C6 position (= C6-P content) is determined by way of a glucose-6-phosphate determination using the opticoenzymic test which is described below
("General methods: determining the phosphate content in the C6 position").
In connection with the present invention, the term "total phosphate content" is to be understood as meaning the quantity of starch phosphate which is in total covalently bonded to glucose molecules in the starch. In connection with the present invention, the total phosphate content is determined using the method which is described below ("General methods: determining the total phosphate content").
In connection with the present invention, the term "elevated content of side chains having a DP of from 12 to 19" means an increase in the proportion of side chains in the starch having a DP (= degree of polymerization) of from 12 to 19 to 125%-200%, preferably to 130%-180%, and particularly preferably to 140%-160%, as compared with the proportion of side chains having a DP of from 12 to 19 in potato starch which is isolated from corresponding wild-type potato plants (100%).
In connection with the present invention, the side chain distribution in the starch is determined as described below in the section entitled "General methods: using gel permeation chromatography to analyze the side chain distribution in total starch".
In connection with the present invention, the term "wild-type potato plant cell" means that the cells are potato plant cells which were used as the starting material for producing the plant cells according to the invention, i.e. their genetic information corresponds, apart from the genetic modification which has been introduced, to that of a plant cell according to the invention. In connection with the present invention, the term "wild-type potato plant" means that the plants are plants which were used as the starting material for producing the plants according to the invention which are described below, i.e. their genetic information corresponds, apart from the genetic modification which has been introduced, to that of a plant according to the invention.
In connection with the present invention, the term "corresponding" means that, when comparing several objects, the objects in question, which are being compared with each other, were maintained under identical conditions. In connection with the present invention, the term
"corresponding" means, with regard to wild-type plant cells or wild-type plants, in particular, that the plant cells or plants which are being compared with each other were grown under identical culture conditions and that they are of the same (culture) age.
In a preferred embodiment of the invention, the potato starches according to the invention have an amylose content, as measured using the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 5% by weight, particularly preferably of less than 3% by weight.
In another preferred embodiment of the invention, the potato starch according to the invention has an elevated phosphate content in the C6 position of 40-85 nmol of C6-P per mg of starch, particularly preferably of 45-70 nmol of C6-P per mg of starch, very particularly preferably of 50- 65 nmol of C6-P per mg of starch.
In another preferred embodiment of the invention, the potato starch according to the invention exhibits an elevated phosphate content as compared with that in potato starch derived from corresponding wild-type potato plants. In connection with the present invention, the term "elevated phosphate content" means that the phosphate content in the C6 position in the starch according to the invention is elevated, in particular elevated by 415%-520%, preferably by 430%-500%, and particularly preferably by
440%-490%, as compared with that in starch which is derived from corresponding wild-type plant cells or plants. In another embodiment of the invention, the potato starch according to the invention exhibits an "elevated content of side chains having a DP of <12". In connection with the present invention, this means an increase in the proportion of the sum of side chains in the starch having a DP (degree of polymerization) of less than 12 to 130%-170%, preferably to 140%-160%, and particularly preferably to 145%-155%, as compared with the proportion of side chains having a DP of less than 12 (100%) in potato starch which is derived from corresponding wild-type potato plants.
In another embodiment of the invention, the potato starch according to the invention exhibits an "elevated content of side chains having a DP of 20-25". In connection with the present invention, this means an increase in the proportion of the sum of side chains in the starch having a DP (= degree of polymerization) of 20-25 to 132%-160%, preferably to 136%- 150%, and particularly preferably to 139%-148%, as compared with the proportion of side chains having a DP of 20-25 (100%) in potato starch which is derived from corresponding wild-type potato plants.
In another embodiment of the invention, the potato starch according to the invention exhibits a "reduced content of side chains having a DP of
63-123". In connection with the present invention, this means a reduction in the proportion of the sum of side chains in the starch having a DP
(= degree of polymerization) of 63-123 to 50%-95%, preferably to 65%-
90%, and particularly preferably to 73%-85%, as compared with the proportion of side chains having a DP of 63-123 (100%) in potato starch which is derived from corresponding wild-type potato plants.
In another embodiment of the invention, the potato starches according to the invention exhibit a "reduced content of side chains having a DP of >123". In connection with the present invention, this means a reduction in the proportion of the sum of side chains in the starch having a DP (= degree of polymerization) of greater than 123 to 0.1%-3.8%, preferably to 0.3%-3.0%, and particularly preferably to 0.5%-2.5%, as compared with the proportion of side chains having a DP greater than 123 (100%) in potato starch which is derived from corresponding wild-type potato plants.
In another preferred embodiment of the invention, the potato starches according to the invention exhibit a total phosphate content to phosphate content in the C6 position ratio of 1.20-1.50, particularly preferably of 1.30- 1.40.
In another embodiment of the invention, the potato starches according to the invention exhibit high freeze/thaw stability.
In connection with the present invention, the term "high freeze/thaw stability" means a freeze/thaw stability of at least 60%, in particular of at least 70%, preferably of at least 80%, and particularly preferably of at least 95%. In connection with the present invention, the freeze/thaw stability is determined using the method which is described below ("General methods").
In another embodiment of the invention, the potato starches according to the invention exhibit a high degree of heat stability.
In connection with the present invention, the term "high degree of heat stability" means a heat stability of at least 30%, in particular of at least 40%, and preferably of at least 50%. In connection with the present invention, the heat stability is determined using the method which is described below ("General methods").
In another embodiment of the invention, the potato starches according to the invention exhibit a high degree of shear stability.
In connection with the present invention, the term "high degree of shear stability" means a shear stability of 58% to 80%, in particular of 60% to 78%, preferably of 66% to 77%, particularly preferably of 67% to 75%. In connection with the present invention, the shear stability is determined using the method which is described below ("General methods: Method k).
In another embodiment of the invention, the potato starches according to the invention exhibit a viscosity behavior (e.g. pasting temperature, final viscosity) which is altered as compared with that of potato starch which is derived from corresponding wild-type potato plants. In connection with the present invention, the viscosity properties are determined using the RVA or the Rotovisko method which is described below ("General methods"). In another embodiment of the invention, the potato starches according to the invention exhibit an increased peak viscosity determined by the Rotovisko method ("General methods: Method I").
In connection with the present invention, the term "increased peak viscosity determined by the Rotovisko method" means an increase of the peak viscosity by 23% to 70%, in particular by 27% to 60%, preferably by 35% to 55%, particularly preferably by 40% to 50% compared with the peak viscosity of potato starch which is derived from corresponding wild-type potato plants (100%).
In another embodiment of the invention, the potato starches according to the invention exhibit a peak viscosity determined by the Rotovisko method of 332 SKT to 500 SKT, in particular of 345 SKT - 450 SKT, preferably of 360 SKT to 420 SKT and particularly preferably of 370 SKT to 400 SKT.
In another embodiment of the invention, the potato starches according to the invention exhibit a DSC peak temperature which is altered as compared with that of potato starch which is derived from corresponding wild-type potato plants. In connection with the present invention, the DSC peak temperature is determined using the method which is described below ("General methods").
In another embodiment of the invention, the potato starches according to the invention exhibit a gel strength which is reduced as compared with that of potato starch which is derived from corresponding wild-type potato plants. In connection with the present invention, the gel strength is determined using the method which is described below ("General methods").
In another embodiment of the invention, the potato starches according to the invention exhibit a gel strength of 1 ,0 g to 10,0 g , in particular of 3,5 g to 7,5 g, preferably of 3,7 g to 6,5 g and particularly preferably of 4,0 g to 6,O g.
The potato starches according to the invention are preferably native potato starches. In connection with the present invention, the term "native starch" means that methods known to the skilled person are used to extract the starch from plants or starch-storing parts of plants without the extracted starch being chemically modified following the extraction.
Furthermore, the present invention relates to a method for the manufacture of the (potato) starch according to the invention, including the step of extracting the starch from a plant cell according to the invention or from a plant according to the invention, from propagation material according to the invention of such a plant and/or from harvestable plant parts according to the invention of such a plant, preferably from starch-storing parts according to the invention of such a plant. Preferably, such a method also includes the step of harvesting the cultivated plants or plant parts and/or the propagation material of these plants before the extraction of the starch and, further, particularly preferably the step of cultivating plants according to the invention before harvesting.
The skilled person is familiar with methods for isolating starch from plants or from starch-storing parts of plants. Methods for extracting the starch from different starch-storing plants have also been described, e.g. in Starch: Chemistry and Technology (eds.: Whistler, BeMiller and Paschall (1994), 2nd edition, Academic Press Inc. London Ltd., ISBN 0-12-746270- 8; see, e.g. Chapter XII, pages 412-468; com and sorghum starches: preparation; by Watson; Chapter XIII1 pages 469-479: tapioca, arrowroot and sago starches: preparation; by Corbishley and Miller; Chapter XIV, pages 479-490: potato starch: preparation and uses; by Mitch; Chapter XV, pages 491 to 506: wheat starch: preparation, modification and uses; by Knight and Oson; and Chapter XVI, pages 507 to 528: rice starch: preparation and uses; by Rohmer and Klem; corn starch: Eckhoff et al., Cereal Chem. 73 (1996), 54-57, as a rule corn starch is extracted on an industrial scale using what is termed "wet milling".
The present invention also relates to potato starches according to the invention which possess one or more of the above-described properties. That is, this invention description discloses any combination of the following starch properties: amylose content or amylose/amylopectin ratio, phosphate content, side chain distribution, freeze/thaw stability and heat stability. Any combinations of two, three, four, five, six, seven, eight, nine and all the properties are to be regarded as being disclosed. The starches according to the invention exhibit properties which appear to make them particularly suitable for being used in processes in which a pronounced ability to swell, a high degree of freeze/thaw stability and/or a high charge density are advantageous. These requirements apply, for example, to thickeners in the foodstuffs industry, especially when these thickeners are frozen for storage or processing and/or a particularly high thickening efficiency is desirable.
Because of their unusually high charge density, which is to be attributed to the covalently bonded phosphate groups, and their low-viscosity thickening, the starches according to the invention are particularly well suited for being used in the paper industry. The high charge density is advantageous since it makes it possible to produce frequently employed amphoteric starches in what is only a one-step derivatization reaction and to a large extent dispense with additional derivatization reactions for introducing negative charges into the starches.
Standard methods, which are known to the skilled person, can be used to chemically and/or physically modify the potato starches according to the invention, preferably native potato starches, after they have been extracted from the potato tubers.
The skilled person knows that the properties of native potato starch can be altered by, e.g., physical (e.g. thermal or mechanical) and/or chemical derivatization and/or breakdown products of the starch (e.g. dextrins) which are obtained by enzymic, acid-hydrolytic or thermal degradation. The starches which are obtained in this connection, and which are to be designated "derivatized potato starches" in connection with the present invention, are particularly suitable for a variety of applications. The native potato starches according to the invention are better suited than are conventional potato starches (derived from wild-type potato plants) for being used as starting substance for preparing the derivatized potato starches because this starting substance exhibits, for example, a higher proportion of reactive functional groups, as a result of the higher content of covalently bonded starch phosphate, is more strongly hydrophilic and is more accessible to chemical agents.
The present invention therefore also relates to derivatized potato starches which contain the, preferably native, potato starches according to the invention and to methods for preparing such a derivatized starch, in which methods potato starch according to the invention, which is preferably native, is subsequently, i.e. after having been extracted from the potato tuber, chemically and/or physically modified, preferably in vitro.
The derivatized starch according to the invention is, in particular, heat- treated starch. The present invention preferably relates to acid-modified starch which has preferably been treated with acid, preferably with hydrochloric acid (at a concentration of up to 1M) in an aqueous system at temperatures of up to 500C.
In another embodiment, the present invention relates to derivatized starches which were obtained by subjecting the, preferably native, potato starch according to the invention to a temperature treatment in a dry system, preferably at temperatures of from preferably 12O0C to 14O0C.
In another embodiment, the derivatized starches are starch ethers, in particular starch alkyl ethers, O-allyl ethers, hydroxyalkyl ethers, O- carboxymethyl ethers, nitrogen-containing starch ethers, phosphate- containing starch ethers or sulfur-containing starch ethers.
In another embodiment, the derivatized starches are crosslinked starches.
In another embodiment, the derivatized starches are starch graft polymers.
In another embodiment, the derivatized starches are oxidized starches.
In another embodiment, the derivatized starches are starch esters, in particular starch esters which were introduced into the starch using organic acids. The starch esters are particularly preferably phosphate, nitrate, sulfate, xanthate, acetate or citrate starches.
The derivatized starches according to the invention are suitable for a variety of uses in the pharmaceutical industry and in the foodstuffs and/or nonfoodstuffs spheres. Methods for preparing derivatized starches according to the invention are known to the skilled person and are adequately described in the general literature. A review regarding the preparation of derivatized starches can be found, for example, in Orthoefer (in: Corn, Chemistry and Technology, 1987, eds. Watson and Ramstad, Chapter 16, 479-499).
The present invention likewise relates to derivatized starch which can be obtained using the method according to the invention for preparing a derivatized starch.
The present invention furthermore relates to the use of potato starches according to the invention, which are preferably native, for preparing derivatized potato starch.
The potato starches according to the invention are suitable, in native or derivatized form, for a variety of uses in the foodstuffs or nonfoodstuffs sphere.
In principle, the possibilities for using the starch can be divided into two large areas. One of the areas comprises the hydrolysis products of the starch, principally glucose and glucan building blocks, which are obtained using enzymic or chemical methods. They serve as starting compounds for further chemical modifications and processes such as fermentation. In this connection, the simplicity and economical implementation of a hydrolysis process can be of importance for reducing the cost. At present, the process proceeds essentially enzymatically using amyloglucosidase. It will be possible to conceive of saving costs by making less use of enzymes. A change in the structure of the starch, e.g. an increase in the surface of the granule, easier digestibility as a result of a lower degree of branching, or a steric structure which limits accessibility for the enzymes employed, could bring this about.
The other area, in which, because of its polymeric structure, the starch is used as what is termed native starch, divides into two further areas of use:
1. Foodstuffs industry Starch is a classical additive for many foodstuffs in which it essentially takes on the function of binding aqueous additives or brings about an increase in viscosity or else an increase in gel formation. Important characteristic features are the flowing and sorption behaviors, the swelling and pasting temperatures, the viscosity and the thickening efficiency, the solubility of the starch, the transparency and paste structure, the heating, shearing and acid stabilities, the tendency to retrogradation, the film-forming ability, the freeze/thaw stability, the digestibility and the ability to form complexes with, for example, inorganic or organic ions.
2. Non-foodstuffs industry
In this large area, the starch can be used as an auxiliary for different production processes or as an additive in industrial products. The paper and paperboard industry is to be mentioned, in particular, in connection with using the starch as an auxiliary. In this connection, the starch is first and foremost for retardation (retention of solids), for binding filler and fines particles, as a stabilizer and for dewatering. In addition to this, the favorable properties of the starch are exploited in relation to stiffness, hardness, rattle, feel, shine, glaze, plybond strength and the surfaces.
2.1 Paper and paperboard industry Four areas of application, namely surface, coating, pulp and spraying are to be distinguished within the paper manufacturing process.
The demands placed on the starch with regard to surface treatment are essentially a high degree of brightness, an appropriate viscosity, high viscosity stability, good film formation and low dust formation. When being used in coating, the solids content, an appropriate viscosity, high binding ability and high pigment affinity are of importance. When being used as a pulp additive, rapid, uniform and loss-free dispersion, high mechanical stability and complete retention in the paper web are of importance. When the starch is being used in the spraying area, an appropriate solids content, a high viscosity and a high binding ability are likewise of importance.
2.2 Adhesives industry
A large area for using the starches is constituted by the adhesives industry, where the possibilities of employment are divided into four constituent areas: use as pure starch glue, use in connection with starch glues which are prepared using special chemicals, use of starch as a substance added to synthetic resins and polymer dispersions, and use of starches as extenders for synthetic adhesives. 90% of the starch-based adhesives are used in the areas constituting corrugated board production, production of paper sacks and bags, production of materials for bonding paper and aluminum, production of cardboard articles, and production of remoistening glue for envelopes, postage stamps, etc.
2.3 Textile industry and textile care product industry
The area of textile production and textile care product production represents a large field for using the starches as auxiliaries and additives. The following four areas of use can be distinguished within the textile industry: the use of starch as a sizing material, i.e. as an auxiliary for smoothing and strengthening burring behavior, for protecting against the tractive forces which act during weaving, and for increasing the abrasion resistance in connection with weaving; starch as an agent for textile finishing, especially after quality- impairing pretreatments such as bleaching, dyeing, etc.; starch as a thickener in connection with producing pigment pastes for preventing dye diffusions; and starch as a substance added to warping agents for sewing cottons.
2.4 Building material industry The fourth area of employment is the use of the starches as additives for building materials. An example is the production of gypsum plasterboards in which the starch which is mixed in the gypsum slurry forms a paste with the water, diffuses to the surface of the gypsum panel, where it binds the paperboard to the panel. Other areas of employment are admixing to rendering fibers and mineral fibers. In the case of ready-mixed concrete, starch products are used for delaying setting.
2.5 Soil stabilization Another market for the starch presents itself in the case of the production of soil stabilization agents, which are employed for temporarily protecting the soil particles from water in association with earth moving operations. While, according to present day knowledge, the erosion-reducing and incrustation-reducing effects of combination products composed of starch and polymer emulsions are on a level with those of previously employed products, their price is markedly lower than that of these products.
2.6 Use in plant protection products and fertilizers
One area of employment lies in using the starch in plant protection products for the purpose of modifying the specific properties of the preparations. Thus, the starch can be used for improving the wetting properties of plant protection products and fertilizers, for the metered release of the active compounds, for converting liquid, volatile and/or malodorous active compounds into microcrystalline, stable and formable substances, for mixing incompatible compounds and for extending the duration of action by reducing decomposition.
2.7 The pharmaceuticals, medicines and cosmetics industry
The area of the pharmaceuticals, medicines and cosmetics industry constitutes another area of employment. In the pharmaceutical industry, the starch can be used as a binder for tablets or for binder dilution in capsules. The starch can also be used as a tablet disintegrant since it absorbs liquid after swallowing and after a short time swells to such an extent that the active compound is released. For reasons of quality, medicinal glidants and wound powders are based on starch. In the sphere of cosmetics, starches are, for example, employed as carriers of powder additives, such as perfumes and salicylic acid. Toothpastes constitute a relatively area for using the starch.
2.8 Addition of starch to coal and briquettes One area of employment is that of using the starch as a substance which is added to coal and briquettes. A starch additive can be used to agglomerate or briquette coal in a quantitatively high-grade manner, thereby preventing any premature decomposition of the briquettes. The addition of starch is between 4 and 6% in the case of grilling coal and between 0.1 and 0.5% in the case of calorized coal.
Starches are also gaining in importance as binders since their addition to coal and briquettes can markedly reduce the release of harmful substances. 2.9 Ore and coal slurry dressing
The starch can also be used as a flocculant in connection with ore and coal slurry dressing.
2.10 Foundry auxiliary
Another area of use is as a substance which is added to foundry auxiliaries. In a variety of casting processes, there is a need for cores which are produced from sands to which binder has been added. The binder which is nowadays mainly used is bentonite to which modified starches, usually swelling starches, have been added.
The purpose of adding the starch is to increase the flow resistance and to improve binding strength. In addition to this, the swelling starches can exhibit other requirements in relation to production technology, such as dispersible in cold water, rehydratable, readily miscible in sand and high water-binding capacity.
2.11 Use in the rubber industry In the rubber industry, the starch can be used for improving technical and optical quality. The reasons in this connection are the improvement in the surface shine, the improvement in the feel and the appearance (for this, starch is dusted onto the tacky gummed areas of rubbers prior to cold vulcanization) and the improvement in the printability of the rubber.
2.12 Use as a drilling auxiliary
Another possible application for the starches according to the invention is in the area of extracting raw materials using drills. Thus, in connection with extracting crude oil, for example, it is necessary to use auxiliaries and/or lubricants which prevent the drill or the drilling gear from overheating.
2.13 Production of leather substitutes Another opportunity for marketing the modified starches is in connection with the production of leather substitutes. 2.14 Starch in synthetic polymers
The following areas of application are apparent in the plastics sector: the integration of secondary starch products into the finishing process (starch is only a filler, there is no direct bond between the synthetic polymer and the starch) or alternatively, the integration of secondary starch products into the production of polymers (the starch and the polymer enter into a stable bond).
When compared with other substances such as talc, it is uncompetitive to use the starch simply as a filler. The situation is different when the specific properties of the starch come into play and the property profiles of the final products are markedly altered as a result. An example of this is the use of starch products in the finishing of thermoplastics such as polyethylene. In this connection, the starch and the synthetic polymer are combined, by being coexpressed in a ratio of 1 :1 , into a "masterbatch", from which various products are produced using granular polyethylene and conventional process technology. The integration of starch into polyethylene films makes it possible to achieve an increase in substance permeability in the case of hollow bodies, an improvement in water vapor permeability, an improvement in antistatic behavior, an improvement in antiblocking behavior and an improvement in printability when using aqueous pigments.
Another possibility is that of using the starch in polyurethane foams. By means of adapting the starch derivatives and optimization with regard to process technology, it is possible to control the reaction between synthetic polymers and the hydroxyl groups of the starches in a selective manner.
This results in polyurethane films which are given the following property profiles as a result of starch being used: a reduction in the thermal expansion coefficient, a reduction in the shrinkage behavior, an improvement in the pressure/tension behavior, an increase in water vapor permeability without any change in water uptake, a reduction in flammability and cracking density, no dripping-off of combustible parts, freedom from halogens and diminished aging. Disadvantages which still exist at present are a reduction in compression strength and a reduction in impact strength.
Product development is by now no longer restricted to films. Solid plastic products, such as pots, plates and bowls, having a starch content of more than 50% can also be produced. Furthermore, starch/polymer mixtures are to be judged as being advantageous since they exhibit a very much higher degree of biodegradability.
Furthermore, because of their extreme ability to bind water, starch graft polymers have become exceptionally important. These polymers are products having a starch backbone and a side lattice of a synthetic monomer which is grafted on in accordance with the principle of the free- radical chain mechanism. The starch graft polymers which are nowadays available are characterized by an improved ability to bind and retain up to 1000 g of water per g of starch in association with high viscosity. The areas in which these superabsorbers can be used have expanded greatly in recent years and lie in the hygiene sphere, involving products such as diapers and paddings, and in the agricultural sector, for example in connection with seed pelleting.
Factors which are crucially relevant for using the novel starches are, on the one hand, the structure, water content, protein content, lipid content, fiber content, ash/phosphate content, amylose/amylopectin ratio, molar mass distribution, degree of branching, granule size and shape, and crystallinity, and also, on the other hand, the properties which lead to the following features: flow and sorption behavior, pasting temperature, viscosity, thickening efficiency, solubility, paste structure and transparency, heat, shearing and acid stability, retrogradation tendency, gel formation, freeze/thaw stability, complex formation, iodine binding, film formation, adhesive strength, enzyme stability, digestibility and reactivity.
The potato starch according to the invention, which is preferably native, can be prepared by isolating it from genetically modified potato plants in which the genetic modification leads to a reduction in the GBSSI, SSIII and BEI activities and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, as compared with the activities of the corresponding wild-type potato plant cells or wild-type potato plants.
The present invention therefore also relates to plant cells and plants which are genetically modified, with the genetic modification leading to a reduction in the GBSSI, SSIII and BEI activities, and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, as compared with the activities of corresponding wild-type plant cells or wild-type plants.
In connection with the present invention, the term "GBSSI" is to be understood as meaning any enzyme which belongs to the isoform I class of starch granule-bound starch synthases (EC 2.4.1.21 ).
In connection with the present invention, the term "GBSSI gene" is to be understood as meaning a nucleic acid molecule or polynucleotide (cDNA or DNA) which encodes GBSSI. Polynucleotides encoding GBSSI have been described in the case of a variety of plant species, such as corn (Genbank Ace. Nos. AF079260, AF079261), wheat (Genbank Ace. Nos. AB019622, AB019623, AB019624), rice (Genbank Ace. Nos. AF092443, AF09244, AF031162), barley (Genbank Ace. Nos. X07931 , X07932), and potato (Genbank Ace. No. X58453). In one embodiment of the invention, the GBSSI gene exhibits an identity of at least 70%, in particular of at least 80%, of at least 90%, preferably of at least 95%, with the coding region of the nucleotide sequence which is depicted in SEQ ID NO 6. In a particularly preferred embodiment, the GBSSI gene is, in connection with the present invention, a nucleic acid molecule (cDNA or DNA) which encodes potato plant GBSSI; particular preference is given to the GBSSI gene which is specified under SEQ ID NO 6.
In connection with the present invention, the term "SSIII" is to be understood as meaning a particular class of soluble starch synthases
(ADP-glucose 1 ,4-α-D-glucan 4-α-D-glucosyltransferase; EC 2.4.1.21).
Soluble starch synthases catalyze a glycosylation reaction in which glucose residues of the substrate ADP-glucose are transferred to α-1 ,4-linked glucan chains with the formation of an α-1 ,4 linkage (ADP-glucose + {(1 ,4)- α-D-glucosylJ(N) <=> ADP + {(1 ,4)- α-D-glucosyl}(N+1 )).
SSIIIs are described, for example, in Marshall et al. (1996, The Plant Cell 8, 1121-1135), Li et al. (2000, Plant Physiology 123, 613-624), Abel et al. (1996, The Plant Journal 10(6), 981-991 ) and in WO 00/66745. The structure of SSIIIs frequently exhibits a sequence of particular domains and possesses a signal peptide, for transport into plastids, at its N terminus. There then follow, in the direction of the C terminus, an N-terminal region, an SSIII-specific region and a catalytic domain (Li et al., 2000, Plant Physiology 123, 613-624). Further analyses based on primary sequence comparisons (http://hits.isb-sib.ch/cgi-bin/PFSCAN) have shown that potato-derived SSIII protein exhibits what is termed a carbohydrate binding domain (CBM). This domain (Pfam motif cbm 25 = SEQ ID NO 3) comprises amino acids 377 to 437 of the potato SSIII protein sequence depicted in SEQ ID NO 2. In connection with the present invention, an SSIII protein is to be understood as being a protein which exhibits an identity of at least 70%, preferably of at least 80%, particularly preferably of at least 90%, very particularly preferably of at least 95%, with the sequence depicted in SEQ ID NO 2.
In connection with the present invention, the term "SSIII gene" is to be understood as meaning a nucleic acid molecule (DNA or cDNA) which encodes an SSIII protein. Nucleic acid molecules encoding SSIIIs have been described in the case of a variety of plant species, for example the potato (Abel et al., 1996, The Plant Journal 10(6), 981-991). In connection with the present invention, an "SSIII gene" is to be understood as meaning a nucleic acid molecule which exhibits an identity of least 70%, in particular of at least 80%, preferably of at least 90%, very particularly preferably of at least 95%, with the coding region of the sequence depicted in SEQ ID NO 1. In a particularly preferred embodiment, the SSIII gene is, in connection with the present invention, a nucleic acid molecule (cDNA or DNA) which encodes potato plant SSIII; particular preference is given to the potato SSIII gene which is specified under SEQ ID NO 1.
In connection with the present invention, the term "BEI" is to be understood as meaning an isoform I branching enzyme (BE) (α-1 ,4-glucan: α-1 ,4- glucan 6-glycosyltransferase; E. C. 2.4.1.18), which catalyzes a trans- glycosylation reaction in which α-1 ,4-linkages in an α-1 ,4-glucan donor are hydrolyzed and the α-1 ,4-glucan chains which are released in this connection are transferred to an α-1 ,4-glucan acceptor chain and, in association with this, converted into α-1 ,6 linkages. BEI is preferably derived from potato plants.
In this connection, the designation of the isoforms follows the nomenclature proposed by Smith-White and Preiss (Smith-White and Preiss, 1994, Plant MoI. Biol. Rep. 12, 67-71 ; Larsson et al., 1998, Plant MoI. Biol. 37, 505- 511 ). This nomenclature is based on all enzymes which exhibit higher homology (identity) at the amino acid level with corn BEI (GenBank Ace. No. D11081 ; Baba et al., 1991 , Blochem. Biophys. Res. Commun. 191 (1), 87-94; Kim et al., 1998, Gene 216, 233-243) than with corn BEII (Genbank Ace. Nos. AF072725, U65948) being designated isoform I branching enzymes or BEIs for short.
In connection with the present invention, the term "BEI gene" is to be understood as meaning a nucleic acid molecule or polynucleotide (cDNA or DNA) which encodes BEI. Polynucleotides encoding BEIs have been described in the case of a variety of plant species, for example in the case of corn (Genbank Ace. Nos. D11081 , AF072724), rice (Genbank Ace. No. D11082) and potato. Various forms of the potato BEI gene or potato BEI have, for example, been described by Khoshnoodi et al. (1996, Eur. J. Biochem. 242 (1 ), 148-155, Genbank Ace. No. Y08786) and by Kossmann et al. (1991 , MoI. Gen. Genet. 230, 39-44). In one embodiment of the invention, the BEI gene exhibits an identity of at least 70%, in particular of at least 80%, of at least 90%, preferably at least 95%, with the coding region of the nucleotide sequence depicted in SEQ ID NO 4. In a particularly preferred embodiment, the BEI gene is, in connection with the present invention, a nucleic acid molecule (cDNA or DNA) which encodes potato plant BEI; particular preference is given to the BEI gene specified under SEQ ID NO 4. In potato plants, the BEI gene is principally expressed in the tubers and hardly at all in the leaves (Larsson et al., 1998, Plant MoI. Biol. 37, 505-511).
In the context of the definitions of the terms "GBSSI gene", "SSIII gene" and/or "BEI gene", the "Genbank Ace" numbers and literature reference citations refer to specific polynucleotide sequences which encode the corresponding enzymes. Embodiments of the present invention in which polynucleotides having the sequences specified in the citations can be used are described below. In this connection, the invention is naturally not restricted to using such precisely described sequences or parts of these sequences. It is also possible, for example, to use polynucleotides which exhibit an identity of at least 80%, preferably at least 90%, particularly preferably of at least 95%, and very particularly preferably of at least 98%, with the sequences which are specified.
Genes which exhibit the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13, and their corresponding proteins which exhibit the amino acid sequence specified under SEQ ID NO 12 or SEQ ID NO 14, are involved in starch biosynthesis in plants. The amino acid sequences of these proteins exhibit homology with Arabidopsis thaliana proteins (GenBank Ace. No: BAB02827), which are described there as being branching enzyme-like proteins. In connection with the present invention, it has been found, surprisingly, that potato plants which exhibit reduced expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, and exhibit a reduction in GBSSI, SSIII and BEI activities, produce the, preferably native, potato starches according to the invention. It can be concluded from this that the gene specified under SEQ ID NO 11 or SEQ ID NO 13, or the protein which is encoded by this gene and has the amino acid sequence specified under SEQ ID NO 12 or SEQ ID NO 14, is involved, in potato plants, in the synthesis of the amylopectin side chains or in the phosphorylation of starch.
In connection with the present invention, the term "identity" is to be understood as meaning the number of amino acids/nucleotides which concur with those of other proteins/nucleic acids, expressed as a percentage. The identity is preferably determined using computer programs. If sequences which are being compared with each other are of differing lengths, the identity is to be determined such that the number of amino acids which the shorter sequence has in common with the longer sequence determines the percentage identity. The identity is preferably determined using the ClustalW computer program (Thompson et al., 1994, Nucleic Acids Research 22, 4673-4680), which is known and available to the public. ClustalW is made publicly available by Julie Thompson (Thompson@EMBL-Heidelberg.de) and Toby Gibson (Gibson@EMBL- Heidelberg.de), European Molecular Biology Laboratory, Meyerhofstrasse 1 , 69117 Heidelberg, Germany. ClustalW can also be downloaded from a variety of internet sites, including from IGBMC (Institut de Genetique et de Biologie Moleculaire et Cellulaire, B.P.163, 67404 lllkirch Cedex, France; (ftp://ftp-igbmcu.-strasbg.fr/pub/) and from EBI
(ftp://ftp.ebi.ac.uk/pub/software/) and from all mirrored internet sites belonging to the EBI (European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 ISD, UK).
Preference is given to using version 1.8 of the ClustalW computer program for determining the identity between the proteins which are described here and other proteins. The following parameter settings are to be used in this connection: KTUPLE=I , TOPDIAG=5, WINDOW=5, PAIRGAP=3, GAPOPEN=IO, GAPEXTEND=0.05, GAPDIST=8, MAXDIV=40, MATRIX=GONNET, ENDGAPS(OFF), NOPGAP, NOHGAP.
Preference is given to using version 1.8 of the ClustalW computer program for determining the identity between the nucleotide sequences of the nucleic acid molecules which are described herein and the nucleotide sequences of other nucleic acid molecules. The following parameter settings are to be used in this connection:
KTUPLE=2, TOPDIAGS=4, PAIRGAP=5, DNAMATRIX:IUB, GAPOPEN=IO, GAPEXT=5, MAXDIV=40, TRANSITIONS: unweighed.
One option for finding similar sequences is to carry out sequence database searches. In the searches, one or more sequences are predetermined to be what is termed the query. Statistical computer programs are then used to compare this query sequence with sequences which are contained in the chosen databases. Such database searches (blast searches) are known to the skilled person and can be carried out using the databases provided by different suppliers. If such a database search is carried out using the NCBI (National Center for Biotechnology Information, http://www.ncbi.nim.nih.gov/) database, the standard settings which are predetermined for the given comparison query should then be used. In the case of protein sequence comparisons (blastp), these settings are as follows: Limit entrez = not activated; Filter = low complexity activated; Expect value = 10; word size = 3; Matrix = BLOSUM62; Gap costs: Existence = 11 , Extension = 1. Such a search also results in the percentage identity between the query sequence and the similar sequences which are found in the databases being presented in addition to other parameters.
In one embodiment of the present invention, the genetic modification of the plant cells according to the invention or of the plants according to the invention is elicited by mutagenesis of one or more genes. The nature of the mutation is immaterial in this regard as long as it leads to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13. In connection with the present invention, the term "mutagenesis" is to be understood as meaning any type of introduced mutations, such as deletions, point mutations (nucleotide substitutions), insertions, inversions, gene conversions or chromosome translocations.
A mutation which leads to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13 can arise spontaneously in a plant and the corresponding plants can be selected and propagated using the methods which are described below.
A mutation which leads to a reduction the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13 can also be produced by using chemical agents or energy-rich radiation (e.g. x-radiation, neutron radiation, gamma radiation or UV radiation).
Agents which can be used for producing chemically induced mutations, and the mutations which arise in this connection as a result of the action of the corresponding mutagens, are described, for example, by Ehrenberg and Husain (1981 , Mutation Research 86, 1-113) and Mϋller (1972, Biologisches Zentralblatt 91 (1 ), 31-48). The generation of rice mutants using gamma rays, ethylmethane sulfonate (EMS), N-methyl-N-nitrosourea or sodium azide (NaNa) is described, for example, by Jauhar and Siddiq (1999, Indian Journal of Genetics, 59 (1 ), 23-28), Rao (1977, Cytologica 42, 443-450), Gupta and Sharma (1990, Oryza 27, 217-219) and Satoh and Omura (1981 , Japanese Journal of Breeding 31 (3), 316-326). The generation of wheat mutants using NaN3 or maleic hydrazide is described by Arora et al. (1992, Annals of Biology 8 (1), 65-69). Scarascia-Mugnozza et al. (1993, Mutation Breeding Review 10, 1-28) provide a review of the generation of wheat mutants using different types of energy-rich radiation and chemical agents. Svec et al. (1998, Cereal Research Communications 26 (4), 391-396) describe the use of N-ethyl-N-nitrosourea for generating mutants in triticale. The use of MMS (methylmethanesulfonic acid) and gamma radiation for generating millet mutants has been described by Shashidhara et al. (1990, Journal of Maharashtra Agricultural Universities 15 (1), 20-23). The production of mutants in plant species which chiefly multiply vegetatively has been described, for example, in the case of potatoes which produce an altered starch (Hovenkamp-Hermelink et al., 1987, see above) and in the case of mint in which the oil yield is increased or the oil quality is altered (Dwivedi et al., 2000, Journal of Medicinal and Aromatic Plant Sciences 22, 460-463).
All these methods are in principle suitable for producing the plant cells according to the invention or the plants according to the invention.
Methods which are known to the skilled person can be used to find mutations in the corresponding genes, in particular in genes which encode GBSSI, SSIII or BEI or genes which exhibit the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13. In particular, it is possible to make use, for this purpose, of analyses which are based on hybridizations with probes (southern blotting), amplification by means of the polymerase chain reaction (PCR), sequencing of relevant genomic nucleic acid fragments and searching for individual nucleotide substitutions. A method for identifying mutations with the aid of hybridization patterns is, for example, that of searching for restriction fragment length differences (restriction fragment length polymorphisms, RFLPs) (Nam et al., 1989, The Plant Cell 1 , 699-705; Leister and Dean, 1993, The Plant Journal 4 (4), 745-750). An example of a PCR-based method is that of analyzing amplified fragment length differences (amplified fragment length polymorphisms, AFLPs) (Castiglioni et al., 1998, Genetics 149, 2039-2056; Meksem et al., 2001 , Molecular Genetics and Genomics 265, 207-214; Meyer et al., 1998, Molecular and General Genetics 259, 150-160). It is also possible to use restriction endonuclease-cut amplified fragments (cleaved amplified polymorphic sequences, CAPS) for identifying mutations (Konieczny and Ausubel, 1993, The Plant Journal 4, 403-400; Jarvis et al., 1994, Plant MoI. Biol. 24, 685-687; Bachem et al., 1996, The Plant Journal 9 (5), 745-753). Methods for determining SNPs have been described by, inter alia, Qi et al. (2001 , Nucleic Acids Research 29 (22), e116), Drenkard et al. (2000, Plant Physiology 124, 1483-1492) and Cho et al. (1999, Nature Genetics 23, 203-207). Methods which enable many plants to be examined within a short time for the presence of mutations in given genes are particularly suitable. Such a method, i.e. what is termed TILLING (targeting-induced local lesions in genomes) has been described by McCallum et al. (2000, Plant Physiology 123, 439-442).
All these methods are in principle suitable for identifying plant cells according to the invention or the plants according to the invention.
Hoogkamp et al. (2000, Potato Research 43, 179-189) have produced stable monoploid mutants from a potato mutant (amή which was produced by means of chemical mutagenesis. These plants no longer synthesize any active GBSSI and therefore produce a starch which is amylose-free. The monoploid potato plants which are obtained can be used as the starting material for further mutageneses.
A reduction in the GBSSI and/or SSIII and/or BEI activities(-ies), and a reduction in the expression of the gene specified under SEQ ID NO 11 or
SEQ ID No 13, can be achieved by reducing the expression of one or more of the gene(s) which encode(s) GBSSI or SSIII or BEI and which exhibit(s) the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13 and/or by reducing the quantity of relevant enzyme material in the plant cells and/or by reducing the enzymic activity of the relevant proteins in the plant cells.
The reduction in the expression can, for example, be determined by measuring the quantity of transcripts which encode the relevant enzymes, e.g. by means of Northern blot analysis or RT-PCR. In this connection, a reduction preferably denotes a reduction in the quantity of transcripts by at least 50%, in particular by at least 70%, preferably by at least 85%, and particularly preferably by at least 95%, as compared with the quantity in corresponding wild-type plant cells.
The reduction in the quantity of GBSSI and/or SSIII and/or BEI, which results in a reduction in the relevant enzyme activities(-ies) in the plant cells, can be determined, for example, using immunological methods such as Western blot analysis, ELISA (enzyme-linked immunosorbent assay) or RIA (radioimmune assay). In this connection, a reduction preferably denotes a reduction in the quantity of relevant protein by at least 50%, in particular by at least 70%, preferably by at least 85%, and particularly preferably by at least 95%, as compared with that in corresponding wild- type plant cells.
In another embodiment of the present invention, the genetic modification of the plant cell according to the invention comprises introducing one or more foreign nucleic acid molecules/polynucleotides whose presence and/or expression leads to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies), and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, as compared with that/those in corresponding wild-type plant cells. In particular, the term genetic modification is understood as meaning the introduction of homologous and/or heterologous and/or mutagenized foreign nucleic acid molecules/polynucleotides into a plant cell, with said introduction of these molecules leading to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene which is specified under SEQ ID NO 11 or SEQ ID NO 13. In this way, it is consequently possible to generate transgenic plant cells according to the invention.
In this connection, the term "transgenic" means that the genetic information in the plant cells according to the invention differs from that of corresponding wild-type plant cells as a result of the introduction of a foreign nucleic acid molecule/polynucleotide, or several foreign nucleic acid molecules/polynucleotides, into the cell.
In connection with the present invention, the term "foreign nucleic acid molecule/polynucleotide" or "foreign nucleic acid molecules/polynucleotides" is to be understood as meaning such a molecule which either naturally does not occur in corresponding wild-type plant cells or which does not occur naturally in the specific spatial arrangement in corresponding wild-type plant cells, or which is located at a site in the genome of the plant cell at which it does not naturally occur. Preference is given to the foreign nucleic acid molecule/polynucleotide being a recombinant molecule which is composed of different elements whose combination, or specific spatial arrangement, does not occur naturally in plant cells.
The foreign nucleic acid molecule(s)/polynucleotide(s) which is/are used for the genetic modification can be one integrated nucleic acid construct or several separate nucleic acid constructs, in particular what are termed single, double, triple or quadruple constructs. Thus, the foreign nucleic acid molecule/polynucleotide can, for example, be what is termed a "quadruple construct", which is understood as meaning a single vector for plant transformation, which vector contains the genetic information for inhibiting the expression of one or more endogenous GBSSI genes, for inhibiting the expression of one or more SSIII genes, for inhibiting the expression of one or more BEI genes and for inhibiting the expression of the gene specified under SEQ ID NO 11 or SED ID NO 13, or whose presence or whose expression leads to a reduction in the GBSSI, SSIII and BEI activities and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13.
In another embodiment, the foreign nucleic acid molecule/polynucleotide can be what is termed a "double construct", which is understood as meaning a vector for plant transformation which contains the genetic information for inhibiting the expression of two of the four target genes (GBSSI gene, SSIII gene, BEI gene, gene having the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13) or whose presence or whose expression leads to a reduction in the activity of two of the four enzymes (GBSSI, SSIII, BEI or protein having the amino acid sequence specified under SEQ ID NO 12 or SEQ ID NO 14). In this exemplary embodiment of the invention, the expression of the third and fourth target genes is inhibited, and/or the activities of the third and fourth enzymes are reduced, using a separate foreign nucleic acid molecule/polynucleotide which contains the appropriate genetic information for inhibiting these two additional target genes.
In another embodiment of the invention, several different foreign nucleic acid molecules/polynucleotides, rather than a quadruple construct, are introduced into the genome of the plant cell, with one of these foreign nucleic acid molecules being, for example, a DNA molecule which, for example, constitutes a cosuppression construct which brings about a reduction in the expression of one or more endogenous GBSSI genes and leads to the inhibition of the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, and another foreign nucleic acid molecule being a DNA molecule which, for example, encodes an antisense RNA which beings about a reduction in the expression of one or more endogenous SSIII and/or BEI genes. In principle, however, the use of any combination of antisense, cosuppression, ribozyme and double-stranded RNA constructs or in-vivo mutagenesis which leads to a simultaneous reduction in the expression of endogenous genes which encode BGSSI, SSIII and BEI or which exhibit the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13, or which leads to a simultaneous reduction in the GBSSI, SSIII or BEI activities and to inhibition of the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, is also suitable when constructing the foreign nucleic acid molecules.
In this connection, the foreign nucleic acid molecules can either be inserted into the genome of the plant cell simultaneously (cotransformation) or consecutively, that is chronologically one after the other (super-transformation).
The foreign nucleic acid molecules/polynucleotides can also be introduced into different individual plants belonging to a species. In this connection, it is possible to generate plants in which the activities(-ies) of one enzyme (e.g. GBSSI or SSIII or BEI) or of two enzymes (e.g. GBSSI and SSIII or GBSSI and BEI or SSIII and BEI) or of three enzymes is/are reduced. Subsequent crossing can then be used to generate plants in which the activities of all three enzymes (GBSSI, SSIII and BEI) are reduced and the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13 is reduced.
It is furthermore possible, for the purpose of introducing a foreign nucleic acid molecule/polynucleotide, or for the purpose of producing the plant cells according to the invention or the plants according to the invention, to use a mutant instead of a wild-type plant cell or wild-type plant, with the mutant being distinguished by the fact that it already exhibits a reduced activity of one or more enzymes (GBSSI, SSIII, BEI and protein having the amino acid sequence specified under SEQ ID NO 12 or SEQ ID NO 14). The mutants can be either spontaneously arising mutants or else mutants which have been generated by the selective use of mutagens. Possibilities for generating such mutants have been described above. The plant cells according to the invention can also be produced by using what is termed insertion mutagenesis (review article: Thorneycroft et al., 2001 , Journal of Experimental Botany 52 (361), 1593-1601 ). "Insertion mutagenesis" is to be understood, in particular, as being the insertion of transposons or of what is termed transfer DNA (T-DNA) into a gene which encodes GBSSI and/or SSIII and/or BEI and/or has the nucleotide sequence specified under SEQ ID NO 11 or SEQ NO 13.
The transposons can be either those which naturally occur in a wild-type plant cell (endogenous transposons) or those which do not naturally occur in said cell but which are introduced into the cell using genetic methods such as transformation of the cell (heterologous transposons). The skilled person is familiar with using transposons to change the expression of genes. Ramachandran and Sundaresan (2001 , Plant Physiology and Biochemistry 39, 234-252) have provided a review regarding the use of endogenous and heterologous transposons as tools in plant biotechnology. The possibility of identifying mutants in which specific genes have been inactivated by transposon insertion mutagenesis is described in a review by Maes et al. (1999, Trends in Plant Science 4 (3), 90-96). The use of endogenous transposons to generate rice mutants has been described by Hirochika (2001 , Current Opinion in Plant Biology 4, 118-122). The use of endogenous retrotransposons to identify corn genes is described, for example, by Hanley et al. (2000, The Plant Journal 22 (4), 557-566). Kumar and Hirochika (2001 , Trends in Plant Science 6 (3), 127-134) describe the possibility of using retrotransposons to produce mutants, and also describe methods for identifying mutants. The activities of heterologous transposons in different species have been described both in the case of dicotyledonous plants and in the case of monocotyledonous plants: e.g. in the case of rice (Greco et al., 2001 , Plant Physiology 125, 1175-1177; Liu et al., 1999, Molecular and General Genetics 262, 413-420; Hiroyuki et al., 1999, The Plant Journal 19 (5), 605-613; Jeon and Gynheung, 2001 , Plant Science 161 , 211-219), barley (Koprek et al., 2000, The Plant Journal 24 (2), 253- 263), Arabidopsis thaliana (Aarts et al., 1993, Nature 363, 715-717; Schmidt and Willmitzer, 1989, Molecular and General Genetics 220, 17-24; Altmann et al., 1992, Theoretical and Applied Genetics 84, 371-383; Tissier et al., 1999, The Plant Cell 11 , 1841-1852), tomato (Belzile and Yoder, 1992, The Plant Journal 2 (2), 173-179) and potato (Frey et al., 1989, Molecular and General Genetics 217, 172-177; Knapp et al., 1988, Molecular and General Genetics 213, 285-290).
In principle, the plant cells according to the invention and the plants according to the invention can be produced using either homologous or heterologous transposons, with the use of homologous transposons also having to be understood as meaning the transposons which are already naturally present in the plant genome.
T-DNA insertion mutagenesis is based on specific segments (T-DNA) of Agrobacterium Ti plasmids being able to integrate into the genome of plant cells. The site for the integration into the plant chromosome is not fixed; rather, integration can take place at any arbitrary site. If the T-DNA integrates into a segment of the chromosome which constitutes a gene function, the integration can then lead to a change in the expression of the gene and consequently also to a change in the activity of a protein which is encoded by the gene in question. In particular, integration of a T-DNA into the coding region of a gene frequently results in the relevant cell either no longer being able to synthesize the corresponding protein at all or else no longer being able to synthesize it in an active form. The use of T-DNA insertions for generating mutants has been described, for example, in the case of Arabidopsis thaliana (Krysan et al., 1999, The Plant Cell 11 , 2283- 2290; Atipiroz-Leehan and Feldmann, 1997, Trends in Genetics 13 (4), 152-156; Parinov and Sundaresan, 2000, Current Opinion in Biotechnology 11 , 157-161) and rice (Jeon and An, 2001 , Plant Science 161 , 211-219; Jeon et al., 2000, The Plant Journal 22 (6), 561-570). Methods for identifying mutants which have been generated using T-DNA insertion mutagenesis have been described, inter alia, by Young et al. (2001 , Plant Physiology 125, 513-518), Parinov et al. (1999, The Plant Cell 11 , 2263- 2270), Thorneycroft et al. (2001 , Journal of Experimental Botany 52, 1593- 1601 ) and McKinney et al. (1995, The Plant Journal 8 (4), 613-622).
T-DNA mutagenesis is in principle suitable for generating the plant cells according to the invention and the plants according to the invention.
In another embodiment of the present invention, the presence and/or the expression of one or more foreign nucleic acid molecules/polynucleotides leads to the expression of endogenous genes which encode GBSSI and/or SSIII and/or BEI, and/or which exhibit the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13, being inhibited.
This can be achieved by means of a variety of methods which are known to a skilled person. These methods include, for example, expressing a corresponding antisense RNA or a double-stranded RNA construct, providing molecules or vectors which mediate a cosuppression effect, expressing an appropriately constructed ribozyme which specifically cleaves transcripts which encode GBSSI or SSIII or BEI, or what is termed "in-vivo mutagenesis". Furthermore, a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and/or a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13 in the plant cells can also be elicited by simultaneously expressing sense and antisense RNA molecules of the respective target gene to be repressed, preferably of the GBSSI and/or SSIII and/or BEI gene and/or of the gene having the nucleotide sequence which is specified under SEQ ID NO 11 or SEQ ID NO 13. The skilled person is familiar with these methods.
In addition to this, it is known that, in planta, the formation of double- stranded RNA molecules of promoter sequences can lead in trans to methylation and transcriptional inactivation of homologous copies of this promoter (Mette et al., 2000, EMBO J. 19, 5194-5201 ).
In order to employ antisense or cosuppression technology for inhibiting gene expression, it is possible, for example, to use a DNA molecule which comprises the entire sequence encoding GBSSI and/or SSIII and/or BEI and/or the nucleotide sequence which is specified under SEQ ID NO 11 or SEQ ID NO 13, including any flanking sequences which may possibly be present, or else use DNA molecules which only comprise parts of the coding sequence, with these parts having to be sufficiently long to bring about an antisense effect or cosuppression effect in the cells. In general, sequences having a minimum length of 15 bp, preferably having a minimum length of 20-30 bp, particularly preferably having a length of 100- 500 bp, in particular sequences having a length of more than 500 bp, are suitable for exerting very efficient antisense or cosuppression inhibition.
The use of polynucleotide sequences which have a high degree of identity with the sequences which occur endogenously in the plant cell and which encode GBSSI or SSIII or BEI, or which are depicted under SEQ ID NO 11 or SEQ ID NO 13, is also suitable for antisense or cosuppression approaches. The minimum identity should be greater than approx. 65%. The use of sequences having identifies of at least 90%, in particular of between 95 and 100%, is to be preferred.
It is furthermore also possible to conceive of using introns, i.e. noncoding regions of genes which encode GBSSI or SSIII or BEI or which exhibit the nucleotide sequence depicted under SEQ ID NO 11 or SEQ ID NO 13, for achieving an antisense or cosuppression effect.
The use of intron sequences for inhibiting the expression of genes which encode starch biosynthesis proteins has been described in WO 97/04112, WO 97/04113, WO 98/37213 and WO 98/37214.
The skilled person knows how he can achieve an antisense or cosuppression effect. The method of cosuppression inhibition has been described, for example, by Jorgensen (1990, Trends Biotechnol. 8, 340- 344), Niebel et al. (1995, Top. Microbiol. Immunol. 197, 91-103), Flavell et al. (1995, Curr. Top. Microbiol. Immunol. 197, 43-46), Palauqui and Vaucheret (1995, Plant MoI. Biol. 29, 149-159), Vaucheret et al. (1995, MoI. Gen. Genet. 248, 311-317) and de Borne et al. (1994, MoI. Gen. Genet. 243, 613-621 ).
Expression of ribozymes for the purpose of reducing the activity of particular enzymes in cells is also known to the skilled person and is described, for example, in EP-B1 0321201. The expression of ribozymes in plant cells has been described, for example, by Feyter et al. (1996, MoI. Gen. Genet. 250, 329-338).
Furthermore, a reduction in the GBSSI and/or SSIII and/or BEI activities(- ies) and/or a reduction in the expression of the gene depicted under SEQ ID NO 11 or SEQ ID NO 13 in the plant cells can also be achieved by what is termed "in-vivo mutagenesis", in which transformation of cells is used to introduce a hybrid RNA-DNA oligonucleotide ("chimeroplast") into cells (Kipp et al., poster session at the 5th International Congress of Plant Molecular Biology, 21-27 September 1997, Singapore; R.A. Dixon and CJ. Arntzen, meeting report relating to Metabolic Engineering in Transgenic Plants, Keystone Symposia, Copper Mountain, CO, USA, 1997, TIBTECH 15, 441-447; WO 95/15972; Kren et al., 1997, Hepatology 25, 1462-1468; Cole-Strauss et al., 1996, Science 273, 1386-1389 and Beetham et al., 1999, PNAS 96, 8774-8778).
While a part of the DNA component of the RNA-DNA oligonucleotide is homologous with a polynucleotide sequence in an endogenous GBSSI and/or SSIII and/or BEI gene and/or a gene depicted under SEQ ID NO 11 or SEQ ID NO 13, it exhibits a mutation as compared with the polynucleotide sequence of an endogenous GBSSI or SSIII or BEI gene or contains a heterologous region which is surrounded by the homolgous regions. As a result of base pairing of the homologous regions of the RNA- DNA oligonucleotide and of the endogenous polynucleotide, followed by homologous recombination, the mutation or heterologous region contained in the DNA component of the RNA-DNA oligonucleotide can be transferred into the genome of a plant cell. This leads to a reduction in the activities(- ies) of GBSSI and/or SSIII and/or BEI and/or to a reduction in the expression of the gene which is specified under SEQ ID NO 11 or SEQ ID NO 13.
In addition, a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) in the plant cells can also be elicited by simultaneously expressing sense and antisense RNA molecules of the respective target gene to be repressed, preferably of the GBSSI and/or SSIII and/or BEI gene and/or of the gene which is specified in SEQ ID NO 11 or SEQ ID NO 13.
This can be achieved, for example, by using chimeric constructs which contain inverted repeats of the respective target gene or parts of the target gene. In this connection, the chimeric constructs encode sense and antisense RNA molecules of the respective target gene. In planta, sense and antisense RNA are synthesized simultaneously as one RNA molecule, with sense and antisense RNA being separated from each other by a spacer and being able to form a double-stranded RNA molecule (RNAi technology).
It has been shown that introducing inverted-repeaT-DNA constructs into the genome of plants is a very efficient method for repressing the genes which correspond to the inverted-repeaT-DNA constructs (Waterhouse et al., 1998, Proc. Natl. Acad. Sci. USA 95, 13959-13964; Wang and Waterhouse, 2000, Plant MoI. Biol. 43, 67-82; Singh et al., 2000, Biochemical Society Transactions 28 (6), 925-927; Liu et al., 2000, Biochemical Society Transactions 28 (6), 927-929; Smith et al., 2000, Nature 407, 319-320; WO 99/53050). Sense and antisense sequences of the target gene or the target genes can also be expressed separately from each other using identical or different promoters (Nap et al., 6th International Congress of Plant Molecular Biology, 18-24 June 2000, Quebec, poster S7-27, lecture session S7).
It is consequently also possible to reduce the GBSSI and/or SSIII and/or BEI activities(-ies), and to reduce the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, in the plant cells by producing double-stranded RNA molecules of GBSSI or SSIII or BEI genes or genes having the nucleotide sequence which is depicted under SEQ ID NO 11 or SEQ ID NO 13. For this, preference is given to introducing inverted repeats of DNA molecules which are derived from GBSSI or SSIII or BEI genes, or genes having the nucleotide sequence depicted under SEQ ID NO 11 or SEQ ID NO 13, or cDNAs, into the genome of plants, with the DNA molecules which are to be transcribed being under the control of a promoter which regulates the expression of said DNA molecules.
In addition to this, it is known that, in plants, forming double-stranded RNA molecules of promoter DNA molecules can lead in trans to methylation and transcriptional inactivation of homolgous copies of these promoters, which will be termed target promoters in that which follows (Mette et al., 2000, EMBO J. 19, 5194-5201).
It is consequently possible to use inactivation of the target promoter to reduce the expression of a particular target gene (e.g. GBSSI, SSIII or BEI gene; gene having the nucleotide sequence depicted under SEQ ID NO 11 or SEQ ID NO 13) which is naturally under the control of this target promoter.
That is, in this case, the DNA molecules which comprise the target promoters of the genes (target genes) to be repressed are not, in contrast to the original function of promoters in plants, being used as elements for regulating the expression of genes or cDNAs but, instead, themselves being used as transcribable DNA molecules. In order to generate the double-stranded target promoter RNA molecules in planta, where the molecules can be present as RNA hairpin molecules, preference is given to using constructs which contain inverted repeats of the target promoter DNA molecules, with the target promoter DNA molecules being under the control of a promoter which regulates the expression of said target promoter DNA molecules. These constructs are then introduced into the genome of plants. The expression of the inverted repeats of said target promoter DNA molecules leads, in planta, to the formation of double-stranded target promoter RNA molecules (Mette et al., EMBO J. 19, 5194-5201 ). These molecules can inactivate the target promoter.
Reduction of the GBSSI and/or SSIII and/or BEI activities(-ies), and inhibition of the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, in the plant cells can consequently also be achieved by generating double-stranded RNA molecules of promoter sequences of GBSSI or SSIII or BEI genes or of genes having the nucleotide sequence depicted under SEQ ID NO 11 or SEQ ID NO 13. For this, preference is given to introducing inverted repeats of promoter DNA molecules of GBSSI and/or SSIII and/or BEI promoters into the genome of plants, with the target promoter DNA molecules (GBSSI, SSIII or BEI promoter) to be transcribed being under the control of a promoter which regulates the expression of said target promoter DNA molecules.
The skilled person also knows that he can reduce the GBSSI and/or SSIII and/or BEI activities(-ies), and inhibit the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, by expressing nonfunctional derivatives, in particular transdominant mutants, of the enzymes and/or by expressing antagonists/inhibitors of the enzymes.
Antagonists/inhibitors of the enzymes can, for example, be antibodies, antibody fragments or molecules having similar binding properties. For example, a cytoplasmic scFv antibody has been used to modulate the activity of the phytochrome A protein in recombinantly altered tobacco plants (Owen, 1992, Bio/Technology 10, 790-794; Review: Franken et al., 1997, Current Opinion in Biotechnology 8, 411-416; Whitelam, 1996, Trends Plant Sci. 1 , 268-272). In a general manner, any promoter which is active in plant cells is suitable for expressing the foreign nucleic acid molecule/polynucleotide (the foreign nucleic acid molecules/polynucleotides). In this connection, the promoter can be selected such that the expression takes place constitutively in the plants according to the invention or only in one particular tissue, at a particular timepoint in the development of the plant or at a timepoint which is determined by external influences. The promoter can be homologous or heterologous in relation to the plant.
Examples of appropriate promoters for expressing nucleic acids/polynucleotides which reduce the activity of a target gene are the promoter of the cauliflower mosaic virus 35S RNA and the corn ubiquitin promoter for constitutive expression, the patatin gene promoter B33 (Rocha-Sosa et al., 1989, EMBO J. 8, 23-29), the MCPI promoter of the potato metallocarboxypeptidase inhibitor gene (HU 9801674) or the potato GBSSI promoter (WO 92/11376) for tuber-specific expression in potatoes or a promoter which allows expression only in photosynthetically active tissues, e.g. the ST-LS1 promoter (Stockhaus et al., 1987, Proc. Natl. Acad. Sci. USA 84, 7943-7947; Stockhaus et al., 1989, EMBO J. 8, 2445- 2451), the Ca/b promoter (see, for example, US 5,656,496; US 5,639,952; Bansal et al., 1992, Proc. Natl. Acad. Sci. USA 89, 3654-3658) and the Rubisco SSU promoter (see, for example, US 5,034,322; US 4,962,028) or, for endosperm-specific expression, the glutelin promoter (Leisy et al., 1990, Plant MoI. Biol. 14, 41-50; Zheng et al., 1993, Plant J. 4, 357-366; Yoshihara et al., 1996, FEBS Lett. 383, 213-218), the shrunken-1 promoter (Werr et al., 1985, EMBO J. 4, 1373-1380), the wheat HMG promoter, the USP promoter, the phaseolin promoter or corn zein gene promoters (Pedersen et al., 1982, Cell 29, 1015-1026; Quatroccio et al., 1990, Plant MoI. Biol. 15, 81-93).
The potato patatin gene, MCPI and GBSSI promoters are promoters which are preferred for expressing the foreign nucleic acid molecule/polynucleotide (the foreign nucleic acid molecules/polynucleotides).
It is particularly advantageous to express the foreign nucleic acid molecule/polynucleotide (the foreign nucleic acid molecules/poly- nucleotides) in those organs in the plant which store starch. The examples of these organs are the tuber of the potato plant or the grains or endosperm of corn, wheat or rice plants. Preference is therefore given to using promoters which mediate expression in these organs.
However, it is also possible to use promoters which are only activated at a timepoint which is determined by external influences (see, for example, WO 93/07279). Promoters of heat shock proteins, which permit simple induction, may be of particular interest in this connection. It is furthermore possible to use seed-specific promoters, such as the Vicia faba USP promoter, which ensures seed-specific expression in Vicia faba and other plants (Fiedler et al., 1993, Plant MoI. Biol. 22, 669-679; Baumlein et al., 1991 , MoI. Gen. Genet. 225, 459-467), and also fruit-specific promoters, as described, for example, in WO 91/01373.
It is furthermore possible for a termination sequence, which serves the purpose of correctly terminating the transcription and of adding a poly A tail to the transcript, with the tail being attributed a function in stabilizing the transcripts, to be present. These elements are described in the literature (see, for example, Gielen et al., 1989, EMBO J. 8, 23-29) and can be substituted as desired.
A large number of techniques are available for introducing DNA into a host plant cell. These techniques include transforming plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transforming agent, fusing protoplasts, injecting, electroporating the DNA, introducing the DNA by means of a biolistic approach, and also other possibilities.
The use of the agrobacterium-mediated transformation of plant cells has been investigated intensively and described adequately in EP-A 0120516 and by Hoekema (1985, The Binary Plant Vector System Offsetdrukkerij Kanters B.V., Alblasserdam, Chapter V), Fraley et al. (Crit. Rev. Plant Sci. 4, 1-46) and An et al. (1985, EMBO J. 4, 277-287). For information regarding potato transformation, see, for example, Rocha-Sosa et al., 1989, EMBO J. 8, 29-33.
The use of agrobacterium transformation-based vectors for transforming monocotyledonous plants has also been described (Chan et al., 1993, Plant. MoI. Biol. 22, 491-506; Hiei et al., 1994, Plant J. 6, 271-282; Deng et al., 1990, Science in China 33, 28-34; Wilmink et al., 1992, Plant Cell Reports 11 , 76-80; May et al., 1995, Bio/Technology 13, 486-492; Conner and Domisse, 1992, Int. J. Plant Sci. 153, 550-555; Ritchie et al, 1993, Transgenic Res. 2, 252-265). Transformation using the biolistic approach (Wan and Lemaux, 1994, Plant Physiol. 104, 37-48; Vasil et al., 1993, Bio/Technology 11 , 1553-1558; Ritala et al., 1994, Plant MoI. Biol. 24, 317- 325; Spencer et al., 1990, Theor. Appl. Genet. 79, 625-631), protoplast transformation, electroporation of partially permeabilized cells, and the use of glass fibers to introduce DNA, represent alternative systems for transforming monocotyledonous plants. The transformation of corn, in particular, has been described repeatedly in the literature (see, for example, WO 95/06128, EP-A 0513849, EP-A 0465875, EP-A 0292435; Fromm et al., 1990, Biotechnology 8, 833-844; Gordon-Kamm et al., 1990, Plant Cell 2, 603-618; Koziel et al., 1993, Biotechnology 11 , 194-200; Moroc et al., 1990, Theor. Appl. Genet. 80, 721-726).
The successful transformation of other cereal types has also been described, for example in the case of barley (Wan and Lemaux, see above; Ritala et al., see above; Krens et al., 1982, Nature 296, 72-74) and in the case of wheat (Nehra et al., 1994, Plant J. 5, 285-297).
The present invention also relates to a plant cell which is genetically modified, with the genetic modification leading to reduction of the GBSSI,
SSIII and BEI activities and to inhibition of the expression of the gene specified under SEQ ID NO 11 or SEQ NO 13 as compared with those of corresponding wild-type plant cells or wild-type plants, and which contains at least one foreign nucleic acid which is selected from the group consisting of a) polynucleotides which encode at least one antisense RNA which leads to a reduction in the expression of at least one endogenous GBSSI gene and/or to a reduction in the expression of at least one endogenous SSIII gene and/or to a reduction in the expression of at least one endogenous BEI gene and/or to a reduction in the expression of at least one gene having the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13; b) polynucleotides which lead, by way of a cosuppression effect, to a reduction in the expression of at least one endogenous GBSSI gene and/or to a reduction in the expression of at least one endogenous SSIII gene and/or to a reduction in the expression of at least one endogenous BEI gene and/or to a reduction in the expression of at least one gene having the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13; c) polynucleotides which encode at least one ribozyme which specifically cleaves transcripts of at least one endogenous GBSSI gene and/or of at least one SSIII gene and/or of at least one BEI gene and/or of at least one gene having the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13; d) polynucleotides which are introduced by means of in-vivo mutagenesis and which lead to a mutation or an insertion in at least one endogenous GBSSI gene and/or to a mutation or an insertion in at least one endogenous SSIII gene and/or to a mutation or an insertion in at least one endogenous BEI gene and/or to a mutation or an insertion in at least one gene having the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13, with the mutation or insertion leading to a reduction in the expression of said gene or to the synthesis of inactive GBSSI and/or of inactive SSIII and/or of inactive BEI and/or of an inactive protein having the amino acid sequence specified under SEQ ID NO 12 or SEQ ID NO 14; e) polynucleotides which encode at least one antisense RNA and at least one sense RNA, with said antisense RNA and said sense RNA being able to form a double-stranded RNA molecule which leads to a reduction in the expression of at least one endogenous GBSSI gene and/or to a reduction in the expression of at least one endogenous SSIII gene and/or to a reduction in the expression of at least one endogenous BEI gene and/or to a reduction in the expression of at least one gene having the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13; f) polynucleotides which contain transposons, with the integration of the transposon sequences leading to a mutation or an insertion in at least one endogenous GBSSI gene and/or to a mutation or an insertion in at least one endogenous SSIII gene and/or to a mutation or an insertion in at least one endogenous
BEI gene, and/or to a mutation or an insertion in at least one gene having the nucleotide sequence specified under SEQ ID
NO 11 or SEQ ID NO 13, with the mutation or insertion leading to a reduction in the expression of said gene or to the synthesis of inactive GBSSI and/or of inactive SSIII and/or of inactive BEI and/or of an inactive protein having the amino acid sequence specified under SEQ ID NO 12 or SEQ ID NO 14; and g) T-DNA molecules which, by insertion in at least one endogenous GBSSI gene and/or by insertion in at least one endogenous SSIII gene and/or by insertion in at least one endogenous BEI gene and/or by insertion in at least one gene having the nucleotide sequence specified under SEQ ID NO 11 or SEQ ID NO 13, lead to a reduction in the expression of said gene or to the synthesis of inactive GBSSI and/or of inactive SSIII and/or of inactive BEI and/or of an inactive protein having the amino acid sequence specified under SEQ ID NO 12 or SEQ ID NO 14.
The present invention also relates to any type of material for propagating plants according to the invention.
The plant cells according to the invention can be used for regenerating whole plants.
The present invention likewise relates to the plants which can be obtained by regenerating the plant cells according to the invention.
The plants according to the invention or the plant cells according to the invention can belong to any arbitrary plant species, that is either to monocotyledonous or to dicotyledonous plants. The plants according to the invention are preferably agriculturally useful plants, i.e. plants which are cultivated by man for purposes of nutrition or for technical, in particular, industrial purposes, and their cells. The invention preferably relates to fiber- forming (e.g. flax, hemp and cotton), oil-storing (e.g. rape, sunflower and soybean), sugar-storing (e.g. sugar beet, sugar cane and sweet sorghum) and protein-storing plants (e.g. leguminosae) and their cells.
In another preferred embodiment, the invention relates to forage plants, in particular forage grasses and pasture grasses (alfalfa, clover, etc.) and vegetable plants (e.g. tomato, salad and chicory) and their cells.
In another preferred embodiment, the invention relates to starch-storing plants (e.g. wheat, barley, oats, rye, potato, corn, rice, pea and tapioca), particularly preferably potatoes, and their cells.
In connection with the present invention, the term "potato plant" or "potato" means plant species of the genus Solanum, particularly tuber-producing species of the genus Solanum and, in particular, Solanum tuberosum.
The present invention furthermore relates to a method for producing a plant according to the invention, in which
a) a plant cell is genetically modified, with the genetic modification being the introduction of one or more foreign nucleic acid molecule(s) whose presence and/or expression leads to a reduction in the GBSSI and/or SSIII and/or BEI activities(-ies) and to a reduction in the expression of the gene specified under SEQ ID NO 11 or SEQ ID NO 13, as compared with those in corresponding wild-type plant cells, b) a plant is regenerated from step a) plant cells; and c) where appropriate, further plants are produced using the plants in accordance with step b).
The genetic modification which is introduced into the plant cell in accordance with step a) can in principle be any type of modification which leads to a reduction in the activity of one or more SSIII proteins which occur(s) endogenously in the plant and of one or more BEI proteins which occur(s) endogenously in the plant and of one or more GBSSI proteins which occur(s) endogenously in the plant and of one or more proteins which occur(s) endogenously in the plant and which exhibit(s) at least 80%, preferably 90%, particularly preferably 95%, identity with the nucleic acid molecule specified under SEQ ID NO 12 or SEQ ID NO 14.
The plants according to step (b) can be regenerated using methods which are known to the skilled person (e.g. described in "Plant Cell Culture Protocols", 1999, edtd. by R.D. Hall, Humana Press, ISBN 0-89603-549-2). Further plants can be regenerated in accordance with step (c) of the method according to the invention by means, for example, of vegetative propagation (for example using cuttings or tubers or using a callus culture and regenerating whole plants) or by means of sexual propagation. In this connection, the sexual propagation preferably takes place in a controlled manner, i.e. selected plants possessing particular properties are crossed with each other and propagated. In this connection, the selection is preferably made such that the further plants which are obtained in accordance with step c) exhibit the genetic modification which was introduced in step a).
The disclosure content of all the documents cited in the patent application is to be included in the disclosure content of the present description of the invention.
General methods
The following methods were used in the examples. These methods are also intended to be employed in connection with the present invention:
1.Method for extracting starch from potatoes
All the tubers belonging to a line (from 4 to 5 kg) are worked up jointly in a commercially available juice extractor (Multipress automatic MP80, Braun). The starch-containing juice is collected in a 10 I bucket (ratio of the height of the bucket/diameter of the bucket = approx. 1.1) in which 200 ml of mains water containing a spoon tip (approx. 3-4 g) of sodium disulfite have been initially introduced. The bucket is then completely filled with mains water. After the starch has settled for 2 hours the supernatant is decanted off and the starch is once again suspended in 10 I of mains water and passed through a sieve having a mesh width of 125 μm. After 2 hours (the starch has once again settled at the bottom of the bucket), the aqueous supernatant is decanted once again. This washing procedure is repeated a further 3 times such that the starch is resuspended in fresh mains water a total of five times. The starches are then dried at 370C down to a water content of 12-17% and homogenized in a mortar. The starches are now available for analyses. 2. Starch analysis a) Determining the amylose/amylopectin ratio
Starch was isolated from potato plants, as described above, and the amylose to amylopectin ratio was determined using the method described by Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246). The amylose content is calculated by applying the formula cited on page 243 of this article.
b) Determining the phosphate content in the C6 position
In the starch, the C2, C3 and C6 positions of the glucose units can be phosphorylated. In order to determine the C6-P content of the starch, 50 mg of starch were hydrolyzed, at 950C for 4 h, in 500 //I of 0.7 M HCI. The mixtures were then centrifuged at 15500 g for 10 min and the supematants were taken off. 7 μ\ volumes of the supematants were mixed with 193 /vl of imidazole buffer (10O mM imidazole, pH 6.9; 5 mM MgCI2,
1 mM EDTA and 0.4 mM NAD). The measurement was carried out at 340 nm in a photometer. After a basal absorption had been established, the enzyme reaction was started by adding 2U of glucose-6-phosphate dehydrogenase (from Leuconostoc mesenteroides, Boehringer Mannheim). The change in absorption is directly proportional to the concentration of the G-6-P content in the starch.
c) Using a Rapid Visco Analyzer (RVA) to determine the viscosity properties:
The viscosity properties were determined following the method which is described in WO 01/19975.
2 g of starch (dry matter) were taken up in 25 ml of H2O (deionized water, conductivity of at least 15 megaohm) and analyzed in a Rapid Visco Analyser (Newport Scientific Pty Ltd., Investmet Support Group, Warriewod NSW 2102, Australia) for the purpose of determining the viscosity properties. The appliance was operated in accordance with the manufacturer's instructions. In order to determine the viscosity of the aqueous solution of the starch, the starch suspension was first of all stirred at 960 rpm (revolutions per minute) for 10 seconds after which it was heated at 500C for 1 min at a stirring rate of 160 rpm (step 1 ). After that, the temperature was increased from 5O0C to 950C at a heating rate of 12°C per min while the stirring rate remained the same (step 2). The temperature was then kept at 950C for 2.5 min while the stirring rate remained the same (step 3). After that, the solution was cooled down from 950C to 500C at a cooling rate of 120C per min while the stirring rate remained the same (step 4). The last step (step 5) maintains the temperature of 500C for 2 min while the stirring rate remains the same. The viscosity was determined during the entire period.
After the program had come to an end, the stirrer was removed and the beaker was covered. The pasted starch was now available for the texture analysis after 24 h (method d) below).
In the RVA analysis profile, there are characteristic values which are presented for comparing different measurements and substances. In connection with the present invention, the following terms are to be understood as follows:
Maximum viscosity (RVA Max):
The maximum viscosity is understood as meaning the highest viscosity value, as measured in cP (centipoise), which is achieved in step 2 or 3 of the temperature profile.
Minimum viscosity (RVA Min):
The minimum viscosity is understood as meaning the lowest viscosity value, as measured in cP, which occurs in the temperature profile after the maximum viscosity. This normally occurs in step 3 of the temperature profile.
Final viscosity (RVA Fin):
The final viscosity is understood as meaning the viscosity value, as measured in cP, which occurs at the end of the measurement.
Setback (RVA Set):
What is termed the "setback" is calculated by subtracting the minimum viscosity value from the final viscosity. Pasting temperature (RVA PT):
The pasting temperature is understood as being the temperature in the temperature profile at which the viscosity for the first time increases by 55 cP over a period of 20 sec.
d) Determining the gel strength (texture analyzer)
2 g of starch (dry matter) were pasted in 25 ml of an aqueous suspension in the RVA appliance (temperature program: see under c) "using a Rapid Visco Analyzer (RVA) to determine the viscosity properties") and then stored, for 24 h at room temperature, in a closed vessel.
The samples were fixed under the probe (cylindrical plunger having a planar surface) of a TA-XT2 texture analyzer supplied by Stable Micro Systems (Surrey, UK), and the gel strength was determined using the following parameters:
- Test speed 0.5 mm/sec
- Penetration depth 7 mm
- Contact area 113 mm2 - Pressure 2 g
e) Using ion exchange chromatography to analyze the side chain distribution of the amylopectin
In order to separate amylose and amylopectin, 200 mg of starch were dissolved in 50 ml reaction vessels containing 12 ml of 90% (v/v) DMSO in H2O. After 3 volumes of ethanol had been added, the precipitate was separated off by centrifuging for 10 minutes at about 1800 g and at room temperature (RT). The pellet was then washed with 30 ml of ethanol, dried and dissolved at 75°C in 40 ml of 1% (w/v) NaCI solution. After the solution had been cooled down to 300C, about 90 mg of thymol were added slowly and this solution was incubated at 300C for at least 60 h. The solution was then centrifuged at 2000 g (RT) for 30 min. The supernatant was treated with 3 volumes of ethanol and the amylopectin which precipitated out was separated off by centrifuging at 2000 g (RT) for 5 minutes. The pellet (amylopectin) was then washed with ethanol and dried using acetone. A 1 % solution of amylopectin was then prepared in 10 mM sodium acetate, pH 3.5, with the amylopectin being dissolved at 65-950C for 1-2 h. In each case 100 μl of this solution were treated, for the digestion, with 180 //I of 10 mM sodium acetate, pH 3.5, and 1 μ\ of isoamylase (Megazyme) and the mixture was incubated at 370C for about 16 h. A 1 :5 aqueous dilution of this digestion was then filtered using an 0.2 //m filter and 100 //I of the filtrate were analyzed by ion chromatography (HPAEC-PAD, Dionex). The separation was effected using a PA-100 column (with appropriate precolumn), and the detection was effected amperometrically.
The elution conditions were as follows: Solution A - 0.15 M NaOH
Solution B - 1 M sodium acetate in 0.15 M NaOH
Figure imgf000050_0001
The relative proportion of short side chains in the total content of all the side chains was determined by determining the content of a particular side chain as a percentage of the total content of all the side chains. The total content of all the detectable side chains was elucidated by determining the total area under the peaks which represent the DP6 to 34 degrees of polymerization in the HPLC chromatogram.
The content of a particular side chain expressed as a percentage of the total content of all the side chains was elucidated by determining the ratio of the area of the peak which represents this side chain in the HPLC chromatogram to the total area. Version 6.20 of the Chromelion 6.20 program supplied by Dionex, USA, was used for determining the peak areas. f) Using gel permeation chromatography to analyze the side chain distribution in total starch
In order to use gel permeation chromatography to determine the side chain distribution in total starch, 10 mg of starch were dissolved, at 600C for approx. 3 h, in 250 μl of 90% (v/v) DMSO. After 375 μl of H2O (dist.) had been added, the solution was heated at 950C for approx. 1 h. For the enzymic digestion of the starch, 200 μl of starch solution were added to 300 μl of 16.6 mM sodium acetate, pH 3.5, and incubated at 37°C for about 16 h by adding 2 μl of isoamylase (Megazyme). An aqueous 1 :4 dilution of this digestion was then filtered using an 0.2 μm filter and 25 μl of the filtrate were analyzed by means of gel permeation chromatography. The separation was effected using two columns which were connected in series; that is firstly a Gram 3000 column (Polymer Standards Service with appropriate precolumn), with this then being followed by a Gram 100 column. A refraction index detector (Rl 71 , Shodex) was used for the detection. The column was equilibrated with 90% (v/v) DMSO, 90 mM sodium acetate. The column was eluted with 90% (v/v) DMSO, 90 mM sodium acetate at a flow rate of 0.7 ml/min and over a period of 1 h. In order to correlate the elution volume with the molar mass, the columns which were used were calibrated with dextran standards (Fluka, product #31430). The dextrans which were used, their appurtenant molar masses, and the elution volumes, are shown in Table 1. The resulting calibration straight lines were used to depict the elution plot as a molecular weight distribution Fi ure 1 :
Figure imgf000051_0001
Tab. 1 : Dextran standard calibration table In this connection, the total area of the GPC chromatogram was divided into individual sections which represented respective groups of side chains of differing lengths. The sections which were chosen contain side chains having the following degrees of polymerization (dp = number of glucose monomers within a side chain): dp<12, dpi 2-19, dp20-25, dp26-31 , dp32- 37, dp38-43, dp44-49, dp50-56, dp57-62, dp63-123 and >dp123. The dextrans which were used, their appurtenant molar masses, and the elution volumes, are shown in Tab. 1. The resulting calibration straight lines are used to depict the elution plot as a molecular weight distribution (Fig. 1 ). In order to determine the molecular weights of the individual side chains, glucose was specified to have a molecular weight of 162. The total area in the GPC chromatogram is stipulated to be 100% and the amounts represented by the area of the individual sections are calculated based on the amount represented by the total area:
g) Determining the freeze/thaw stability
In order to determine the freeze/thaw stability, in each case 3.5 g of starch (dry weight) were made up to 70 ml with distilled water and pasted for 15 min at 900C (128 rpm, inclined blade stirrer) in a rotary viscometer (Rotovisko, Haake). The starch paste was then autoclaved, at 1210C for 15 min, in a glass vessel having a screw closure. After that, in each case 5 g of this paste were subjected 3 times, likewise in a glass vessel having a screw closure, to a freeze/thaw cycle (from room temperature down to -200C). This quantity of paste was then treated with 25 ml of distilled water, homogenized at 8000 rpm for 1 min in an Ultra-Turrax, and then extracted on a magnetic stirrer for 1 h at 37°C in a drying oven. The sample was then transferred to a 50 ml volumetric flask and made up to 50 ml with distilled water; this mixture was then centrifuged at 2800 g for 5 min and filtered. An aliquot of this filtrate was inspissated overnight at 1050C and the residue was weighed. The freeze/thaw stability was then calculated as follows:
Freeze/thaw stability(%)= 50 x 100 x TS in the weighing pan (g) aliquot (g) x starch TS in the sample (g) h) Determining the heat stability
In order to determine the heat stability, in each case 3.5 g of starch (dry weight) were made up to 70 ml with distilled water and pasted for 15 min at 9O0C (128 rpm, inclined blade stirrer) in a rotary viscometer (Rotovisko, Haake). The starch paste was then autoclaved, at 1210C for 15 min, in a glass vessel having a screw closure and subsequently transferred back to the rotary viscometer beaker.
After 6 min at 900C, and with the blade stirrer rotating at 128 rpm, the scale graduation was read and compared with the value which was measured after 21 min at 128 rpm and 90°C without any autoclaving.
Heat stability (%) = Scale graduation (after autoclaving) x 100
Scale graduation (21 min, 128 rpm, 9O0C)
i) Differential scanning calorimetry (DSC) measurement
For a DSC measurement, 10 mg of starch were weighed into a stainless steel cup (volume 50 μl) containing 30 μl of distilled water. An empty stainless steel cup was used as reference. The sample was heated from 2O0C to 12O0C at a heating rate of 10°C/min in a Diamond DSC appliance (Perkin Elmer). The data were analyzed using a Pyres software program. This involved determining T(onset), T(peak) and the free enthalpy.
j) The total phosphate content was determined using the Ames method (Methods in Enzymology VIII1 (1966), 115-118)
30 μl of ethanolic magnesium nitrate solution are added to approx. 50 mg of starch and the mixture is incinerated at 6600C for three hours in a muffle furnace. 500 μl of 0.5 M hydrochloric acid are added to the residue and the mixture is incubated at 6O0C for 30 min. An aliquot of 10 or 20 μl (depending on the expected phosphate content) is then made up to 300 μl with 0.5 M hydrochloric acid and this mixture is added to a mixture of 100 μl of 10% ascorbic acid and 600 μl of 0.42% ammonium molybdate in 0.5 M sulfuric acid and the whole is incubated at 450C for 20 min. This is then followed by a photometric determination at 820 nm using a phosphate calibration series as standard. k) Determination of the shear stability of starches
Shear stability was determined using a ,,Viskotester VT 550" (Type 002 - 7026), Gebrϋder Haake, Dieselstraβe 4, D 76227 Karlsruhe. 70 g of a starch suspension (5% w/v) were transferred to the container that is used for the measurements. This container was transferred to the heating device which had been adjusted to 900C prior to that. Upon starting the measurement the slurry was stirred by a paddle agitator at 128 rpm (revolutions per minute) while the viscosity was recorded (software version 2.30. P). After 15 minutes the speed of the stirrer was increased to 512 rpm. After 5 minutes stirrer speed again was reduced to 128 rpm. Total time for the measurement was 21 minutes.
To determine the stability against shear forces, a suspension of the same starch having the same concentration was examined under identical conditions. However, in this second experiment the stirrer speed was kept at 128 rpm for the entire period of 21 min.
Viscosity is expressed as a relative viscosity having the unit "Skalenteile" (SKT). Shear stability is expressed as the ratio of the viscosities after 21 min of the starch slurry that was stirred at 512 rpm to the slurry that was stirred at 128 rpm only.
Viscosity^ min) stirred at 512 rpm x 100 Shear stability ( % ) = Viscosity^ min) stirred at 128 rpm
I) Determination of the peak viscosity by the Rotovisko method
Peak viscosity was determined using a ,,Viskotester VT 550" (Type 002 - 7026) Gebrϋder Haake, Dieselstraβe 4, D 76227 Karlsruhe.
70 g of a starch suspension (5% w/v) were transferred to the container that is used for the measurements. This container was transferred to the heating device which had been adjusted to 9O0C prior to that. Upon starting the measurement the slurry was stirred by a paddle agitator at 128 rpm (revolutions per minute) while the viscosity was recorded (software version 2.30.P). The measurement was terminated after 15 minutes. Viscosity is expressed as a relative viscosity having the unit "Skalenteile" (SKT). Peak viscosity is the maximum viscosity as recorded during the period of measurement.
Description of the sequences
Seq lD I : Nucleic acid sequence of the potato (Solanum tuberosum) starch synthase SSIII, with the sequences which encode the corresponding SSIII protein being indicated.
Seq ID 2: Amino acid sequence of a potato SSIII protein.
Seq ID 3: Amino acid sequence of the Pfam cbm25 binding domain of the potato (Solanum tuberosum) SSIII protein.
Seq ID 4: Nucleic acid sequence encoding the potato (Solanum tuberosum) branching enzyme BEI.
Seq ID 5: Amino acid sequence of the potato (Solanum tuberosum) branching enzyme BEI.
Seq ID 6: Coding nucleic acid sequence of the potato (Solanum tuberosum) GBSSI gene.
Seq ID 7: Amino acid sequence of potato (Solanum tuberosum) GBSSI.
Seq ID 8: Primer B1_Asp
SEQ ID NO 9: Nucleic acid sequence containing the region encoding the 31 region of a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence is inserted in plasmid AN 46-196.
SEQ ID NO 10: Nucleic acid sequence containing the region encoding the 51 region of a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence is inserted in plasmid AN 47-196.
SEQ ID NO 11 : Nucleic acid sequence containing the complete region encoding a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence is inserted in plasmid AN 49. This plasmid was deposited, in accordance with the Budapest Treaty, on September 15,
2003 in the Deutsche Sammlung von Mikroorganismen und Zellkulturen
[German Collection of Microorganisms and Cell Cultures] GmbH, Mascheroder Weg 1 b, 38124 Braunschweig, Germany, under the number
DSM 15926.
SEQ ID NO 12: Amino acid sequence encoding a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence can be deduced from the nucleic acid sequence inserted in plasmid AN 49 or from the nucleic acid sequence described under SEQ ID NO 11.
SEQ ID NO 13: Nucleic acid sequence containing the complete region encoding a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence was obtained by joining together the nucleic acid sequences which are described under SEQ ID NO 9 and SEQ ID NO 10. This nucleic acid sequence constitutes an allelic variant of the nucleic acid sequence described under SEQ ID NO 11 encoding a protein involved in starch biosynthesis.
SEQ ID NO 14: Amino acid sequence encoding a Solanum tuberosum (cv Desiree) protein involved in starch biosynthesis. This sequence can be deduced from the nucleic acid sequence described under SEQ ID NO 13 and constitutes the amino acid sequence of an allelic variant of the amino acid sequence described under SEQ ID NO 12 encoding a protein involved in starch biosynthesis.
SEQ ID NO 15: Primer B2_Sal (TCA AGT CGA CCA CAA CCA GTC CAT TTC TGG)
SEQ ID NO 16 Primer KM2_Spe (δ'-TCAAACTAGTCACAACCAGTCC- ATTTCTGG-31) SEQ ID NO 17 Primer SoputE (5l-CACTTTAGAAGGTATCAGAGC-31)
SEQ ID NO 18 Primer So_put5' (5I-GTATTTCTGCGAAGGAACGACC-3I)
SEQ ID NO 19 Primer So_putA (5'-AACAATGCTCTCTCTGTCGG-31)
SEQ ID NO 20 Primer B3_Sal (GCT TGT CGA CGG GAG AAT TTT GTC CAG AGG)
SEQ ID NO 21 Primer B4_Sal (GAT CGT CGA CAG CAC TTC TAC TTG GCA GAG G)
Description of the figures
Fig. 1 : Calibration curve for GPC
Example 1
Producing transgenic potato plants which exhibit a reduced expression of the BEI, SSIII and GBSSI genes
In order to generate transgenic plants which exhibit reduced BEI, SSIII and GBSSI activities, transgenic plants which exhibited reduced BEI and SSIII activities were first of all generated. For this purpose, agrobacteria were used, as described in Rocha-Sosa et al. (1989, EMBO J. 8, 23-29), to transfer the T-DNA of the plasmid pB33-aBEI-aSSIII-Kan into potato plants.
In order to construct the plasmid pB33-aBEI -aSSIII-Kan, the expression vector pBin33-Kan was first of all constructed. For this, the promoter of the Solanum tuberosum patatin gene B33 (Rocha-Sosa et al., 1989, see above) was ligated, as a Dra\ fragment (nucleotides -1512 - +14), into the vector pUC19 (Genbank Ace. No. M77789), which had been cut with Sst\ and whose ends had been smoothed using T4 DNA polymerase. This resulted in the plasmid pUC19-B33. The B33 promoter was excised from this plasmid using EcoRI and Sma\ and ligated into the vector pBinAR, which had been cut correspondingly. This resulted in the plant expression vector pBin33-Kan. The plasmid pBinAR is a derivative of the vector plasmid pBin19 (Bevan, 1984, Nucl. Acid Research 12, 8711-8721) and was constructed by Hόfgen and Willmitzer (Plant Sci. 66 (1990), 221-230). A Hindll fragment of 1631 bp in length, which contains a partial cDNA encoding the potato BEI enzyme (Kossmann et al., 1991 , MoI. Gen. Genet. 230(1 -2):39-44), was then smoothed and introduced into vector pBinB33, which had been previously cut with Sma\, in the antisense orientation in regard to the B33 promoter (promoter of the Solanum tuberosum patatin gene B33; Rocha-Sosa et al., 1989, loc. cit). The resulting plasmid was cut with BamH\. A BamH\ fragment of 1363 bp in length, containing a partial cDNA encoding the potato SSIII protein (Abel et al., 1996, loc. cit.), was introduced into the cleavage site, likewise in the antisense orientation with regard to the B33 promoter.
In order to detect the activity of soluble starch synthases by means of nondenaturing gel electrophoresis, tissue samples of potato tubers were disrupted in 5O mM Tris-HCI, pH 7.6, 2 mM DTT, 2.5 mM EDTA, 10% glycerol and 0.4 mM PMSF. The electrophoresis was carried out in a MiniProtean Il chamber (BioRAD). The monomer concentration of the gels, which were 1.5 mm thick, was 7.5% (w/v), while 25 mM Tris-glycine, pH 8.4, served as the gel buffer and running buffer. Equal quantities of protein extract were loaded on and fractionated for 2 h at 10 mA per gel.
The activity gels were then incubated in 50 mM Tricine-NaOH, pH 8.5, 25 mM potassium acetate, 2 mM EDTA, 2 mM DTT, 1 mM ADP-glucose, 0.1% (w/v) amylopectin and 0.5 M sodium citrate. Glucans which were formed were stained with Lugol's solution.
BEI activity was likewise detected using nondenaturing gel electrophoresis: in order to isolate proteins from plants, the sample material was triturated in liquid nitrogen, taken up in extraction buffer (50 mM Na citrate, pH 6.5; 1 mM EDTA, 4 mM DTT) and, after centrifugation (10 min, 14 000 g, 4°C), used directly for measuring the protein concentration as described by Bradford. From 5 to 20 μg, as required, of total protein extract were then treated with 4-fold loading buffer (20% glycerol, 125 mM Tris HCI, pH 6.8) and loaded onto a "BE activity gel". The composition of the running buffer (RB) was as follows: RB = 30.2 g of Tris base, pH 8.0, 144 g of glycine made up to 1 I with H2O. After the gel run had come to an end, the gels were in each case incubated overnight at 370C in 25 ml of "phosphorylase buffer" (25 ml of 1 M Na citrate, pH 7.0, 0.47 g of glucose-1 -phosphate, 12.5 mg of AMP, 2.5 mg of rabbit phosphorylase a/b). The gels were stained with Lugol's solution.
It was possible to identify different lines of transgenic potato plants whose tubers exhibited markedly reduced BEI and SSIII activities. The line (asBEI-asSSIII), whose isolated starches exhibited the highest phosphate content of all the independent transformants which were investigated, was then transformed with the plasmid p35SaGBSSI-Met as described in Rocha-Sosa et al. (1989, EMBO J. 8, 23-29).
Plasmid p35SaGBSSI-Met was prepared by inserting an Asp718/Xbal fragment of 1921 bp in length, containing a partial cDNA encoding potato GBSSI (Hergersberg, 1988, see above) into the vector pBinAR-Met, which had also been opened, in the antisense orientation with regard to the 35S promoter.
Vector pBinAR-Met is derived from the plasmid pGPTV-DHFR, which is a derivative of the vector pBin19 (Becker et al., 1992, Plant MoI. Biol. 20, 1195-1197). pBinAR-Met contains the dhfr gene, which mediates resistance to methotrexate, instead of the nptll gene and the 3" end of gene 7 of the T-DNA of the Ti plasmid pTiACHδ (nucleotides 2106-2316; Gielen et al., 1984, EMBO J. 3, 835-846) instead of the 3' end of the nopaline synthase gene. Taking plasmid pA7 (compare description of vector pBinAR above) as the starting point, the EcoRI/Hindlll fragment, comprising the 35S promoter, the ocs terminator and the intercollated part of the polylinker, was ligated into plasmid pGPTV-DHFR, which was cut correspondingly. The resulting vector was designated pBinAR-Met.
Tissue samples were taken from tubers derived from the independent transformants among the plants which were obtained by transformation with the plasmid p35SaGBSSI-Met, and which were designated asBEI-asSSIII-asGBSSI plants, and the samples were stained with iodine solution and examined under the microscope. The starches of the independent lines whose granules stained brown were used for further analysis of the starch properties. Example 2
Cloning a full-length sequence of a Solanum tuberosum gene having the sequence specified under SEQ ID NO 11 or 13
The nucleotide sequence (SEQ ID No. 11 or SEQ ID No.13) encoding a Solanum tuberosum protein having the amino acid sequence specified under SEQ ID No. 12 or SEQ ID No.14 has not been previously described. By making sequence comparisons using different branching enzymes, it was possible to identify a domain which was used to screen EST databases. The potato EST TC73137 (TIGR database; http://www.tigr.org/tigr-scripts/tgi/tc_report.pl?tc=TC73137&species=potato) was identified in this connection. The primers B1_Asp (GAT GGG TAC CAG CAC TTC TAC TTG GCA GAG G = SEQ ID No. 8) and B2_Sal (TCA AGT CGA CCA CAA CCA GTC CAT TTC TGG = SEQ ID No. 15) were used to amplify a sequence, which corresponded to this EST sequence, from a tuber-specific Solanum tuberosum (cv Desiree) cDNA library. Attempts to use leaf-specific, sink or source tissue-specific cDNA libraries as templates for the PCR reaction did not give rise to any amplificate.
Primers which were complementary to the ends of the previously known sequence and vector sequences of the relevant cDNA libraries were prepared for the purpose of amplifying the entire sequence encoding the protein concerned, which sequence also comprised previously unknown sequences. None of the primer combinations for amplifying a full-length sequence which were used when taking this approach led to any further region being amplified. Tomato EST databases were consequently screened once again. In this connection, it was possible to identify two tomato ESTs (TIGR database; BG127920 and TC130382) which either exhibited a high degree of homology with the above-described amplificate of the potato protein (TC130382) or (BG 127920) or with a putative branching enzyme derived from Arabidopsis (Genbank: GP|9294564|dbj|BAB02827.1 ).
Primers were now prepared once again in order to also amplify previously unknown sequences of the protein having the amino acid sequence depicted under SEQ ID NO 12 or SEQ ID NO 14. The 31 region of the protein concerned was amplified by means of PCR, using the primers KM2_Spe (5'-TCAAACTAGTCACAACCAGTCCATTTCTGG-31 = SEQ ID No. 16) and SoputE (5I-CACTTTAGAAGGTATCAGAGC-31 = SEQ ID No. 17), from a cDNA library which was prepared from Solanum tuberosum (cv Desiree) tubers. The resulting fragment, of approx. 1 kb in size, was cloned in an undirected manner into the pCR4-TOPO vector supplied by Invitrogen (product number: 45-0030). The resulting plasmid was designated AN 46-196. The sequence of the fragment inserted in plasmid AN 46-196 is depicted under SEQ ID NO 9.
The 51 region was likewise amplified by means of the PCR technique from the same cDNA library using the primers So_put5' (δ'-GTATTTCTGCGAAGGAACGACC-S' = SEQ ID No. 18) and So_putA (δ'-AACAATGCTCTCTCTGTCGG-S1 = SEQ ID No. 19). The resulting fragment, of approx. 2 kb in size, was cloned in an undirected manner into the pCR4-TOPO Invitrogen vector (product number: 45-0030). The resulting plasmid was designated AN 47-196. The sequence of the fragment inserted in plasmid AN 47-196 is depicted under SEQ ID NO 10.
Primers were now prepared once again in order to amplify a full-length sequence.
The following primers were used: SOputA (AACAATGCTCTCTCTGTCGG = SEQ ID No. 19) and SO_putE (CACTTTAGAAGGTATCAGAGC = SEQ ID No. 17). A PCR product of approximately 3.2 kb in size was obtained and cloned into the Invitrogen vector pCR2.1 (product number: 45-0030). The resulting plasmid (deposited under DSM 15926) was designated AN 49. The sequence of the fragment inserted in plasmid AN 49 is depicted under SEQ ID NO H .
The sequence information in the nucleic acid sequence depicted under SEQ ID No. 13 was obtained by joining the nucleic acid sequences described under SEQ ID NO 9 and SEQ ID NO 10. This nucleic acid sequence is an allelic variant of the nucleic acid sequence described under SEQ ID No 11 encoding a protein (SEQ ID No. 14) which is involved in starch biosynthesis. Example 3
Producing transgenic potato plants which exhibit a reduced expression of the BEI, SSIII and GBSSI genes and a reduced expression of the gene which is specified under SEQ ID No. 11 or SEQ ID No. 13
Agrobacteria were used, as described in Rocha-Sosa et al. (EMBO J. 8, (1989), 23-29), to the T-DNA of the plasmid AN 54-196 (see below) into the potato plants having a reduced expression of the BEI, SSIII and GBSSI genes, which plants were described in example 1 and designated, in that example, as asBEI-asSSIII-asGBSSI plants. The plants which were obtained by transformation with plasmid AN 54-196 were designated asBEI-asSSIII-asGBSSMBE3 and, in addition to exhibiting reduced expression of the BEI, SSIII and GBSSI genes, also exhibited a reduction in the expression of the gene described under SEQ ID No. 11 or SEQ ID No. 13. Tissue samples were taken from tubers derived from independent transformants, stained with iodine and examined under the microscope. The phosphate content in the C6 position was also determined. The starches from the independent lines whose granules stained brown and which exhibited a phosphate content which was greater than that of the starting lines (see example 1 ) were used for further analysis of the starch properties.
Information concerning vector AN 54-196
AN 54-196 is a derivative of plasmid pBinB33-Hyg, into which a constituent sequence of the coding nucleic acid sequence specified under SEQ ID NO 11 or SEQ ID NO 13 was inserted as an inverted repeat (RNAi technology) under the control of the promoter of the Solanum tuberosum patatin gene B33 (Rocha-Sosa et al., 1989). For this, a PCR product was first of all amplified from a tuber-specific Solanum tuberosum (cv Desiree) cDNA library using the primers B1_Asp (GAT GGG TAC CAG CAC TTC TAC TTG GCA GAG G) and B2_Sal (TCA AGT CGA CCA CAA CCA GTC CAT TTC TGG) resulting in the cleavage sites Asp7"\8 and Sail being added. The PCR product (625 bp) which was obtained was cloned, in the antisense orientation with regard to the B33 promoter, by way of these two cleavage sites. A second PCR fragment, which was amplified from a tuber- specific Solatium tuberosum (cv Desiree) cDNA library using the primers B3_Sal (GCT TGT CGA CGG GAG AAT TTT GTC CAG AGG = SEQ ID No. 20) and B4_Sal (GAT CGT CGA CAG CAC TTC TAC TTG GCA GAG G = SEQ ID No. 21), and which was identical to 301 bp of the first fragment, was cloned, by way of the Sail cleavage site, downstream of the first fragment but in the sense orientation with regard to the B33 promoter. This arrangement is designated an inverted repeat (RNAi technology).
Information concerning vector pBinB33-Hyg The EcoR\-Hind\\\ fragment comprising the B33 promoter, a part of the polylinker and the ocs terminator, was excised from plasmid pBinB33 and ligated into the vector pBIB-Hyg (Becker, 1990), which had been cut correspondingly. The plasmid pBinB33 was obtained by ligating the promoter of the Solanum tuberosum patatin gene B33 (Rocha-Sosa et al., 1989), as a Dra\ fragment (nucleotides -1512 - +14), into the Ssfl-cut vector pUC19, whose ends had been smoothed using T4 DNA polymerase. This resulted in the plasmid pUC19-B33. The B33 promoter was excised from this plasmid using EcoRI and Sma\ and ligated into vector pBinAR, which had been cut correspondingly. This resulted in the plant expression vector pBinB33.
The plasmid pBinAR is a derivative of the vector plasmid pBin19 (Bevan, 1984) and was constructed as follows:
A fragment of 529 bp in length, which comprises nucleotides 6909-7437 of the cauliflower mosaic virus 35S RNA promoter (Pietrzak et al., 1986, Nucleic Acids Research 14, 5857-5868), was isolated, as an EcoR\/Kpn\ fragment, from the plasmid pDH51 (Pietrzak et al., 1986) and ligated between the EcoRI and Kpn\ cleavage sites of the pUC18 polylinker. This resulted in the plasmid pUC18-35S. A fragment of 192 bp in length, which comprises the polyadenylation signal (31 end) of the octopine synthase gene (gene 3) of the T-DNA of the Ti-plasmid pTiACHδ (Gielen et al., 1984) (nucleotides 11749-11939), was isolated from the plasmid pAGV40 (Herrera-Estrella et al., 1983) using the restriction endonucleases Hind\\\ and PvuW. After Ssp\ linkers had been added to the PwII cleavage site, the fragment was ligated between the Sph\ and Hind\\\ cleavage sites of pUC18-35S. This resulted in the plasmid pA7.
The entire polylinker, containing the 35S promoter and the ocs terminator, was excised from pA7 using EcoRI and Hind\\\ and ligated into pBin19, which had been cut correspondingly. This resulted in the plant expression vector pBinAR (Hofgen and Willnnitzer, 1990).
Example 4
Analyzing the starch of transgenic potato plants which exhibit reduced expression of the BEI, SSIII and GBSSI genes and reduced expression of the gene which is specified under SEQ ID No. 11 or SEQ ID No. 13
The starches were isolated from the tubers obtained from different independent lines of the asBEI-asSSIII-asGBSSI-iBE3 potato transformants described in example 3. The physicochemical properties of these starches were then analyzed. The results which were obtained on the basis of the starches which were prepared from the plant cells or plants according to the invention are given below either as absolute values or as percentage values based on starch from corresponding wild-type plant cells or wild-type plants (designated WT starch in that which follows) (table 2). In addition, the table contains starch data from "single" or "double" combinations disclosed in WO 00/08184 and WO 01/12782:
Table 2
Figure imgf000064_0001
In addition, the absolute values for the amylose content (determined using the methods of Hovenkamp-Hermelink) and for the phosphate content in the C6 position (method description, see "General methods" above) were determined in the case of the starches from the corresponding wild-type plants (Desiree variety), from the starting line (asBEI-asSSIII-asGBSSI) and from the asBEI-asSSIII-asGBSSI-iBE3 potato plants (table 3):
Table 3: Amylose content and phosphate content in the C6 position
Figure imgf000065_0001
The side-chain profile of the potato starch was analyzed by determining the content of a particular group of side chains expressed as a percentage of the total content of all the side chains in the GPC chromatogram (table 4) (see General methods "Using gel permeation chromatography to analyze the side-chain distribution of total starch"):
Table 4: Distribution of the side-chain profile of total starch in the lines asBEI-asSIII, asBEI-asSSIII-asGBSSI asBEI-asSSIII-asGBSSI-iBE3 and the corresponding wild type, divided into groups having different degrees of polymerization
Figure imgf000065_0002
The ratio of the total phosphate content to the phosphate content in the C6 position was also determined:
Figure imgf000066_0001
The gel strength of the potato starches according to the invention was analyzed by the method described above (see General Methods, Method d) "Determining the gel strength (texture analyzer)"):
Figure imgf000066_0002
The shear stability of the potato starches according to the invention was analyzed by the method described above (see General Methods, Method k):
Figure imgf000066_0003
The peak viscosity of the potato starches according to the invention was analyzed by the Rotovisko method described above (see General Methods, Method I):
Figure imgf000066_0004
The freeze/thaw stability of the potato starches according to the invention was analyzed by the method described above (see General Methods, Method g) "Determining the freeze/thaw stability"):
Figure imgf000067_0001

Claims

Patent claims
1. A potato starch which exhibits an amylose content, as measured by the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight, a phosphate content in the C6 position of between 35 and IOO nmol of phosphate per milligram of starch (dry weight), and a content of side chains having a DP of from 12 to 19 which is elevated as compared with that in potato starch from corresponding wild-type potato plants.
2. The potato starch as claimed in claim 1 , which exhibits a phosphate content in the C6 position of between 40 and 85 nmol of phosphate per milligram of starch (dry weight).
3. The potato starch as claimed in claim 1 , which exhibits a phosphate content in the C6 position of between 45 and 70 nmol of phosphate per milligram of starch (dry weight).
4. The potato starch as claimed in claim 1 , which exhibits a phosphate content in the C6 position of between 50 and 65 nmol of phosphate per milligram of starch (dry weight).
5. The potato starch as claimed in one of claims 1 to 4, which exhibits an amylose content, as measured by the method of Hovenkamp- Hermelink et al. (1988, Potato Research 31 , 241-246), of less than
5% by weight.
6. The potato starch as claimed in one of claims 1 to 4, which exhibits an amylose content, as measured by the method of Hovenkamp- Hermelink et al. (1988, Potato Research 31 , 241-246), of less than
3% by weight.
7. The potato starch as claimed in one of claims 1 to 6, wherein the proportion of side chains having a DP of from 12 to 19 is increased to 125%-200% as compared with potato starch from corresponding wild-type potato plants.
8. The potato starch as claimed in one of claims 1 to 6, wherein the proportion of side chains having a DP of from 12 to 19 is increased to 130%-180% as compared with potato starch from corresponding wild-type potato plants.
9. The potato starch as claimed in one of claims 1 to 8, wherein the proportion of side chains having a DP of from 63 to 123 is reduced as compared with potato starch from corresponding wild-type potato plants.
10. The potato starch as claimed in claim 9, wherein the proportion of side chains having a DP of from 63 to 123 is reduced to 50%-95% as compared with potato starch from corresponding wild-type potato plants.
11. A derivatized potato starch which contains potato starch as claimed in one of claims 1 to 10.
12. A potato starch which exhibits an amylose content, as measured by the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 10% by weight and a peak viscosity determined by the Rotovisko method of 332 SKT to 500 SKT
13. The potato starch as claimed in claim 12, which exhibits a peak viscosity determined by the Rotovisko method of 345 SKT - 450 SKT.
14. The potato starch as claimed in claim 12, which exhibits a peak viscosity determined by the Rotovisko method of 360 SKT - 420 SKT.
15. The potato starch as claimed in one of claims 12 to 14, which exhibits a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per milligram of starch (dry weight).
16. The potato starch as claimed in one of claims 12 to 14, which exhibits a phosphate content in the C6 position of between 40 and 85 nmol of phosphate per milligram of starch (dry weight).
17. The potato starch as claimed in one of claims 12 to 14, which exhibits a phosphate content in the C6 position of between 45 and 70 nmol of phosphate per milligram of starch (dry weight).
18. The potato starch as claimed in one of claims 12 to 17, which exhibits an amylose content, as measured by the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 5% by weight.
19. The potato starch as claimed in one of claims 12 to 17, which exhibits an amylose content, as measured by the method of Hovenkamp-Hermelink et al. (1988, Potato Research 31 , 241-246), of less than 3% by weight.
20. The potato starch as claimed in one of claims 12 to 19, which exhibits a content of side chains having a DP of from 12 to 19 which is elevated as compared with that in potato starch from corresponding wild-type potato plants.
21. The potato starch as claimed in claim 20, wherein the proportion of side chains having a DP of from 12 to 19 is increased to 125%-200% as compared with potato starch from corresponding wild-type potato plants.
PCT/EP2006/003027 2005-04-01 2006-03-30 Phosphorylated waxy potato starch WO2006103107A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP06723985.5A EP1869089B1 (en) 2005-04-01 2006-03-30 Phosphorylated waxy potato starch
US11/909,926 US8148517B2 (en) 2005-04-01 2006-03-30 Phosphorylated waxy potato starch
CA2600989A CA2600989C (en) 2005-04-01 2006-03-30 Phosphorylated waxy potato starch
AU2006228670A AU2006228670B2 (en) 2005-04-01 2006-03-30 Phosphorylated waxy potato starch

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05090085.1 2005-04-01
EP05090085A EP1707632A1 (en) 2005-04-01 2005-04-01 Phosphorylated waxy potato starch
US66966505P 2005-04-08 2005-04-08
US60/669,665 2005-04-08

Publications (1)

Publication Number Publication Date
WO2006103107A1 true WO2006103107A1 (en) 2006-10-05

Family

ID=34938422

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/003027 WO2006103107A1 (en) 2005-04-01 2006-03-30 Phosphorylated waxy potato starch

Country Status (5)

Country Link
US (1) US8148517B2 (en)
EP (2) EP1707632A1 (en)
AU (1) AU2006228670B2 (en)
CA (1) CA2600989C (en)
WO (1) WO2006103107A1 (en)

Cited By (174)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2039772A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants introduction
EP2039771A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2039770A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2072506A1 (en) 2007-12-21 2009-06-24 Bayer CropScience AG Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide
EP2090168A1 (en) 2008-02-12 2009-08-19 Bayer CropScience AG Method for improving plant growth
EP2168434A1 (en) 2008-08-02 2010-03-31 Bayer CropScience AG Use of azols to increase resistance of plants of parts of plants to abiotic stress
EP2198709A1 (en) 2008-12-19 2010-06-23 Bayer CropScience AG Method for treating resistant animal pests
EP2201838A1 (en) 2008-12-05 2010-06-30 Bayer CropScience AG Active ingredient-beneficial organism combinations with insecticide and acaricide properties
EP2204094A1 (en) 2008-12-29 2010-07-07 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants Introduction
WO2010083955A2 (en) 2009-01-23 2010-07-29 Bayer Cropscience Aktiengesellschaft Use of enaminocarboxylic compounds for fighting viruses transmitted by insects
WO2010086095A1 (en) 2009-01-29 2010-08-05 Bayer Cropscience Ag Method for improved utilization of the production potential of transgenic plants introduction
WO2010086311A1 (en) 2009-01-28 2010-08-05 Bayer Cropscience Ag Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives
EP2218717A1 (en) 2009-02-17 2010-08-18 Bayer CropScience AG Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives
WO2010094728A1 (en) 2009-02-19 2010-08-26 Bayer Cropscience Ag Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
WO2010094666A2 (en) 2009-02-17 2010-08-26 Bayer Cropscience Ag Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
EP2223602A1 (en) 2009-02-23 2010-09-01 Bayer CropScience AG Method for improved utilisation of the production potential of genetically modified plants
EP2232995A1 (en) 2009-03-25 2010-09-29 Bayer CropScience AG Method for improved utilisation of the production potential of transgenic plants
EP2239331A1 (en) 2009-04-07 2010-10-13 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2251331A1 (en) 2009-05-15 2010-11-17 Bayer CropScience AG Fungicide pyrazole carboxamides derivatives
EP2255626A1 (en) 2009-05-27 2010-12-01 Bayer CropScience AG Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress
WO2011006603A2 (en) 2009-07-16 2011-01-20 Bayer Cropscience Ag Synergistic active substance combinations containing phenyl triazoles
WO2011015524A2 (en) 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
EP2292094A1 (en) 2009-09-02 2011-03-09 Bayer CropScience AG Active compound combinations
EP2319872A1 (en) 2009-11-04 2011-05-11 BASF Plant Science GmbH Amylopectin type starch with enhanced retrogradation stability
WO2011080255A2 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011080254A2 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011080256A1 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
EP2343280A1 (en) 2009-12-10 2011-07-13 Bayer CropScience AG Fungicide quinoline derivatives
WO2011089071A2 (en) 2010-01-22 2011-07-28 Bayer Cropscience Ag Acaricide and/or insecticide active substance combinations
WO2011107504A1 (en) 2010-03-04 2011-09-09 Bayer Cropscience Ag Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants
EP2374791A1 (en) 2008-08-14 2011-10-12 Bayer CropScience Aktiengesellschaft Insecticidal 4-phenyl-1H pyrazoles
WO2011124554A2 (en) 2010-04-06 2011-10-13 Bayer Cropscience Ag Use of 4-phenylbutyric acid and/or the salts thereof for enhancing the stress tolerance of plants
WO2011124553A2 (en) 2010-04-09 2011-10-13 Bayer Cropscience Ag Use of derivatives of the (1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress
WO2011134911A2 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011134912A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011134913A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011151369A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
WO2011151368A2 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives
WO2011151370A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues
WO2011154159A1 (en) 2010-06-09 2011-12-15 Bayer Bioscience N.V. Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
WO2011154158A1 (en) 2010-06-09 2011-12-15 Bayer Bioscience N.V. Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
US8080688B2 (en) 2007-03-12 2011-12-20 Bayer Cropscience Ag 3, 4-disubstituted phenoxyphenylamidines and use thereof as fungicides
WO2012010579A2 (en) 2010-07-20 2012-01-26 Bayer Cropscience Ag Benzocycloalkenes as antifungal agents
WO2012028578A1 (en) 2010-09-03 2012-03-08 Bayer Cropscience Ag Substituted fused pyrimidinones and dihydropyrimidinones
WO2012038480A2 (en) 2010-09-22 2012-03-29 Bayer Cropscience Ag Use of biological or chemical control agents for controlling insects and nematodes in resistant crops
WO2012045798A1 (en) 2010-10-07 2012-04-12 Bayer Cropscience Ag Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative
WO2012052490A1 (en) 2010-10-21 2012-04-26 Bayer Cropscience Ag N-benzyl heterocyclic carboxamides
WO2012052489A1 (en) 2010-10-21 2012-04-26 Bayer Cropscience Ag 1-(heterocyclic carbonyl) piperidines
WO2012059497A1 (en) 2010-11-02 2012-05-10 Bayer Cropscience Ag N-hetarylmethyl pyrazolylcarboxamides
WO2012065945A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazole(thio)carboxamides
WO2012065947A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazolecarboxamides
WO2012065944A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag N-aryl pyrazole(thio)carboxamides
EP2460406A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Use of fluopyram for controlling nematodes in nematode resistant crops
EP2460407A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Agent combinations comprising pyridylethyl benzamides and other agents
WO2012072660A1 (en) 2010-12-01 2012-06-07 Bayer Cropscience Ag Use of fluopyram for controlling nematodes in crops and for increasing yield
WO2012089757A1 (en) 2010-12-29 2012-07-05 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2012089721A1 (en) 2010-12-30 2012-07-05 Bayer Cropscience Ag Use of substituted spirocyclic sulfonamidocarboxylic acids, carboxylic esters thereof, carboxamides thereof and carbonitriles thereof or salts thereof for enhancement of stress tolerance in plants
EP2474542A1 (en) 2010-12-29 2012-07-11 Bayer CropScience AG Fungicide hydroximoyl-tetrazole derivatives
EP2494867A1 (en) 2011-03-01 2012-09-05 Bayer CropScience AG Halogen-substituted compounds in combination with fungicides
WO2012120105A1 (en) 2011-03-10 2012-09-13 Bayer Cropscience Ag Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds
WO2012123434A1 (en) 2011-03-14 2012-09-20 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2012136581A1 (en) 2011-04-08 2012-10-11 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
EP2511255A1 (en) 2011-04-15 2012-10-17 Bayer CropScience AG Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives
WO2012139890A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted 5-(cyclohex-2-en-1-yl)-penta-2,4-dienes and 5-(cyclohex-2-en-1-yl)-pent-2-en-4-ines as active agents against abiotic stress in plants
WO2012139892A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted 5-(bicyclo[4.1.0]hept-3-en-2-yl)-penta-2,4-dienes and 5-(bicyclo[4.1.0]hept-3-en-2-yl)-pent-2-ene-4-ines as active agents against abiotic stress in plants
WO2012139891A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants
US8299302B2 (en) 2007-03-12 2012-10-30 Bayer Cropscience Ag 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides
WO2012168124A1 (en) 2011-06-06 2012-12-13 Bayer Cropscience Nv Methods and means to modify a plant genome at a preselected site
US8334237B2 (en) 2007-03-12 2012-12-18 Bayer Cropscience Ag Substituted phenylamidines and the use thereof as fungicides
WO2013004652A1 (en) 2011-07-04 2013-01-10 Bayer Intellectual Property Gmbh Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants
WO2013020985A1 (en) 2011-08-10 2013-02-14 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
EP2561759A1 (en) 2011-08-26 2013-02-27 Bayer Cropscience AG Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
WO2013026740A2 (en) 2011-08-22 2013-02-28 Bayer Cropscience Nv Methods and means to modify a plant genome
WO2013026836A1 (en) 2011-08-22 2013-02-28 Bayer Intellectual Property Gmbh Fungicide hydroximoyl-tetrazole derivatives
US8394991B2 (en) 2007-03-12 2013-03-12 Bayer Cropscience Ag Phenoxy substituted phenylamidine derivatives and their use as fungicides
WO2013034621A1 (en) 2011-09-09 2013-03-14 Bayer Intellectual Property Gmbh Acyl-homoserine lactone derivatives for improving plant yield
WO2013037958A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of phenylpyrazolin-3-carboxylates for improving plant yield
WO2013037717A1 (en) 2011-09-12 2013-03-21 Bayer Intellectual Property Gmbh Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4h)-one derivatives
WO2013037956A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of 5-phenyl- or 5-benzyl-2 isoxazoline-3 carboxylates for improving plant yield
WO2013037955A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of acylsulfonamides for improving plant yield
WO2013041602A1 (en) 2011-09-23 2013-03-28 Bayer Intellectual Property Gmbh Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress
WO2013050324A1 (en) 2011-10-06 2013-04-11 Bayer Intellectual Property Gmbh Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress
WO2013050410A1 (en) 2011-10-04 2013-04-11 Bayer Intellectual Property Gmbh RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE
WO2013075817A1 (en) 2011-11-21 2013-05-30 Bayer Intellectual Property Gmbh Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives
US8455480B2 (en) 2007-09-26 2013-06-04 Bayer Cropscience Ag Active agent combinations having insecticidal and acaricidal properties
WO2013079566A2 (en) 2011-11-30 2013-06-06 Bayer Intellectual Property Gmbh Fungicidal n-bicycloalkyl and n-tricycloalkyl (thio)carboxamide derivatives
WO2013092519A1 (en) 2011-12-19 2013-06-27 Bayer Cropscience Ag Use of anthranilic acid diamide derivatives for pest control in transgenic crops
WO2013098147A1 (en) 2011-12-29 2013-07-04 Bayer Intellectual Property Gmbh Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
WO2013098146A1 (en) 2011-12-29 2013-07-04 Bayer Intellectual Property Gmbh Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
US8487118B2 (en) 2009-01-19 2013-07-16 Bayer Cropscience Ag Cyclic diones and their use as insecticides, acaricides and/or fungicides
US8519003B2 (en) 2007-03-12 2013-08-27 Bayer Cropscience Ag Phenoxyphenylamidines as fungicides
WO2013124275A1 (en) 2012-02-22 2013-08-29 Bayer Cropscience Ag Use of succinate dehydrogenase inhibitors (sdhis) for controlling wood diseases in grape.
WO2013127704A1 (en) 2012-02-27 2013-09-06 Bayer Intellectual Property Gmbh Active compound combinations containing a thiazoylisoxazoline and a fungicide
WO2013139949A1 (en) 2012-03-23 2013-09-26 Bayer Intellectual Property Gmbh Compositions comprising a strigolactame compound for enhanced plant growth and yield
WO2013153143A1 (en) 2012-04-12 2013-10-17 Bayer Cropscience Ag N-acyl- 2 - (cyclo) alkylpyrrolidines and piperidines useful as fungicides
WO2013156559A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
WO2013156560A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives
WO2013160230A1 (en) 2012-04-23 2013-10-31 Bayer Cropscience Nv Targeted genome engineering in plants
EP2662361A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazol indanyl carboxamides
EP2662370A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole benzofuranyl carboxamides
EP2662363A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole biphenylcarboxamides
EP2662360A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole indanyl carboxamides
EP2662364A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole tetrahydronaphthyl carboxamides
EP2662362A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole indanyl carboxamides
WO2013167544A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag 5-halogenopyrazole indanyl carboxamides
WO2013167545A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag Pyrazole indanyl carboxamides
WO2013174836A1 (en) 2012-05-22 2013-11-28 Bayer Cropscience Ag Active compounds combinations comprising a lipo-chitooligosaccharide derivative and a nematicide, insecticidal or fungicidal compound
WO2014009322A1 (en) 2012-07-11 2014-01-16 Bayer Cropscience Ag Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress
WO2014037340A1 (en) 2012-09-05 2014-03-13 Bayer Cropscience Ag Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
WO2014060520A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives
WO2014060518A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method of plant growth promotion using carboxamide derivatives
WO2014060502A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Active compound combinations comprising carboxamide derivatives
WO2014060519A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives
EP2735231A1 (en) 2012-11-23 2014-05-28 Bayer CropScience AG Active compound combinations
WO2014079957A1 (en) 2012-11-23 2014-05-30 Bayer Cropscience Ag Selective inhibition of ethylene signal transduction
WO2014083088A2 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Binary fungicidal mixtures
WO2014083089A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Ternary fungicidal and pesticidal mixtures
WO2014083031A2 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Binary pesticidal and fungicidal mixtures
WO2014083033A1 (en) 2012-11-30 2014-06-05 Bayer Cropsience Ag Binary fungicidal or pesticidal mixture
WO2014082950A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Ternary fungicidal mixtures
EP2740356A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives
EP2740720A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants
WO2014086751A1 (en) 2012-12-05 2014-06-12 Bayer Cropscience Ag Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress
WO2014090765A1 (en) 2012-12-12 2014-06-19 Bayer Cropscience Ag Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops
WO2014095826A1 (en) 2012-12-18 2014-06-26 Bayer Cropscience Ag Binary fungicidal and bactericidal combinations
WO2014095677A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic- tetrahydronaphtyl carboxamides
US8796175B2 (en) 2008-08-29 2014-08-05 Bayer Cropscience Ag Method for enhancing plant intrinsic defense
US8828906B2 (en) 2009-03-25 2014-09-09 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US8828907B2 (en) 2009-03-25 2014-09-09 Bayer Cropscience Ag Active ingredient combinations having insecticidal and acaricidal properties
WO2014135608A1 (en) 2013-03-07 2014-09-12 Bayer Cropscience Ag Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives
US8835657B2 (en) 2009-05-06 2014-09-16 Bayer Cropscience Ag Cyclopentanedione compounds and their use as insecticides, acaricides and/or fungicides
US8846567B2 (en) 2009-03-25 2014-09-30 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US8846568B2 (en) 2009-03-25 2014-09-30 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
WO2014161821A1 (en) 2013-04-02 2014-10-09 Bayer Cropscience Nv Targeted genome engineering in eukaryotes
WO2014167009A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazole derivatives
WO2014167008A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazolinthione derivatives
WO2014170364A1 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Binary insecticidal or pesticidal mixture
WO2014170345A2 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Method for improved utilization of the production potential of transgenic plants
WO2014177514A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag Nematicidal n-substituted phenethylcarboxamides
WO2014177582A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag N-(2-fluoro-2-phenethyl)carboxamides as nematicides and endoparasiticides
WO2014206953A1 (en) 2013-06-26 2014-12-31 Bayer Cropscience Ag N-cycloalkyl-n-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives
US8927583B2 (en) 2006-12-22 2015-01-06 Bayer Cropscience Ag Pesticidal composition comprising a 2-pyrdilmethylbenzamide derivative and an insecticide compound
WO2015004040A1 (en) 2013-07-09 2015-01-15 Bayer Cropscience Ag Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
US9012360B2 (en) 2009-03-25 2015-04-21 Bayer Intellectual Property Gmbh Synergistic combinations of active ingredients
WO2015082587A1 (en) 2013-12-05 2015-06-11 Bayer Cropscience Ag N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
WO2015082586A1 (en) 2013-12-05 2015-06-11 Bayer Cropscience Ag N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
US9173394B2 (en) 2007-09-26 2015-11-03 Bayer Intellectual Property Gmbh Active agent combinations having insecticidal and acaricidal properties
US9199922B2 (en) 2007-03-12 2015-12-01 Bayer Intellectual Property Gmbh Dihalophenoxyphenylamidines and use thereof as fungicides
US9232794B2 (en) 2009-06-02 2016-01-12 Bayer Intellectual Property Gmbh Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp
WO2016012362A1 (en) 2014-07-22 2016-01-28 Bayer Cropscience Aktiengesellschaft Substituted cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes as active substances against abiotic plant stress
EP2997825A1 (en) 2011-04-22 2016-03-23 Bayer Intellectual Property GmbH Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
EP3000809A1 (en) 2009-05-15 2016-03-30 Bayer Intellectual Property GmbH Fungicide pyrazole carboxamides derivatives
WO2016096942A1 (en) 2014-12-18 2016-06-23 Bayer Cropscience Aktiengesellschaft Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
WO2016166077A1 (en) 2015-04-13 2016-10-20 Bayer Cropscience Aktiengesellschaft N-cycloalkyl-n-(biheterocyclyethylene)-(thio)carboxamide derivatives
US9763451B2 (en) 2008-12-29 2017-09-19 Bayer Intellectual Property Gmbh Method for improved use of the production potential of genetically modified plants
WO2018019676A1 (en) 2016-07-29 2018-02-01 Bayer Cropscience Aktiengesellschaft Active compound combinations and methods to protect the propagation material of plants
WO2018054911A1 (en) 2016-09-23 2018-03-29 Bayer Cropscience Nv Targeted genome optimization in plants
WO2018054829A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives and their use as fungicides
WO2018054832A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives
WO2018077711A2 (en) 2016-10-26 2018-05-03 Bayer Cropscience Aktiengesellschaft Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications
EP3332645A1 (en) 2016-12-12 2018-06-13 Bayer Cropscience AG Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress
WO2018104392A1 (en) 2016-12-08 2018-06-14 Bayer Cropscience Aktiengesellschaft Use of insecticides for controlling wireworms
WO2018108627A1 (en) 2016-12-12 2018-06-21 Bayer Cropscience Aktiengesellschaft Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants
DE102007045953B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
DE102007045919B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
DE102007045920B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistic drug combinations
CN109312358A (en) * 2016-05-03 2019-02-05 莱克拜斯塔奇公司 Amylopectin-potato starch with improved anti-retrogradation stability and improved freeze-thaw stability
WO2019025153A1 (en) 2017-07-31 2019-02-07 Bayer Cropscience Aktiengesellschaft Use of substituted n-sulfonyl-n'-aryl diaminoalkanes and n-sulfonyl-n'-heteroaryl diaminoalkanes or salts thereof for increasing the stress tolerance in plants
WO2019060746A1 (en) 2017-09-21 2019-03-28 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
WO2019233863A1 (en) 2018-06-04 2019-12-12 Bayer Aktiengesellschaft Herbicidally active bicyclic benzoylpyrazoles
WO2020131862A1 (en) 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof
US10968257B2 (en) 2018-04-03 2021-04-06 The Broad Institute, Inc. Target recognition motifs and uses thereof
US11180751B2 (en) 2015-06-18 2021-11-23 The Broad Institute, Inc. CRISPR enzymes and systems
US11591601B2 (en) 2017-05-05 2023-02-28 The Broad Institute, Inc. Methods for identification and modification of lncRNA associated with target genotypes and phenotypes

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007003743A1 (en) * 2006-12-22 2008-07-11 Bayer Cropscience Ag COMPOSITION THAT INCLUDES FENAMIDONA AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY.
EP1969931A1 (en) 2007-03-12 2008-09-17 Bayer CropScience Aktiengesellschaft Fluoroalkyl phenylamidines and their use as fungicides
WO2008128639A1 (en) 2007-04-19 2008-10-30 Bayer Cropscience Aktiengesellschaft Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide
WO2009046837A2 (en) * 2007-10-02 2009-04-16 Bayer Cropscience Ag Methods of improving plant growth
JP5768252B2 (en) * 2009-08-12 2015-08-26 公立大学法人大阪府立大学 Antilipidemic and visceral fat prevention food
CN113116747A (en) * 2020-01-14 2021-07-16 罗盖特公司 Natural and porous starches as white pigments in toothpaste
CN114933661B (en) * 2022-06-27 2022-12-20 上海交通大学 Preparation method of sodium trimetaphosphate crosslinked starch

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292435A1 (en) 1987-05-20 1988-11-23 Ciba-Geigy Ag Zea mays plants and transgenic zea mays plants regenerated from protoplasts or protoplast-derived cells
EP0465875A1 (en) 1990-06-23 1992-01-15 Hoechst Schering AgrEvo GmbH Improved Zea mays (L.) genotypes with capability of long term, highly efficient plant regeneration
WO1995006128A2 (en) 1993-08-25 1995-03-02 Dekalb Genetics Corporation Fertile, transgenic maize plants and methods for their production
WO2000008184A1 (en) * 1998-07-31 2000-02-17 Aventis Cropscience Gmbh Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch
WO2001012782A2 (en) * 1999-08-12 2001-02-22 Aventis Cropscience Gmbh Transgenically modified plant cells and plants having modified gbssi- and be-protein activity
WO2001019975A2 (en) * 1999-09-15 2001-03-22 National Starch And Chemical Investment Holding Corporation Plants having reduced activity in two or more starch-modifying enzymes

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2845368A (en) * 1954-05-27 1958-07-29 Staley Mfg Co A E Dextrinization process
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
NL8300698A (en) 1983-02-24 1984-09-17 Univ Leiden METHOD FOR BUILDING FOREIGN DNA INTO THE NAME OF DIABIC LOBAL PLANTS; AGROBACTERIUM TUMEFACIENS BACTERIA AND METHOD FOR PRODUCTION THEREOF; PLANTS AND PLANT CELLS WITH CHANGED GENETIC PROPERTIES; PROCESS FOR PREPARING CHEMICAL AND / OR PHARMACEUTICAL PRODUCTS.
US4962028A (en) 1986-07-09 1990-10-09 Dna Plant Technology Corporation Plant promotors
ATE115999T1 (en) 1987-12-15 1995-01-15 Gene Shears Pty Ltd RIBOZYMES.
US5639952A (en) 1989-01-05 1997-06-17 Mycogen Plant Science, Inc. Dark and light regulated chlorophyll A/B binding protein promoter-regulatory system
WO1991001373A1 (en) 1989-07-19 1991-02-07 Calgene, Inc. Fruit-specific transcriptional factors
SE467358B (en) 1990-12-21 1992-07-06 Amylogene Hb GENETIC CHANGE OF POTATISE BEFORE EDUCATION OF AMYLOPECT TYPE STARCH
DE4104782B4 (en) 1991-02-13 2006-05-11 Bayer Cropscience Gmbh Novel plasmids containing DNA sequences that cause changes in carbohydrate concentration and carbohydrate composition in plants, as well as plants and plant cells containing these plasmids
JPH05199877A (en) 1991-10-03 1993-08-10 Sumitomo Chem Co Ltd Controlling region for induction type plant protecting gene of potato and rice plant, its use and method for assay
ATE196311T1 (en) 1993-12-09 2000-09-15 Univ Jefferson COMPOUNDS AND METHODS FOR SITE-SPECIFIC MUTATION IN EUKARYOTIC CELLS
GB9514435D0 (en) 1995-07-14 1995-09-13 Danisco Inhibition of gene expression
GB9514437D0 (en) 1995-07-14 1995-09-13 Danisco Inhibition of gene expression
DE19628705A1 (en) * 1996-07-08 1998-01-15 Fresenius Ag New oxygen transport agents, hemoglobin-hydroxyethyl starch conjugates containing them, processes for their preparation and their use as blood substitutes
US6483009B1 (en) 1997-02-21 2002-11-19 Danisco A/S Antisense intron inhibition of starch branching enzyme expression
AU738311B2 (en) 1997-02-21 2001-09-13 Dupont Nutrition Biosciences Aps Sense intron inhibition of starch branching enzyme expression
US6479468B1 (en) * 1997-12-09 2002-11-12 Biomedical Frontiers, Inc. Modified polysaccharides exhibiting altered biological recognition
NZ507093A (en) 1998-04-08 2003-08-29 Commw Scient Ind Res Org Methods and means for reducing the phenotypic expression of a nucleic acid of interest in a plant
AUPQ005299A0 (en) 1999-04-29 1999-05-27 Commonwealth Scientific And Industrial Research Organisation Novel genes encoding wheat starch synthases and uses therefor
BRPI0213423A2 (en) * 2001-10-17 2017-05-02 Basf Plant Science Gmbh starch and method for its production
ATE491784T1 (en) * 2003-09-30 2011-01-15 Bayer Cropscience Ag PLANTS WITH REDUCED CLASS 3 BRANCHING ENZYME ACTIVITY
DE102004029763A1 (en) * 2004-06-21 2006-01-05 Bayer Cropscience Gmbh Plants that produce amylopectin starch with new properties

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292435A1 (en) 1987-05-20 1988-11-23 Ciba-Geigy Ag Zea mays plants and transgenic zea mays plants regenerated from protoplasts or protoplast-derived cells
EP0513849A2 (en) 1987-05-20 1992-11-19 Ciba-Geigy Ag Zea mays plants and transgenic Zea mays plants regenerated from protoplasts or protoplast-derived cells
EP0465875A1 (en) 1990-06-23 1992-01-15 Hoechst Schering AgrEvo GmbH Improved Zea mays (L.) genotypes with capability of long term, highly efficient plant regeneration
WO1995006128A2 (en) 1993-08-25 1995-03-02 Dekalb Genetics Corporation Fertile, transgenic maize plants and methods for their production
WO2000008184A1 (en) * 1998-07-31 2000-02-17 Aventis Cropscience Gmbh Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch
WO2001012782A2 (en) * 1999-08-12 2001-02-22 Aventis Cropscience Gmbh Transgenically modified plant cells and plants having modified gbssi- and be-protein activity
WO2001019975A2 (en) * 1999-09-15 2001-03-22 National Starch And Chemical Investment Holding Corporation Plants having reduced activity in two or more starch-modifying enzymes

Non-Patent Citations (48)

* Cited by examiner, † Cited by third party
Title
AARTS ET AL., NATURE, vol. 363, 1993, pages 715 - 717
ALTMANN ET AL., THEORETICAL AND APPLIED GENETICS, vol. 84, 1992, pages 371 - 383
BACHEM ET AL., THE PLANT JOURNAL, vol. 9, no. 5, 1996, pages 745 - 753
BELZILE; YODER, THE PLANT JOURNAL, vol. 2, no. 2, 1992, pages 173 - 179
CASTIGLIONI ET AL., GENETICS, vol. 149, 1998, pages 2039 - 2056
CHAN ET AL., PLANT. MOL. BIOL., vol. 22, 1993, pages 491 - 506
CHO ET AL., NATURE GENETICS, vol. 23, 1999, pages 203 - 207
CONNER; DOMISSE, INT. J. PLANT SCI., vol. 153, 1992, pages 550 - 555
CORN: "Chemistry and Technology", 1987, pages: 479 - 499
DENG ET AL., SCIENCE IN CHINA, vol. 33, 1990, pages 28 - 34
DRENKARD ET AL., PLANT PHYSIOLOGY, vol. 124, 2000, pages 1483 - 1492
DWIVEDI ET AL., JOURNAL OF MEDICINAL AND AROMATIC PLANT SCIENCES, vol. 22, 2000, pages 460 - 463
FREY ET AL., MOLECULAR AND GENERAL GENETICS, vol. 217, 1989, pages 172 - 177
FROMM ET AL., BIOTECHNOLOGY, vol. 8, 1990, pages 833 - 844
GORDON-KAMM ET AL., PLANT CELL, vol. 2, 1990, pages 603 - 618
GRECO ET AL., PLANT PHYSIOLOGY, vol. 125, 2001, pages 1175 - 1177
HANLEY ET AL., THE PLANT JOURNAL, vol. 22, no. 4, 2000, pages 557 - 566
HIEI ET AL., PLANT J., vol. 6, 1994, pages 271 - 282
HIROCHIKA, CURRENT OPINION IN PLANT BIOLOGY, vol. 4, 2001, pages 118 - 122
HIROYUKI ET AL., THE PLANT JOURNAL, vol. 19, no. 5, 1999, pages 605 - 613
HOOGKAMP ET AL., POTATO RESEARCH, vol. 43, 2000, pages 179 - 189
JARVIS ET AL., PLANT MOL. BIOI., vol. 24, 1994, pages 685 - 687
JEON; GYNHEUNG, PLANT SCIENCE, vol. 161, 2001, pages 211 - 219
KONIECZNY; AUSUBEL, THE PLANT JOURNAL, vol. 4, 1993, pages 403 - 400
KOPREK ET AL., THE PLANT JOURNAL, vol. 24, no. 2, 2000, pages 253 - 263
KOZIEL ET AL., BIOTECHNOLOGY, vol. 11, 1993, pages 194 - 200
KRENS ET AL., NATURE, vol. 296, 1982, pages 72 - 74
KUMAR; HIROCHIKA, TRENDS IN PLANT SCIENCE, vol. 6, no. 3, 2001, pages 127 - 134
LEISTER; DEAN, THE PLANT JOURNAL, vol. 4, no. 4, 1993, pages 745 - 750
LIU ET AL., MOLECULAR AND GENERAL GENETICS, vol. 262, 1999, pages 413 - 420
MAES ET AL., TRENDS IN PLANT SCIENCE, vol. 4, no. 3, 1999, pages 90 - 96
MAY ET AL., BIO/TECHNOLOGY, vol. 13, 1995, pages 486 - 492
MCCALLUM ET AL., PLANT PHYSIOLOGY, vol. 123, 2000, pages 439 - 442
MEKSEM ET AL., MOLECULAR GENETICS AND GENOMICS, vol. 265, 2001, pages 207 - 214
MEYER ET AL., MOLECULAR AND GENERAL GENETICS, vol. 259, 1998, pages 150 - 160
MOROC ET AL., THEOR. APPL. GENET., vol. 80, 1990, pages 721 - 726
NAM ET AL., THE PLANT CELL, vol. 1, 1989, pages 699 - 705
NEHRA ET AL., PLANT J., vol. 5, 1994, pages 285 - 297
QI ET AL., NUCLEIC ACIDS RESEARCH, vol. 29, no. 22, 2001, pages E116
RAMACHANDRAN; SUNDARESAN, PLANT PHYSIOLOGY AND BIOCHEMISTRY, vol. 39, 2001, pages 234 - 252
RITALA ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 317 - 325
RITCHIE ET AL., TRANSGENIC RES., vol. 2, 1993, pages 252 - 265
SCHMIDT; WILLMITZER, MOLECULAR AND GENERAL GENETICS, vol. 220, 1989, pages 17 - 24
SPENCER ET AL., THEOR. APPL. GENET., vol. 79, 1990, pages 625 - 631
TISSIER ET AL., THE PLANT CELL, vol. 11, 1999, pages 1841 - 1852
VASIL ET AL., BIO/TECHNOLOGY, vol. 11, 1993, pages 1553 - 1558
WAN; LEMAUX, PLANT PHYSIOL., vol. 104, 1994, pages 37 - 48
WILMINK ET AL., PLANT CELL REPORTS, vol. 11, 1992, pages 76 - 80

Cited By (200)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8927583B2 (en) 2006-12-22 2015-01-06 Bayer Cropscience Ag Pesticidal composition comprising a 2-pyrdilmethylbenzamide derivative and an insecticide compound
US8519003B2 (en) 2007-03-12 2013-08-27 Bayer Cropscience Ag Phenoxyphenylamidines as fungicides
US8748662B2 (en) 2007-03-12 2014-06-10 Bayer Cropscience Ag 4-cycloalkyl or 4-aryl substituted phenoxyphenylamidines and use thereof as fungicides
US8080688B2 (en) 2007-03-12 2011-12-20 Bayer Cropscience Ag 3, 4-disubstituted phenoxyphenylamidines and use thereof as fungicides
US8299302B2 (en) 2007-03-12 2012-10-30 Bayer Cropscience Ag 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides
US8334237B2 (en) 2007-03-12 2012-12-18 Bayer Cropscience Ag Substituted phenylamidines and the use thereof as fungicides
US8785692B2 (en) 2007-03-12 2014-07-22 Bayer Cropscience Ag Substituted phenylamidines and the use thereof as fungicides
US9199922B2 (en) 2007-03-12 2015-12-01 Bayer Intellectual Property Gmbh Dihalophenoxyphenylamidines and use thereof as fungicides
US8394991B2 (en) 2007-03-12 2013-03-12 Bayer Cropscience Ag Phenoxy substituted phenylamidine derivatives and their use as fungicides
US9173394B2 (en) 2007-09-26 2015-11-03 Bayer Intellectual Property Gmbh Active agent combinations having insecticidal and acaricidal properties
DE102007045953B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
US8455480B2 (en) 2007-09-26 2013-06-04 Bayer Cropscience Ag Active agent combinations having insecticidal and acaricidal properties
DE102007045919B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
DE102007045920B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistic drug combinations
EP2072506A1 (en) 2007-12-21 2009-06-24 Bayer CropScience AG Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide
EP2090168A1 (en) 2008-02-12 2009-08-19 Bayer CropScience AG Method for improving plant growth
EP2168434A1 (en) 2008-08-02 2010-03-31 Bayer CropScience AG Use of azols to increase resistance of plants of parts of plants to abiotic stress
EP2374791A1 (en) 2008-08-14 2011-10-12 Bayer CropScience Aktiengesellschaft Insecticidal 4-phenyl-1H pyrazoles
US8796175B2 (en) 2008-08-29 2014-08-05 Bayer Cropscience Ag Method for enhancing plant intrinsic defense
EP2201838A1 (en) 2008-12-05 2010-06-30 Bayer CropScience AG Active ingredient-beneficial organism combinations with insecticide and acaricide properties
EP2198709A1 (en) 2008-12-19 2010-06-23 Bayer CropScience AG Method for treating resistant animal pests
EP2204094A1 (en) 2008-12-29 2010-07-07 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants Introduction
WO2010075994A1 (en) 2008-12-29 2010-07-08 Bayer Cropscience Aktiengesellschaft Treatment of transgenic crops with mixtures of fiproles and chloronicotinyls
US9763451B2 (en) 2008-12-29 2017-09-19 Bayer Intellectual Property Gmbh Method for improved use of the production potential of genetically modified plants
EP2039771A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2039772A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants introduction
EP2039770A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
US8487118B2 (en) 2009-01-19 2013-07-16 Bayer Cropscience Ag Cyclic diones and their use as insecticides, acaricides and/or fungicides
WO2010083955A2 (en) 2009-01-23 2010-07-29 Bayer Cropscience Aktiengesellschaft Use of enaminocarboxylic compounds for fighting viruses transmitted by insects
EP2227951A1 (en) 2009-01-23 2010-09-15 Bayer CropScience AG Application of enaminocarbonyl compounds for combating viruses transmitted by insects
WO2010086311A1 (en) 2009-01-28 2010-08-05 Bayer Cropscience Ag Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives
WO2010086095A1 (en) 2009-01-29 2010-08-05 Bayer Cropscience Ag Method for improved utilization of the production potential of transgenic plants introduction
WO2010094666A2 (en) 2009-02-17 2010-08-26 Bayer Cropscience Ag Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
EP2218717A1 (en) 2009-02-17 2010-08-18 Bayer CropScience AG Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives
WO2010094728A1 (en) 2009-02-19 2010-08-26 Bayer Cropscience Ag Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
EP2223602A1 (en) 2009-02-23 2010-09-01 Bayer CropScience AG Method for improved utilisation of the production potential of genetically modified plants
US8846568B2 (en) 2009-03-25 2014-09-30 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US9012360B2 (en) 2009-03-25 2015-04-21 Bayer Intellectual Property Gmbh Synergistic combinations of active ingredients
EP2232995A1 (en) 2009-03-25 2010-09-29 Bayer CropScience AG Method for improved utilisation of the production potential of transgenic plants
US8828906B2 (en) 2009-03-25 2014-09-09 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US8828907B2 (en) 2009-03-25 2014-09-09 Bayer Cropscience Ag Active ingredient combinations having insecticidal and acaricidal properties
US8846567B2 (en) 2009-03-25 2014-09-30 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
EP2239331A1 (en) 2009-04-07 2010-10-13 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
US8835657B2 (en) 2009-05-06 2014-09-16 Bayer Cropscience Ag Cyclopentanedione compounds and their use as insecticides, acaricides and/or fungicides
EP3000809A1 (en) 2009-05-15 2016-03-30 Bayer Intellectual Property GmbH Fungicide pyrazole carboxamides derivatives
EP2251331A1 (en) 2009-05-15 2010-11-17 Bayer CropScience AG Fungicide pyrazole carboxamides derivatives
EP2255626A1 (en) 2009-05-27 2010-12-01 Bayer CropScience AG Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress
US9232794B2 (en) 2009-06-02 2016-01-12 Bayer Intellectual Property Gmbh Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp
US9877482B2 (en) 2009-06-02 2018-01-30 Bayer Intellectual Property Gmbh Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp
WO2011006603A2 (en) 2009-07-16 2011-01-20 Bayer Cropscience Ag Synergistic active substance combinations containing phenyl triazoles
WO2011015524A2 (en) 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
WO2011035834A1 (en) 2009-09-02 2011-03-31 Bayer Cropscience Ag Active compound combinations
EP2292094A1 (en) 2009-09-02 2011-03-09 Bayer CropScience AG Active compound combinations
WO2011054729A2 (en) 2009-11-04 2011-05-12 Basf Plant Science Company Gmbh Amylopectin type starch with enhanced retrogradation stability
EP2319872A1 (en) 2009-11-04 2011-05-11 BASF Plant Science GmbH Amylopectin type starch with enhanced retrogradation stability
EP2343280A1 (en) 2009-12-10 2011-07-13 Bayer CropScience AG Fungicide quinoline derivatives
WO2011080254A2 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011080255A2 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011080256A1 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
US8722072B2 (en) 2010-01-22 2014-05-13 Bayer Intellectual Property Gmbh Acaricidal and/or insecticidal active ingredient combinations
WO2011089071A2 (en) 2010-01-22 2011-07-28 Bayer Cropscience Ag Acaricide and/or insecticide active substance combinations
WO2011107504A1 (en) 2010-03-04 2011-09-09 Bayer Cropscience Ag Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants
WO2011124554A2 (en) 2010-04-06 2011-10-13 Bayer Cropscience Ag Use of 4-phenylbutyric acid and/or the salts thereof for enhancing the stress tolerance of plants
WO2011124553A2 (en) 2010-04-09 2011-10-13 Bayer Cropscience Ag Use of derivatives of the (1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress
WO2011134913A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011134911A2 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011134912A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011151369A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
WO2011151370A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues
WO2011151368A2 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives
US9593317B2 (en) 2010-06-09 2017-03-14 Bayer Cropscience Nv Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
WO2011154158A1 (en) 2010-06-09 2011-12-15 Bayer Bioscience N.V. Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
WO2011154159A1 (en) 2010-06-09 2011-12-15 Bayer Bioscience N.V. Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
US9574201B2 (en) 2010-06-09 2017-02-21 Bayer Cropscience Nv Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
WO2012010579A2 (en) 2010-07-20 2012-01-26 Bayer Cropscience Ag Benzocycloalkenes as antifungal agents
WO2012028578A1 (en) 2010-09-03 2012-03-08 Bayer Cropscience Ag Substituted fused pyrimidinones and dihydropyrimidinones
WO2012038480A2 (en) 2010-09-22 2012-03-29 Bayer Cropscience Ag Use of biological or chemical control agents for controlling insects and nematodes in resistant crops
WO2012038476A1 (en) 2010-09-22 2012-03-29 Bayer Cropscience Ag Use of active ingredients for controlling nematodes in nematode-resistant crops
WO2012045798A1 (en) 2010-10-07 2012-04-12 Bayer Cropscience Ag Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative
WO2012052489A1 (en) 2010-10-21 2012-04-26 Bayer Cropscience Ag 1-(heterocyclic carbonyl) piperidines
WO2012052490A1 (en) 2010-10-21 2012-04-26 Bayer Cropscience Ag N-benzyl heterocyclic carboxamides
WO2012059497A1 (en) 2010-11-02 2012-05-10 Bayer Cropscience Ag N-hetarylmethyl pyrazolylcarboxamides
WO2012065944A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag N-aryl pyrazole(thio)carboxamides
WO2012065947A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazolecarboxamides
US9206137B2 (en) 2010-11-15 2015-12-08 Bayer Intellectual Property Gmbh N-Aryl pyrazole(thio)carboxamides
WO2012065945A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazole(thio)carboxamides
EP3103338A1 (en) 2010-12-01 2016-12-14 Bayer Intellectual Property GmbH Agent combinations comprising pyridylethyl benzamides and other agents
WO2012072660A1 (en) 2010-12-01 2012-06-07 Bayer Cropscience Ag Use of fluopyram for controlling nematodes in crops and for increasing yield
EP3103340A1 (en) 2010-12-01 2016-12-14 Bayer Intellectual Property GmbH Agent combinations comprising pyridylethyl benzamides and other agents
EP3103334A1 (en) 2010-12-01 2016-12-14 Bayer Intellectual Property GmbH Agent combinations comprising pyridylethyl benzamides and other agents
EP3092900A1 (en) 2010-12-01 2016-11-16 Bayer Intellectual Property GmbH Active ingredient combinations comprising pyridylethylbenzamides and other active ingredients
EP2460406A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Use of fluopyram for controlling nematodes in nematode resistant crops
EP2460407A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Agent combinations comprising pyridylethyl benzamides and other agents
WO2012072696A1 (en) 2010-12-01 2012-06-07 Bayer Cropscience Ag Active ingredient combinations comprising pyridylethylbenzamides and other active ingredients
EP3103339A1 (en) 2010-12-01 2016-12-14 Bayer Intellectual Property GmbH Agent combinations comprising pyridylethyl benzamides and other agents
WO2012089757A1 (en) 2010-12-29 2012-07-05 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
EP2474542A1 (en) 2010-12-29 2012-07-11 Bayer CropScience AG Fungicide hydroximoyl-tetrazole derivatives
WO2012089721A1 (en) 2010-12-30 2012-07-05 Bayer Cropscience Ag Use of substituted spirocyclic sulfonamidocarboxylic acids, carboxylic esters thereof, carboxamides thereof and carbonitriles thereof or salts thereof for enhancement of stress tolerance in plants
WO2012089722A2 (en) 2010-12-30 2012-07-05 Bayer Cropscience Ag Use of open-chain carboxylic acids, carbonic esters, carboxamides and carbonitriles of aryl, heteroaryl and benzylsulfonamide or the salts thereof for improving the stress tolerance in plants
EP2494867A1 (en) 2011-03-01 2012-09-05 Bayer CropScience AG Halogen-substituted compounds in combination with fungicides
WO2012120105A1 (en) 2011-03-10 2012-09-13 Bayer Cropscience Ag Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds
WO2012123434A1 (en) 2011-03-14 2012-09-20 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2012136581A1 (en) 2011-04-08 2012-10-11 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2012139891A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants
EP2511255A1 (en) 2011-04-15 2012-10-17 Bayer CropScience AG Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives
WO2012139890A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted 5-(cyclohex-2-en-1-yl)-penta-2,4-dienes and 5-(cyclohex-2-en-1-yl)-pent-2-en-4-ines as active agents against abiotic stress in plants
WO2012139892A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted 5-(bicyclo[4.1.0]hept-3-en-2-yl)-penta-2,4-dienes and 5-(bicyclo[4.1.0]hept-3-en-2-yl)-pent-2-ene-4-ines as active agents against abiotic stress in plants
EP2997825A1 (en) 2011-04-22 2016-03-23 Bayer Intellectual Property GmbH Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
WO2012168124A1 (en) 2011-06-06 2012-12-13 Bayer Cropscience Nv Methods and means to modify a plant genome at a preselected site
WO2013004652A1 (en) 2011-07-04 2013-01-10 Bayer Intellectual Property Gmbh Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants
WO2013020985A1 (en) 2011-08-10 2013-02-14 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
US9265252B2 (en) 2011-08-10 2016-02-23 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
WO2013026740A2 (en) 2011-08-22 2013-02-28 Bayer Cropscience Nv Methods and means to modify a plant genome
WO2013026836A1 (en) 2011-08-22 2013-02-28 Bayer Intellectual Property Gmbh Fungicide hydroximoyl-tetrazole derivatives
US10538774B2 (en) 2011-08-22 2020-01-21 Basf Agricultural Solutions Seed, Us Llc Methods and means to modify a plant genome
US9670496B2 (en) 2011-08-22 2017-06-06 Bayer Cropscience N.V. Methods and means to modify a plant genome
EP2561759A1 (en) 2011-08-26 2013-02-27 Bayer Cropscience AG Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
WO2013034621A1 (en) 2011-09-09 2013-03-14 Bayer Intellectual Property Gmbh Acyl-homoserine lactone derivatives for improving plant yield
WO2013037717A1 (en) 2011-09-12 2013-03-21 Bayer Intellectual Property Gmbh Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4h)-one derivatives
WO2013037958A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of phenylpyrazolin-3-carboxylates for improving plant yield
WO2013037956A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of 5-phenyl- or 5-benzyl-2 isoxazoline-3 carboxylates for improving plant yield
WO2013037955A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of acylsulfonamides for improving plant yield
WO2013041602A1 (en) 2011-09-23 2013-03-28 Bayer Intellectual Property Gmbh Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress
WO2013050410A1 (en) 2011-10-04 2013-04-11 Bayer Intellectual Property Gmbh RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE
WO2013050324A1 (en) 2011-10-06 2013-04-11 Bayer Intellectual Property Gmbh Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress
WO2013075817A1 (en) 2011-11-21 2013-05-30 Bayer Intellectual Property Gmbh Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives
WO2013079566A2 (en) 2011-11-30 2013-06-06 Bayer Intellectual Property Gmbh Fungicidal n-bicycloalkyl and n-tricycloalkyl (thio)carboxamide derivatives
WO2013092519A1 (en) 2011-12-19 2013-06-27 Bayer Cropscience Ag Use of anthranilic acid diamide derivatives for pest control in transgenic crops
WO2013098147A1 (en) 2011-12-29 2013-07-04 Bayer Intellectual Property Gmbh Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
WO2013098146A1 (en) 2011-12-29 2013-07-04 Bayer Intellectual Property Gmbh Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
WO2013124275A1 (en) 2012-02-22 2013-08-29 Bayer Cropscience Ag Use of succinate dehydrogenase inhibitors (sdhis) for controlling wood diseases in grape.
WO2013127704A1 (en) 2012-02-27 2013-09-06 Bayer Intellectual Property Gmbh Active compound combinations containing a thiazoylisoxazoline and a fungicide
WO2013139949A1 (en) 2012-03-23 2013-09-26 Bayer Intellectual Property Gmbh Compositions comprising a strigolactame compound for enhanced plant growth and yield
WO2013153143A1 (en) 2012-04-12 2013-10-17 Bayer Cropscience Ag N-acyl- 2 - (cyclo) alkylpyrrolidines and piperidines useful as fungicides
WO2013156559A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
WO2013156560A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives
WO2013160230A1 (en) 2012-04-23 2013-10-31 Bayer Cropscience Nv Targeted genome engineering in plants
US11518997B2 (en) 2012-04-23 2022-12-06 BASF Agricultural Solutions Seed US LLC Targeted genome engineering in plants
EP2662361A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazol indanyl carboxamides
EP2662364A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole tetrahydronaphthyl carboxamides
EP2662362A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole indanyl carboxamides
EP2662360A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole indanyl carboxamides
WO2013167545A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag Pyrazole indanyl carboxamides
WO2013167544A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag 5-halogenopyrazole indanyl carboxamides
EP2662363A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole biphenylcarboxamides
EP2662370A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole benzofuranyl carboxamides
WO2013174836A1 (en) 2012-05-22 2013-11-28 Bayer Cropscience Ag Active compounds combinations comprising a lipo-chitooligosaccharide derivative and a nematicide, insecticidal or fungicidal compound
WO2014009322A1 (en) 2012-07-11 2014-01-16 Bayer Cropscience Ag Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress
WO2014037340A1 (en) 2012-09-05 2014-03-13 Bayer Cropscience Ag Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
WO2014060520A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives
WO2014060518A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method of plant growth promotion using carboxamide derivatives
WO2014060519A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives
WO2014060502A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Active compound combinations comprising carboxamide derivatives
WO2014079957A1 (en) 2012-11-23 2014-05-30 Bayer Cropscience Ag Selective inhibition of ethylene signal transduction
WO2014079789A1 (en) 2012-11-23 2014-05-30 Bayer Cropscience Ag Active compound combinations
EP2735231A1 (en) 2012-11-23 2014-05-28 Bayer CropScience AG Active compound combinations
WO2014083088A2 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Binary fungicidal mixtures
WO2014083033A1 (en) 2012-11-30 2014-06-05 Bayer Cropsience Ag Binary fungicidal or pesticidal mixture
WO2014083089A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Ternary fungicidal and pesticidal mixtures
WO2014083031A2 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Binary pesticidal and fungicidal mixtures
WO2014082950A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Ternary fungicidal mixtures
EP2740356A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives
EP2740720A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants
WO2014086751A1 (en) 2012-12-05 2014-06-12 Bayer Cropscience Ag Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress
WO2014090765A1 (en) 2012-12-12 2014-06-19 Bayer Cropscience Ag Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops
WO2014095826A1 (en) 2012-12-18 2014-06-26 Bayer Cropscience Ag Binary fungicidal and bactericidal combinations
WO2014095677A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic- tetrahydronaphtyl carboxamides
WO2014135608A1 (en) 2013-03-07 2014-09-12 Bayer Cropscience Ag Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives
WO2014161821A1 (en) 2013-04-02 2014-10-09 Bayer Cropscience Nv Targeted genome engineering in eukaryotes
WO2014167008A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazolinthione derivatives
WO2014167009A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazole derivatives
WO2014170345A2 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Method for improved utilization of the production potential of transgenic plants
WO2014170364A1 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Binary insecticidal or pesticidal mixture
WO2014177582A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag N-(2-fluoro-2-phenethyl)carboxamides as nematicides and endoparasiticides
WO2014177514A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag Nematicidal n-substituted phenethylcarboxamides
WO2014206953A1 (en) 2013-06-26 2014-12-31 Bayer Cropscience Ag N-cycloalkyl-n-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives
WO2015004040A1 (en) 2013-07-09 2015-01-15 Bayer Cropscience Ag Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
WO2015082586A1 (en) 2013-12-05 2015-06-11 Bayer Cropscience Ag N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
WO2015082587A1 (en) 2013-12-05 2015-06-11 Bayer Cropscience Ag N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
WO2016012362A1 (en) 2014-07-22 2016-01-28 Bayer Cropscience Aktiengesellschaft Substituted cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes as active substances against abiotic plant stress
WO2016096942A1 (en) 2014-12-18 2016-06-23 Bayer Cropscience Aktiengesellschaft Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
WO2016166077A1 (en) 2015-04-13 2016-10-20 Bayer Cropscience Aktiengesellschaft N-cycloalkyl-n-(biheterocyclyethylene)-(thio)carboxamide derivatives
US11180751B2 (en) 2015-06-18 2021-11-23 The Broad Institute, Inc. CRISPR enzymes and systems
CN109312358A (en) * 2016-05-03 2019-02-05 莱克拜斯塔奇公司 Amylopectin-potato starch with improved anti-retrogradation stability and improved freeze-thaw stability
US11905343B2 (en) 2016-05-03 2024-02-20 Sveriges Starkelseproducenter, Forening U.P.A. Amylopectin potato starch with improved stability against retrogradation and improved freeze and thaw stability
EP3452602A4 (en) * 2016-05-03 2020-03-25 Sveriges Stärkelseproducenter, förening u.p.a. Amylopectin potato starch with improved stability against retrogradation and improved freeze and thaw stability
WO2018019676A1 (en) 2016-07-29 2018-02-01 Bayer Cropscience Aktiengesellschaft Active compound combinations and methods to protect the propagation material of plants
WO2018054832A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives
WO2018054829A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives and their use as fungicides
WO2018054911A1 (en) 2016-09-23 2018-03-29 Bayer Cropscience Nv Targeted genome optimization in plants
WO2018077711A2 (en) 2016-10-26 2018-05-03 Bayer Cropscience Aktiengesellschaft Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications
WO2018104392A1 (en) 2016-12-08 2018-06-14 Bayer Cropscience Aktiengesellschaft Use of insecticides for controlling wireworms
WO2018108627A1 (en) 2016-12-12 2018-06-21 Bayer Cropscience Aktiengesellschaft Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants
EP3332645A1 (en) 2016-12-12 2018-06-13 Bayer Cropscience AG Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress
US11591601B2 (en) 2017-05-05 2023-02-28 The Broad Institute, Inc. Methods for identification and modification of lncRNA associated with target genotypes and phenotypes
WO2019025153A1 (en) 2017-07-31 2019-02-07 Bayer Cropscience Aktiengesellschaft Use of substituted n-sulfonyl-n'-aryl diaminoalkanes and n-sulfonyl-n'-heteroaryl diaminoalkanes or salts thereof for increasing the stress tolerance in plants
WO2019060746A1 (en) 2017-09-21 2019-03-28 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
US10968257B2 (en) 2018-04-03 2021-04-06 The Broad Institute, Inc. Target recognition motifs and uses thereof
WO2019233863A1 (en) 2018-06-04 2019-12-12 Bayer Aktiengesellschaft Herbicidally active bicyclic benzoylpyrazoles
WO2020131862A1 (en) 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof

Also Published As

Publication number Publication date
EP1869089A1 (en) 2007-12-26
AU2006228670B2 (en) 2012-05-17
CA2600989A1 (en) 2006-10-05
CA2600989C (en) 2014-02-04
AU2006228670A1 (en) 2006-10-05
US8148517B2 (en) 2012-04-03
EP1707632A1 (en) 2006-10-04
EP1869089B1 (en) 2014-12-10
US20090105469A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
AU2006228670B2 (en) Phosphorylated waxy potato starch
US8067670B2 (en) Plants that produce amylopectin starch with novel properties
CA2603919C (en) High-phosphate starch
CA2505776C (en) Plant cells and plants which synthesize a starch with an increased final viscosity
AU782182B2 (en) Transgenically modified plant cells and plants having modified GBSSI- and BE-protein activity
US7626080B2 (en) Plants with reduced activity of a class 3 branching enzyme
AU772364B2 (en) Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch
WO2002101059A2 (en) Transgenic plants synthesising high amylose starch
AU2002316971C1 (en) Transgenic plants synthesising high amylose starch
AU2002316971A1 (en) Transgenic plants synthesising high amylose starch

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006723985

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2600989

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2006228670

Country of ref document: AU

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2006228670

Country of ref document: AU

Date of ref document: 20060330

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006228670

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2006723985

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11909926

Country of ref document: US